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Sulfur-containing compounds, such as glutathione (GSH), cysteamine (CSH), homocysteine 
(Hcy), cysteine (Cys) and their disulfides, are critical for maintaining various cellular functions. 
Concentration profiles of these compounds in biological samples are useful for evaluating 
cellular physiological status and diagnosing diseases. Traditional quantitative methods involve 
tedious sample pretreatment and are not suited to dealing with submicroliter samples. We have 
developed a microfluidic system for online analysis of thiol-containing compounds in the 
extracellular space of rat organotypic hippocampal slices cultures (OHSCs). This system is also 
capable of monitoring ectoenzymatic activity involved in the metabolism of thiols/disulfides.  
A microfluidic chip capable of derivatization, multiple injection, separation, and 
quantitation was designed and coupled to a homemade confocal laser induced fluorescence 
detector with a multifunctional control program. The microfluidic system was evaluated in an 
on-chip kinetic study of the reduction of oxidized glutathione (GSSG) catalyzed by glutathione 
reductase (GR, EC 1.8.1.7) followed by derivatization of GSH with ThioGlo-1. The separation of 
analytes was successfully achieved within 4.5 s and 9 mm separation length. The linear range of 
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 v 
the system is up to 50 µM (GSH). The mass and concentration detection limits are 10
-18
 mol and 
4.2 nM, respectively. Based on GSH growth rates, the apparent Michaelis constants of GR were 
determined to be 40 ± 11 μM (GSSG) and 4.4 ± 0.6 μM (β-NADPH). Electroosmotic sampling 
of the extracellular fluid of OHSCs was further coupled to a microfluidic device for in situ 
quantitation of endogenous aminothiols in OHSCs, by which CSH (10.6 ± 1.0 nM), Hcy (0.18 ± 
0.01 μM) and Cys (11.1 ± 1.2 μM) were separated and evaluated simultaneously. Using this 
method, we also observed the complete biodegradation of coenzyme A (CoA) in the extracellular 
space of OHSCs and determined the kinetic parameters of this sequential multi-enzyme reaction 
in in situ. Metabolism of cystamine (CSSC) and pantethine (PSSP) in OHSCs have also been 
investigated and the percentage yields of CSH from CSSC and PSSP after ~55 s exposure time to 
OHSCs were 91% ± 4% and 0.01% - 0.03%, respectively, which explains the differences of the 
drugs in clinical effectiveness and toxicity. 
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 1 
1.0  INTRODUCTION 
A portion of this work is adapted from the master’s thesis “Online determination of extracellular 
glutathione in organotypic hippocampal slice cultures with a microfluidic device and confocal 
laser-induced fluorescence detection system”, Juanfang Wu (2010) 
Sulfur-containing compounds, such as glutathione (GSH), cysteamine (CSH), homocysteine 
(Hcy) and cysteine (Cys), are critical for maintaining various cellular functions.
1
 Each of these 
molecules contributes to the cellular pool of organic sulfur and sulfur homeostasis.
2
 Changes in 
the plasma or urine concentration of these compounds and their oxidized disulfide forms are 
indications of diseases or cellular dysfunction.
1
 Current methods for determination of these 
aminothiols from a variety of biological samples are reviewed in the following section. The 
integration of sampling, sample transport, and microfluidic analysis will increase automation, 
improve sample integrity, reduce sample dilution, and reduce cost in time and reagents in the 
determination of aminothiols. More importantly, such integration makes possible online 
monitoring of target analytes and reactions with minimal delay and excellent time resolution, 
which is a necessary step towards the ultimate goal of understanding dynamic changes in living 
systems.  
 
 2 
1.1 FUNCTIONS AND METABOLISM OF AMINOTHIOLS  
1.1.1 Biological functions of GSH/GSSG  
Adult human brain cells use ~20% of the oxygen needed by the body, which generates reactive 
oxygen species (ROS) at a high rate through oxidative metabolism.
3
 Compared with other organs, 
brain is especially vulnerable to ROS because it is rich in lipids with unsaturated fatty acids.
4
 
Maintaining brain functions relies on an effective antioxidant system.
4
 GSH (-GluCysGly) is a 
well-known antioxidant.
5-7
 GSH and its oxidized form, GSSG, are the most abundant 
intracellular low molecular weight thiol/disulfide couple.
8, 9
 The cytosolic GSH concentration in 
astrocyte cultures is up to 8 mM,
10, 11
 which is higher than the GSH concentration in neurons 
(0.1-4 mM).
12, 13
 In contrast, the intracellular GSSG concentration is less than 1% of that of 
GSH.
14, 15
 Generally, the physiological redox potential (Eh) for GSH/GSSG couple ranges from -
260 mV to -150 mV in cells depending on different cellular status, such as proliferation, 
differentiation and apoptosis.
16
 The redox potential of GSH is usually used as an in vivo indicator 
of oxidative stress.
16
 GSH can react with ROS directly or with the help of enzymes.
3
 It works 
together with other antioxidants, such as ascorbate and α-tocopherol to form a firm cellular 
defense system against reactive oxygen species (ROS) in brain.
5, 9, 17-19
 GSH also plays a key role 
in the detoxification of cellular xenobiotics.
4, 20
 GSH is a cofactor in isomerization reactions and 
a safe form for storing and transporting Cys.
10, 20, 21
 In addition, GSH is essential for regulating 
cell proliferation,
22-24
 apoptosis
23, 25-27
 and maintenance of the thiol redox potential  in cells.
22, 28
  
Although the extracellular concentration of GSH in brain is in the low micromolar range, 
which is much lower than that in the intracellular space,
29, 30
 this portion of GSH also has many 
functions in brain.
10 
 Extracellular GSH released by astrocytes is the precursor of neural GSH 
 3 
synthesis.
3, 10, 31
 GSH also acts as a detoxifying agent for toxic compounds such as glutamate by 
forming γ-glutamyl glutamate.32-34 In addition, GSH and γ-glutamyl peptides act as agonists and 
modulators of glutamate receptors (NMDA and AMPA) in brain.
35-38
 GSH is also involved in the 
metabolism of leukotrienes which have neuroendocrine and excitatory functions in brain.
10
 GSH 
released to extracellular space is also found to contribute to the GSH concentration in the 
cerebrospinal fluid.
39
 The extracellular concentration of GSH is found to be elevated upon the 
onset of cerebral ischemia, which is effective in scavenging the ROS formed in the insulted brain 
tissue. 
30, 40, 41
   
GSH has many biological functions and disturbing GSH metabolism and redox 
homeostasis can lead to a number of diseases.
10, 31, 42-44
 Monitoring the distributions and 
concentrations of GSH and related metabolites can provide valuable information regarding 
oxidative stresses and responses of biological samples. It will also facilitate the analysis of the 
enzyme activities and cellular interactions involved in GSH metabolism. 
 
 
1.1.2 Metabolism of GSH/GSSG  
The synthesis of GSH in brain cells the same way as in other tissues.
31
 The synthesis of GSH in 
the cytoplasm begins with the formation of the dipeptide γ-glutamylcysteine (γGluCys) catalyzed 
by glutamate cysteine ligase (EC 6.3.2.2). This dipeptide reacts with glycine to generate GSH 
catalyzed by GSH synthase (EC 6.3.2.3) as shown in Fig. 1.
10, 14, 21
 Both steps are adenosine 
triphosphate (ATP)-consuming steps. Feedback inhibition of γGluCys ligase by GSH controls 
the product’s steady state concentration.45 
 
 4 
 
 
Figure 1. Metabolism of GSH in cell
10, 31
 
X represent acceptors of the γ-glutamyl moiety transferred by γ-glutamyl transpeptidase from glutathione. Y is a 
substrate of glutathione-S-transferase. 1-7 represent different enzymes involved in this metabolism cycle. 1. 
glutamate cysteine ligase; 2.glutathione synthase; 3. glutathione peroxidase; 4. glutathione reductase; 5. glutathione-
S-transferase; 6. multidrug resistance proteins;7. γ-glutamyl transpeptidase. 
 
Astrocytes and neurons use different precursors to synthesize GSH in the cytosol.
3, 46-48
 
Astrocytes prefer to use extracellular glutamate and cystine, the disulfide from the oxidation of 
Cys, as GSH precursors.
49
 However, neurons can only use extracellular Cys as precursor.
50
 and 
the best extracellular glutamate source for neurons is glutamine.
51
 Astrocytes can be a source of 
GSH for neurons as shown in Fig. 2.
10, 31
 GSH released from astrocytes will be first metabolized 
to CysGly by the ectoenzyme, γ-glutamyl transpeptidase (γGT, EC. 2.3.2.2).31 CysGly cannot be 
taken up by neurons directly; instead it must be hydrolyzed by aminopeptidase N (ApN, EC 
3.4.11.2) to Cys, which can be used for neuronal GSH synthesis.
31, 52
 As the concentration of Cys 
in the extracellular space is maintained at low concentration due to its toxicity, GSH synthesis in 
neurons strongly depends on the Cys provided by the neighboring astrocytes.
10, 31
 Neurons also 
1
GluCys
2
Glu Precursors
Cys Precursors
Gly Precursors
Cys GSH
Glu
Gly GSSG
3
4
5
GS-YY
GSSG
GSH
GS-Y
6
6
6
7
7
CysGly
X
GluX
Y-CysGly
X
GluX
 5 
rely on the glutamine exported by astrocytes as a source of glutamate in neuronal GSH 
synthesis.
31
 Astrocytes play a key role in the defense of neurons against ROS by supplying the 
precursors for neuronal GSH synthesis.
3, 19, 53
 
  
 
Figure 2. Metabolic interactions between astrocytes and neurons in GSH metabolism
10, 31
 
A represents amino acid to be metabolized by astrocytes to produce glutamate. X represents an acceptor of the γ-
glutamyl moiety transferred by γGT from GSH. 
 
GSH is involved in several metabolic pathways.
3
 In the detoxification of ROS, GSH 
reacts directly with radicals or forms glutathione disulfide (GSSG) with peroxides under the 
catalysis of glutathione peroxidase (GPx, EC. 1.11.1.9) as shown in Fig. 3.
3, 31
 GSSG can be 
converted back into GSH intracellularly at the presence of NADPH by glutathione reductase (GR, 
EC 1.8.1.7),
3
 or exported out of the cells.
31
 GSH can also be conjugated with a variety of 
electrophilic xenobiotics to form less toxic and more hydrophilic GSH-S-conjugates by 
glutathione S-transferases (GSTs, EC 2.5.1.18).
54
 These products can then be excreted from 
cells,
54-56
 and become the substrates of γGT to form CysGly conjugates.10 Finally, intracellular 
 6 
GSH can be directly released to the extracellular space,
19, 33, 34, 57-60
 although the release of GSH 
from brain cells has been reported mainly for astrocytes.
31, 58
 Under unstressed conditions, 
astrocytes release GSH but not GSSG.
58, 61, 62 
On the contrary, during oxidative stress, an 
effective release of GSSG has been reported as a mechanism of cellular self-defense.
15, 63
 
Neurons, microgial cells and oligodendrocytes only excrete a marginal amount of GSH.
61
 The 
transporters that are in charge of the export of GSH, GSSG and GSH S-conjugates to the 
extracellular space are members of the family of multidrug resistance proteins (MRPs for human 
transporters; Mrps for the transporters of other species).
31, 64
  
 
Figure 3.GSH pathways in the detoxification of ROS3 
GSH reacts with radical (R•) directly and GSH reacts with peroxides (ROOH) catalyzed by GPx. The regeneration 
of GSH is achieved by glutathione reductase (GR) and cofactor NADPH. 
1.1.3 Biological functions of CoA and Cys/cystine 
Coenzyme A (CoA) is an essential cofactor for about 4% of all known enzymes.
65, 66
 In the 
intracellular space of animal tissues, CoA is distributed mainly in cytosol, mitochondria and 
peroxisomes with estimated concentrations of 0.02-0.14 mM, 2.2-5 mM and 0.7 mM, 
respectively.
65
 CoA is an ideal acyl carrier and carbonyl-activating group due to its reactive thiol 
group in cells.
65, 67
 CoA is a cofactor of oxidative metabolism of carbon substrates and the 
synthesis of many cellular structural components.
68
 The last product of CoA biodegradation, 
 7 
CSH, exists in a relatively low concentration in the tissue.
69
 It has been recognized as a vital 
source of taurine, the second most abundant amino acid in mammalian tissues.
70
 It also plays an 
active role as a potent radio-protective agent against DNA-induced radiation damage, and a 
neuroprotective agent against neurodegenerative diseases.
71
 The endogenous concentration of 
free CSH in brain tissue homogenates is usually below the detection limits of the most sensitive 
detection methods (<10 nmol/L).
69, 72-74
 Development of analytical methods to measure the 
concentration of CSH in biological samples and its production rate through CoA biodegradation 
are vital for understanding its metabolic fate. This data is also critical for evaluating the kinetic 
parameters of the sequential multi-enzyme reactions involved in CoA catabolism. 
Due to the efficient reduction of cystine to Cys by GSH in the intracellular space, cystine 
is maintained at very low concentration in normal cells.
75
 Accumulation of abnormal high 
amount of cystine in lysosomes will result in cystinosis, a lysosomal storage disorder.
76
 The 
intracellular Cys concentration is relatively higher than that of cystine and usually on the order of 
0.1 mM.
77
 High concentration of Cys in the tissue is neurotoxic and cytotoxic. Cys at 1 mM 
concentration is the lethal threshold via NMDA receptors.
78
 Cys is the rate-limiting precursor in 
intracellular GSH biosynthesis.
50, 79
 It is also indispensable in the synthesis of protein, CoA, 
taurine and inorganic sulfur.
1
 Due to the ability to form inter-chain or intra-chain disulfide bond 
with other cysteine residues, Cys is critical in controlling the tertiary structure of proteins.
80
 To 
fulfill the essential functions of Cys in the synthesis of the metabolites mentioned above at a 
relatively low concentration, GSH is used effectively as the major redox buffer for cellular Cys.
1
 
In the extracellular space, however, Cys and its oxidized form cystine is the predominant low 
molecular weight thiol/disulfide pool found in human plasma with a 20 to 50-fold higher 
concentration than that of GSH/GSSG.
81, 82
 The plasma concentration of Cys is normally at 10 to 
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25 µM, which is much lower than that of the cystine (50-150 µM).
83
 This ratio of Cys/cystine 
concentration is quite different from that of GSH/GSSG in the plasma. It has been reported that 
the acid soluble fraction of total cysteine composed of 5.9% Cys and 83.1% cystine in rat plasma 
compared to 28% GSH and 9.5% GSSG.
84
 The physiological redox potential, Eh, of Cys/cystine 
couple is around -80 mV in normal human plasma, which is more oxidized compared to -137 
mV for GSH/GSSG.
8, 84, 85
 Like Cys, tissue concentration of Hcy exists at low concentration in 
tissue, as excessive Hcy is toxic to cells.
1, 86
 In the extracellular space, Hcy is readily oxidized 
and exists at low concentrations.
1
 Only trace amounts (0.05-0.3 µM) of free Hcy (1-2% of total 
homocysteine) exist in its reduced form in plasma.
87
 Hcy works effectively as an essential 
intermediate metabolite, which connects the methionine (Met) and Cys metabolic cycles.
1, 88
  
Changes in the concentrations of Cys and Hcy or their oxidized forms in biological 
systems usually indicate dysfunctions of related metabolic cycles or problems with cellular 
processes.
23
 For example, the Hcy concentration in plasma/serum is considered to be a biomarker 
of clinical disorders, such as Alzheimer’s disease and cardiovascular disease, while the 
concentrations of Cys and its oxidized form are indicators of oxidative damage.
1
 Therefore, 
measuring the concentration profiles and metabolism of these compounds in biological samples 
would provide useful information in evaluation of biological conditions and disease diagnosis.  
 
1.1.4 Metabolism of CoA and Cys/cystine 
Cys, as well as pantothenic acid and ATP, are well known as the three basic substrates for the 
biosynthesis of CoA.
1
 Starting from these substrates, CoA can be biosynthesized in the cytosol 
through five well-established steps with the aid of multiple enzymes as shown in Fig. 5.
65, 68, 89
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However, relatively little is known about CoA degradation and even less is known about the 
regulation and kinetic characteristics for this sequential multi-enzyme reactions and its turnover 
rate.
1, 65, 68, 88
 The degradation of pantetheine (PSH) to pantothenic acid and CSH is identified as 
the last step in the CoA degradation pathway.
65, 68, 88
 This process is catalyzed by Vanins, which 
comprise a group of membrane-associated extracellular pantetheinases (EC 3.5.1.92).
65
 CSH will 
be further oxidized to hypotaurine and finally taurine under the catalysis of CSH dioxygenase.
88
  
 
Figure 4.Biosynthesis and biodegradation of CoA88 
As a semi-essential amino acid of human, Cys can either be obtained from dietary intake 
or biosynthesized from methionine (Met) and serine (Ser) in the cytosol through a 
transsulfuration pathway with Hcy, a non-protein-forming sulfur amino acid, as one of the key 
intermediates.
1, 90
 Hcy may also be converted back to Met through remethylation catalyzed by 
cystathionine β-synthase (EC 4.2.1.22) or be released to the extracellular space.86, 91 Cys 
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participates actively as a precursor for biosynthesis of proteins and several other essential 
molecules including GSH, CoA, taurine, inorganic sulfur and cystine as shown in Fig. 4.
1, 88
 For 
clarity purposes, multistep pathways are represented by bold arrows. Cys can be oxidized by 
cysteine dioxygenase (CDO) (EC 1.13.11.20) to form cysteinesulfinate in the cytosol, which will 
then be metabolized into taurine and CO2 or into pyruvate and sulfate.
88
 Besides, Cys can also be 
converted to pyruvate and sulfide through β-mecaptopyruvate.1 In the oxygenated extracellular 
space, Cys is readily auto-oxidized to cystine.
83, 92
 Cystine can be transported into the 
intracellular spac5e again for the biosynthesis of GSH or desulfurized through β-cleavage by 
cystathionine γ-lyase to form pyruvate, ammonia and thiocysteine; the last product can be 
converted back to Cys by releasing the sulfide.
1
 These final products from Cys metabolism are 
much less toxic than Cys itself.
88
 
 
Figure 5.Cys metabolic pathway1, 88 
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1.2 CURRENT METHODS FOR DETERMINATION OF AMINOTHIOLS 
1.2.1 Sample collection and pretreatment  
The most common bio-specimens used in the thiol assay are extracellular fluid, cells, tissue, and 
even a partial of a specific organ in in vivo.
93
 To study the thiols in the intracellular fluid, cells 
must first be separated from their matrix by centrifugation and then lysed. The lysate could then 
be stored at -80 ºC for further analysis.
94
 For single cell analysis, the lysis step can be achieved 
right before or after cells are introduced into the analysis system.
95-97
  Procedures for preparing 
plasma from a blood sample is similar to those described for erythrocytes, except that the plasma 
portion is collected and stored for further use.
98, 99
 When the matrix is tissue, there are usually 
several choices for sample collection. If the total GSH in the tissue is of interest, the sample 
could first be homogenized and diluted in EDTA buffer. The resultant solution is then sonicated 
for a short time depending on the kind of tissue. The mixture is further treated with 
centrifugation and the supernatant is eligible for storage and analysis.
100
 The incubation medium 
is also an informative source for monitoring the efflux of GSH from slice cultures to the 
extracellular space. The incubation medium of the slice can be collected at certain intervals and 
the concentration of analytes can be determined after separation and detection.
34, 101
 
Microdialysis is a good choice for sampling extracellular GSH in vivo with relatively good 
spatial resolution and small damage to tissue.
102
 The membrane region of a probe is usually made 
of semipermeable membrane materials with a specific molecular weight cutoff. This tiny probe 
could be inserted into a specific region of a tissue or experimental animal for analysis. During 
the operation, perfusion fluid with a calibrator is pumped through the probe at a low and constant 
flow rate, usually between 0.1 and 5.0 µL/minute. The molecules below the cutoff weight of the 
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membrane may undergo exchange in both directions across the membrane based on the 
concentration gradient. The dialysate containing analyte and calibrator will then be collected for 
assay.
102
 This method has been widely used for in vivo analysis of extracellular GSH in rat 
brains.
29, 30, 103, 104
  Our lab has developed an electroosmotic sampling method, which uses 
electroosmotic flow (EOF) as the driving force for collecting interstitial fluid in organotypic 
hippocampal slice cultures (OHSCs).
105, 106
 Compared to microdialysis, this method does not 
require extra pumps, allows high recovery of the analytes, and has better spatial and time 
resolution.   
For offline analysis, it is often the case that samples containing thiols will be stored for 
hours, days or months before the measurement. Special precautions must be taken to prevent 
artificial errors introduced by improper sample pretreatment procedure. Oxidation and 
proteolysis are two major factors that lead to transformation of one form of thiol to another.
93
 For 
example, at pH values greater than 7, GSH undergoes auto-oxidization to form GSSG. 
Meanwhile, γGT coexisting in the samples with thiols will reach its optimum activity at neutral 
pH, which catalyzes the first step of GSH proteolysis.
93
 Thus, it is necessary to keep the pH 
value of the buffer below neutral and store samples in refrigeration to minimize autoxidation and 
proteolysis of the thiols. It is also helpful to precipitate the proteins from the sample by 
acidification and centrifugation, addition of organic solvent modifier or ultrafiltration to 
minimize proteolysis, which will also improve the separation efficiency in high-performance 
liquid chromatography (HPLC) and capillary electrophoresis (CE).
93, 107
 Moreover, it has also 
been suggested to add redox quenching buffers composed of HCl, ascorbic acid and 
diethylenetriaminepentaacetic acid into the system to restrain thiol oxidation.
108
 Chromophore or 
fluorescence tags are often used to block thiol groups and prevent oxidation.
98
 Inhibitors of γGT 
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and chelating agents of ferrous ions like 1,10-phenanthroline or EDTA have also been used to 
prevent oxidation and proteolysis to a certain extent.
109
 For online analysis achieved under 
normal conditions (room temperature, physiological buffer), samples are collected and 
derivatized right before the separation and measurement. The errors caused by autoxidation are 
greatly reduced as these reactions take place on the time scale of hours.
110-113
     
 
1.2.2 Separation based methods 
So far, many analytical methods have been applied to analyze thiol containing compounds from 
different biological sources or matrixes. These methods have been summarized in several 
informative review articles.
93, 114
 The dominant methods can be classified into two categories, 
separative and non-separative.
85
 Among all the separative methods, HPLC and CE are the most 
common techniques widely used in various applications.
110
 Other methods such as thin layer 
chromatography (TLC), gas chromatography (GC) and the newly developed microfluidic 
technique have also appeared in some works.
93, 107, 115
 Common detection techniques applied in 
separative methods include the UV-Vis absorbance, the electrochemical detection (ECD), the 
mass spectrometry (MS) and the fluorescence (FL).
93, 107
 Because thiol compounds usually lack 
of strong chromophores or fluorophores, it is normally required to label them with chromophoric 
or fluorescent tags to enhance the detection limit in optical detection.
93
 Due to its specificity, 
reactivity and selectivity, the thiol group is a more popular target of derivatization than the 
carboxylic and amino groups. Derivatization of the thiol group also protects it from being 
oxidized in the following experiments.
93
 The most widely used reagents to introduce a 
chromophore tag are Ellman’s reagent (5, 5’-dithio-(bis-2-nitrobenzoic) acid, DTNB), Sanger’s 
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reagent (1-fluoro-2,4-dinitrobenzene, DNFB), monoiodoacetic acid (MIAA), N-
ethylmaleimmide (NEM) and its analogues; the famous reagents used for fluorophore 
introduction include o-phthalaldehyde (OPA), monobromobimane (mBBr) and 4-aminosulfonyl-
7-fluoro-2,1,3-benzoxadiazole-4-sulfonate (SBD-F).
93, 107, 114, 116
 Some structures of the above 
reagents are shown in Fig. 6.  
 
Figure 6. Structures of common derivatizing agents 
HPLC is a well-known chromatographic technique used for its advantages in high 
efficient separation, identification, quantitation, as well as purification of analytes of interests 
from mixtures. Analytes are separated in an HPLC column based on the differences in retention 
times caused by the equilibrium distribution of solutes between the stationary phase and mobile 
phase.
117
 Most thiol analysis performed by HPLC uses octadecylsilica gel (ODS) as the 
stationary phase and is performed by reversed-phase (RP) mode.
114
 Detectors such as UV, ECD, 
ECD, FL and MS are compatible with HPLC.
114
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have been separated by HPLC-UV with post-column derivatization.
100
 Microdialysis has been 
coupled to HPLC for in vivo monitoring of extracellular GSH concentration in rat brains using 
either FL or EC detections.
30, 104
 A 2D HPLC-FL has also been applied in analyzing trace amount 
of GSH and GSSG in minute plasma samples.
99
 A detailed summary of HPLC techniques in 
determination of thiols can be found in some good review papers.
93, 107, 114, 118
   
CE is another separative technique widely used in thiol determination. Under a strong 
electric field, ionic and neutral species can be separated in a capillary based on the differences in 
the charge and frictional forces.
119
 Different from HPLC, CE uses EOF as a driving force rather 
than hydraulic pressure, which results in a plug flow profile instead of parabolic laminar flow 
profile.
120
 Unlike HPLC, there is no mass transfer between phases in CE. As a result, band-
broadening in CE is much less significant than that in HPLC, which contributes to its higher 
separation efficiency.
121
 Meanwhile, because the internal diameters of capillary used in CE are 
usually within the range of 20 µm-100 µm, CE requires lower volume of sample for analysis 
than HPLC does.
122
 In addition, high voltage applied in the CE system enables the separation to 
be completed at high speed within several minutes.
122
 Because of all these advantages, CE has 
been widely used in analysis of biological samples. CE coupled to laser induced fluorescence 
(LIF) method has been reported to measure the total plasma thiols. After offline reduction and 
derivatization of the plasma samples, baseline separation of CysGly, Hcy, Cys and GSH was 
achieved within 5-9 minutes.
98
 The same method has also been applied to measure protein-bound 
GSH in cultured cells.
123
 Microdialysis has been coupled to CE-LIF by a flow-gated interface for 
continuously monitoring thiols in vivo in the caudate nucleus of the rat brain, where analytes 
were derivatized before entering into the separation capillary and detected by a laser-induced 
fluorescence detector after separation with LODs (detection of limits) in the range of 20-40 
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nM.
29, 124
 Determination of the intracellular thiols from a single human erythrocyte has also been 
achieved using CE-LIF.
95
 More examples can be found in other review papers.
93, 107, 114
  
1.2.3 Non-separation based methods 
The non-separative methods used for determination of thiol compounds mainly include 
spectrophotometry, spectrofluorimetry and amperometry.
93, 107
 The major advantage of non-
separative methods is that there is no need to separate the analytes of interest from the matrices. 
In order to obtain accurate and reliable results, non-separative methods require highly selective 
ways to detect the analytes from a complicated background. High selectivity detection can be 
achieved through labeling of the analyte with special tag molecules. Determination of GSSG and 
GSH have been reported using a spectrophotometric method, which is based on the UV-Vis 
absorbance change resulting from the redox of added reagents along with that of GSH/GSSG.
125
 
GSH has been selectively measured in the presence of Cys by using a GSH selective 
fluorescence probe, 5-maleimidyl-2(m-methylphenyl)benzoxazole.
126
 The measurement of 
GSH/GSSG redox potential in the cytosol and mitochondria in vivo has been achieved by 
applying genetically encoded redox sensitive green fluorescent protein probes (roGFPs) followed 
by fluorescence imaging.
127-130
 Electrochemical sensors have also developed for selective 
detection of thiols.
131, 132
 In addition, nuclear magnetic resonance (NMR) has been used for in 
vivo determination of the GSH in the human brain
133
 and measurement of GSH redox status in 
both intracellular and extracellular compartments of human erythrocytes in a non-separative 
way.
134
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1.3 MICROFLUIDIC DEVICES WITH CONFOCAL LASER-INDUCED 
FLUORESCENCE DETECTION 
1.3.1 Theory of miniaturization 
The concept of miniaturized total analysis systems (µTAS) or the lab-on-a-chip (LOC) system 
was first brought forward by Manz et al. in 1990. They envisioned a system that incorporates all 
sample handling steps, including sample pretreatment, chromatographic or electrophoretic 
separation, and detection, close together on one device.
135
 This idea was promoted by rapid 
development of techniques in the field of micro-electro mechanical systems (MEMS) in the 
1980s and the urgent practical needs of miniaturization, integration and portability in 
biotechnology, pharmacology, medical diagnostics and forensics. Generally, the LOC system can 
be viewed as the shrinkage of various normal laboratory functions on a single chip. The 
connection of these functions on chip is achieved by controlling the fluid flow between different 
function modules at micrometric length scales. The study of fluid flow circulating in artificial 
microsystems later became a popular research topic, microfluidics.
136
 Although the original aim 
of miniaturization was to enhance the analytical performance of the µTAS as a new generation of 
chemical sensor, it was recognized that the miniaturized device not only enables faster and more 
efficient transportations and separations, but also dramatically reduces the amount of required 
sample, carrier, reagent or mobile phase.
135
 Attracted by these advantages, many research groups 
have joined their efforts in the field of microfluidics since 1994. A lot of pioneering works in the 
development of the theory, technologies, analytical operations and applications are summarized 
in some excellent reviews.
137-140
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Flow injection (FI), chromatography and capillary electrophoresis (CE) are three 
analytical techniques commonly used in experiments performed on microfluidic device.
135
 FI is a 
liquid handling technique that is capable of introducing a series of sample zones with a well-
defined volume into a continuously flowing carrier reagent with high reproducibility and 
sampling rate.
141
 These features make FI a popular method for automatic sample introduction in 
micro-channels.
142
 Chromatography and electrophoresis are two separation methods based on 
different mechanisms. Unlike the traditional capillary column, microfluidic channels are usually 
more complicated with a two dimensional channel network, and the lengths of these channels are 
usually shorter than that of the capillary column used in traditional CE and capillary HPLC. 
However, the existing theories of chromatographic and electrophoretic separations will still 
apply to the separation behaviors on a microfluidic chip.
117
  
Chromatographic separation is based on the different equilibrium distribution of analytes 
between the stationary and the mobile phases. Different distribution coefficients among analytes 
lead to various retentions in chromatographic analysis and result in the separated analyte 
bands.
117
  The extent of the band spreading directly determines the efficiency and performance of 
the separation.
117
 Band broadening in a chromatogram occurs when the solutes travel through 
both inside and outside the separation column, the latter is usually known as the extra-column 
band broadening resulting from sample injection, detection step and the dead volume in the 
connecting tubing.
143
 In an ideal experiment, analytes of interest will be introduced into the 
system as a narrow zone and travel through the column at a same constant rate. However, in 
practice, the velocity for individual solute molecules are not always the same, which constitutes 
the origin of band-broadening. There are three major contributions to the difference in the 
velocity as the solutes travel through the column: (1) the resistance to mass transfer between 
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phases; (2) the flow differences with radial position in the column, which is due to the parabolic 
flow profile of the laminar flow when a pressure gradient is applied to an open-tubular column. 
The radial mass transfer of the solute, however, helps to reduce the band spreading by mixing the 
analyte molecules with different velocity; (3) the longitudinal molecular diffusion.
117, 143
 The 
overall plate height H (or the height of an equivalent theoretical plate, HETP) can be expressed 
in Eq. 1 to describe the band-broadening inside an coated capillary column and is an important 
parameter for measuring column efficiency.
117
          
            (1) 
where HS, HM and HL are terms of stationary phase mass transfer, mobile phase effect and 
longitudinal diffusion, respectively. By studying the origin and mechanism, a mathematical 
expression for each term can be derived as in Eq. 2, Eq. 3 and Eq. 4. 
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Where q is shape factor of the liquid stationary phase dispersed on the surface of a solid 
support. k’ is the capacity factors, df is the characteristic distance of the liquid stationary phase, 
such as the film thickness or droplet diameter; r is the inner radius of the column; υ is the mean 
flow velocity of the mobile phase; DS and DM are the solute diffusion coefficient in the stationary 
and mobile phase, respectively.
117
 
Compared with chromatography, the HETP for the ideal CE experiment has no 
contribution from resistance to mass transfer between phases. Meanwhile, the flow velocity 
driven by electroosmotic flow (EOF) has a flat flow profile rather than a parabolic shape as in 
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the chromatographic analysis.
119, 144
 Therefore, only the longitudinal diffusion term contributes to 
the final separation efficiency when band broadening caused by Joule heating, injection and 
analyte interaction with the capillary wall are all minimized
145
 and that is why CE usually has a 
theoretical plate number approaching several hundred thousand,
146
 which is usually 10- to 100- 
fold higher than that of a chromatographic separation.
121
 Besides, technically, it is much easier 
and space-saving to apply EOF as a driving force on a compact microfluidic device than to 
integrate series of mechanically moving parts, such as micro valves and pumps as used in 
chromatographic analysis.
137
 From these points of view, CE is a better choice to achieve 
separation of analytes on chip than chromatography.  
Proportionality consideration is a convenient approach to predict the trends of physical 
parameters of a simple flow system during the miniaturization, especially when there is little 
knowledge of the material constants.
147
 Typically, physical parameters of interest can be 
expressed as functions of the variables to be miniaturized, space (l) and time (t). There are two 
situations for a simple three-dimensional downscaling process based on the scaling factor l, time-
constant system and diffusion-controlled system. The time-constant system assumes that the 
timescale keeps constant when the system is miniaturized. It is applicable to the simple 
transportation system and flow injection analysis (FIA) system.
147
 In a diffusion-controlled 
system, molecular diffusion, heat diffusion and flow characteristics determine the separation 
efficiency, such as in a chromatographic or an electrophoretic system.
147
 In these systems, time is 
proportional to l
2
. Proportionalities of selected physical parameters in relation with the scaling 
factor, l, are summarized in Table 1 for these two systems.
135, 136, 147, 148
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Table 1. Proportionalities of mechanical parameters in relation to the characteristic length l 
 Time-constant system Diffusion-controlled system 
Time, t const. l
2
 
Space, l l l 
Linear velocity, u l l
-1
 
Volume flow rate, F l
3
 l 
Pressure drop, Δp (laminar flow) const. l
-2
 
Voltage drop, ΔV (EOF) l
2
 const. 
Electric field, V/L, E (EOF) l l
-1
 
Reynolds number, Re l
2
 const. 
Joule heat, Q l
5
 l
3
 
Plate number --- const. 
 
According to Table 1, in a time-constant system, if the pressure drop remains constant 
during the miniaturization, the analysis time that relies on the linear velocity will keep 
unchanged. However, the consumption of the sample and carrier reagent will be decreased 
considerably. For, example, a 10-fold decrease in the dimension would result in a 1000-fold 
reduction of the sample and reagent consumption determined by the volume flow rate. In a 
diffusion controlled system, the time scale is treated as a surface.
135
 Therefore, a downscale to 
1/10 of the original size will lead to 100 fold decrease in the analysis time while the voltage and 
the separation efficiency (plate number) remain constant for an electrophoretic system. A higher 
voltage drop can be applied to a downscaled system as the Joule heat will be tremendously 
reduced and the heat dissipation will also be promoted when the surface-to-volume ratio is 
increased, which will contribute to an even faster analysis and higher separation efficiency.
149
 
This evidence supports that EOF is more advantageous than pump-driven flow for miniaturized 
systems.  
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1.3.2 Confocal laser induced fluorescence (LIF) detection 
Currently, various detection methods have be applied to microfluidic device, which include FL, 
ECD, chemiluminescence detection (CL), electrochemiluminescence detection (ECL), MS and 
other less commonly used detection methods, for example, surface plasmon resonance (SPR), 
thermal lens microscopy (TLM), time-scanning Fourier transform spectrometry, flame analyzer 
and atomic/molecular emission detector and so on.
137-140, 150
 In a typical microfluidic analysis, the 
volume of sample is confined by the dimensions of the microchannel, usually on the order of a 
few hundred picoliters to low nanoliters.  Meanwhile, analytes of interest are usually present in 
extremely low concentrations.
151
 The limited sample volume and concentration requires 
microfluidic analysis to be coupled with highly sensitive detection methods.
150
 Compared with 
other detectors, laser induced fluorescence (LIF) detection is one of the most sensitive detection 
methods widely used in microfluidic analysis.
150, 151
 Under the best conditions, the concentration 
limit of detection (LOD) is on the order of 100 fM and the mass LOD of about a few tens of 
molecules has been achieved.
151
 Presently, LIF has become a standard detection method for 
microfluidic analysis with low LOD and high selectivity, although the sample to be analyzed 
must be naturally fluorescent or capable of being labeled with fluorescent tag.
150
  
To achieve ultrasensitive fluorescence detection, it is necessary to increase the signal-to-
noise ratio (S/N).
151
 In molecular photoluminescence spectrometry, the signal is directly 
proportional to the incident radiant power under most conditions.
152
 Therefore, using a laser as 
the an excitation source will provide greater irradiance compared to conventional light sources 
without excitation wavelength selector.
152
 The noise for the photoluminescence comes from two 
main sources, the shot and flicker noise in the analyte luminescence signal and the blank noise 
including the amplifier readout noise, dark current noise, background luminescence and 
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scattering signal.
152
 Confocal optical arrangement is capable of achieving highly sensitive 
fluorescence detection by increasing the S/N through elimination of the scatter or out-of-focus 
light.
151, 153, 154
 In conventional fluorescence setup, the entire field of sample both in focus and 
out of focus will fluoresce like a three-dimensional incoherent light source when excited by the 
incident light.
155
 Mathematically, the image formed by an ideal optical system at the detector is a 
convolution of the object with the defocused point spread function (DPSF).
156
 On the contrary, in 
a confocal LIF system, the detection volume is minimized by a laser beam focused onto the 
specimen for maximizing the S/N.
151, 157
 The fluorescence signal collected at the focal point of 
the objective forms an image before the detector where there is a pinhole as a spatial filter 
conjugated to the focal point of the objective.
155
 Due to this spatial filter, the detector only 
detects fluorescence generated from the focal point on optical slice with a submicron thickness, 
typically at best 0.5 µm.
158, 159
 All other light rays, such as fluorescence coming from out-of-
focus planes, or fluorescence from the focal plane, but not at the focal point, and laser light 
reflected or scattered from the cover glass and channel walls, will be blocked and filtered out by 
spectral and spatial filters before they reach the detector.
159
 In summary, the confocal LIF 
detection has higher axial resolution than normal FL detection and is able to control the depth of 
field.
160, 161
 It also works well to eliminate or reduce background noise and improve the S/N.
154, 
162
 All of these advantages make the confocal LIF one of the most ultrasensitive techniques for 
microfluidic devices.
151, 154
 Fig. 7 is sketch of a typical confocal LIF setup.
154, 155, 163
 A laser is 
used as the light source to produce an intense and spatially and spectrally constrained point 
source of illumination. The beam first passes through a laser line exciter filter and is reflected by 
the dichroic filter positioned at 45° and focused onto the sample stream in the microchannel via a 
microscope objective. A pinhole is placed in front of the detector at the optical position that is 
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exactly where the fluorescence from the focal point of the objective is focused after the tube lens. 
A band pass emission filter is placed after the pinhole to exclude light at unwanted wavelengths. 
The straight line in Fig. 7 represents the fluorescence signal produced by the sample on the focal 
plane, which is focused right at the pinhole, thus capable of passing through the pinhole and 
finally reaches the detector. The dashed blue line denotes the fluorescence generated by the 
sample above the focal plane. As the image of the out-of-focus fluorescence forms a much larger 
disk at the pinhole, only a very small portion of this light will pass through the pinhole and 
contributes negligibly to the ultimate signal at the detector.
164
 In a true confocal system, the 
excitation volume depends on the objective NA and the diameter of the entering laser beam, 
while the collection volume depends on NA and the spatial filter diameter.
151
 
 
 
Figure 7. Sketch of a typical confocal LIF detector 
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Since the first introduction of LIF as a detection technique for CE in 1985 by Gassmann, 
Kuo and Zare,
165
 LIF has attracted a lot of research interest because of its high sensitivity 
extended to the single molecule concentration.
157
 Early pioneering papers in LIF detection
166-169
 
laid solid experimental and theoretical foundations for subsequent research in the field of 
ultrasensitive confocal LIF detection
170-172
 coupled to micro-analytical systems. Recently, 
various laser sources and detectors have been introduced into the LIF system.
173-175
 Parameters of 
optical components and its arrangements are further discussed according to their effects on 
experimental results.
151, 154, 176
 More studies were aimed at applying confocal LIF for single cells 
and single molecule analysis in microfluidic devices.
176, 177
   
 
1.3.3 Microfluidic chip and thiols determination 
With the development of a microfluidic system and its attractive advantages in handling small 
amounts of samples, research on separation and determination of thiol compounds from 
biological samples has been switched from traditional analytical techniques, such as CE and LC, 
to the more integrated microfluidic platform.
114
 Currently, a majority of studies in measurement 
of intracellular GSH together with reactive oxygen species (ROS) on microfluidic devices treat 
these two molecules as model compounds to demonstrate the performance of on-chip single cell 
analysis
96, 97, 178-181
 or as signaling molecules to evaluate the apoptosis and oxidative stress of 
cells.
182-184
 These studies were either achieved after offline extraction of cellular components or 
through direct single cell analysis on the microfluidic chip and the signals from the labeled 
molecules have been measured using LIF 
96, 97, 178-184
 or CL detection.
185
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Simultaneous determination of individual thiols in mixture solutions has been a research 
focus. Hcy, Cys, GSH and/or N-acetylcysteine (NAC) in a standard mixture,
186, 187
 or in the 
blood samples,
188
 the human plasma
189, 190
 and the red blood cell lysate,
115, 191
 have been 
successfully analyzed on a microfluidic chip coupled to an electrochemical detector with LODs 
ranging from submicromolar to low micromolar and an analysis time of several minutes. The 
intracellular concentration of GSH, Cys and hemoglobin (Hb) in individual red blood cells from 
cancer patients were simultaneously determined using a microfluidic chip coupled to CL 
detection and the results were compared with samples from healthy subjects indicating a 
tremendous increase in GSH and Cys concentrations in samples from cancer patients.
192
 GSH in 
a mixture with other biological anions, NO2
-
, ascorbic acid and tyrosine at pH 11 in a standard 
mixture has been separated and analyzed in a microfluidic chip integrated with the EC 
detection.
193
 Cys, in a mixture of native amino acids, has been successfully separated and 
analyzed on microfluidic chip with either EC
194
 or LIF detection.
195
  
Thiol containing drugs are widely used for treating many diseases. The analysis of these 
thiol drugs in standard mixtures or from biological samples has also obtained some research 
interest. For example, microfluidic electrophoresis integrated with online labeling and post-
column CL detection has been used for simultaneous quantitation of four thiol drugs including 2-
mercaptopropionylglycine (2-MPG), captopril (CP), 6-thioguanine (6-TG) and 6-mercaptopurine 
(6-MP) with LODs in the range of 8.9-13.5 nM.
196
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2.0  DEVELOPMENT OF A CONFOCAL LASER INDUCED FLUORESCENCE 
DTECTION SYSTEM 
This part of work is adapted from the master’s thesis “Online determination of extracellular 
glutathione in organotypic hippocampal slice cultures with a microfluidic device and confocal 
laser-induced fluorescence detection system”, Juanfang Wu (2010) 
Several aspects must be considered in building a confocal laser induced fluorescence (LIF) 
detection system. 1) Selection of an optimized set of optical components based on the analytes of 
interest. Parameters for a specific optical component, such as the type and wavelength of the 
laser, cut-on and cut-off wavelength of a filter set, magnification and numeric aperture (NA) of 
the microscope objective, etc., must meet goal of the research. Meanwhile, different parameters 
of various optical components must be compatible with each other to achieve the best optical 
performance. 2) Design and assembly of an opto-mechanical system. This usually includes 
designing a platform for accommodating the microfluidic device and choosing series of holders 
and stages to support and arrange optical components in the light path. A good arrangement of 
optical components will not only ease the beam alignment, but also increase the sensitivity and 
decrease the detection limit. 3) Development of a multi-task controlling program. Computer 
remote control allows for automation of detection and measurement. It should be capable of 
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achieving different functions, such as data collection and averaging, voltage and current 
monitoring, high voltage power supply (HVPS) manipulating, and sampling control with a user-
friendly interface.  
2.1 OPTIMIZATION OF OPTICAL COMPONENTS OF THE CONFOCAL LIF 
DETECTOR  
2.1.1 Laser  
Laser beams are well-known for their beneficial qualities such as high collimation, 
monochromaticity, coherent and high radiance.
152
 These characteristics allow for the directional 
delivery of intense irradiance with high spectral purity to the sample.
197
 According to confocal 
theory, only the fluorescence signal generated from the focal point will be detected by the 
detector; the photoluminescence signal is mostly proportional to the incident radiant power, it is 
therefore necessary to use a laser as an excitation source and focus it into a small spot to get a 
strong signal.
152
 
One of the most important criteria in choosing a suitable laser source is its wavelength. It 
must match the absorbance spectrum of the analyte. As the derivatizing reagent of thiols in the 
following experiments is ThioGlo-1 (the reason of choosing this dye will be further discussed 
later), the excitation and emission spectra of aminothiols labeled with this dye must be examined. 
Fig. 8 shows the excitation (emission wavelength: 513 nm) and emission (excitation wavelength: 
379 nm) spectra of labeled GSH taken with a SpectraMax M2 (Molecular Devices, Sunnyvale, 
CA). The spectra were taken right after mixing of the GSH in deionized H2O and ThioGlo-1 in 
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DMSO at final concentrations of 52 µM and 20 µM, respectively at 24.8 ºC. Fig. 8 shows that 
the excitation and emission maxima are 370 nm and 502 nm for ThioGlo-1 conjugated with GSH, 
which are different than the literature values (excitation wavelength: 379 nm and emission 
wavelength: 513 nm) provided by the product catalog. This may be caused by the different 
experimental conditions under which the spectra were taken. The laser with wavelength a little 
higher than 400 nm was chosen for several reasons. First, although 370 nm is the peak excitation 
wavelength for the GSH-ThioGlo-1 conjugate, it is falls out of the wavelength range of visible 
light (380–750 nm) for the human eye. Thus it may cause some difficulty in beam alignment. 
Second, the closer the wavelength is to the ultraviolet portion of the spectrum, the more chance 
that other analytes in the sample and different materials in optical path may be excited and 
fluoresce, which will increase the background signal. Third, it is less expensive to get a laser 
with longer wavelength. 
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Figure 8. Excitation and emission spectra of GSH labeled with ThioGlo-1 
Another factor that dominates the selection of a laser is its operational modes. Generally, 
continuous-wave (cw) lasers have better spatial coherence than pulsed lasers and may be focused 
to a few micrometers spot size.
167
 Meanwhile, pulsed lasers tend to have much higher intensity in 
a very short time compared with cw lasers;
152
 this will lead to saturation and photo-degradation 
of dye, which should be avoided during the measurement. Finally, the stability of the laser is of 
vital importance to obtain shot noise limited performance and high LOD.
167
 
The most widely used lasers mainly include gas lasers, dye lasers, solid-state lasers, and 
semiconductor lasers and chemical lasers.
152
 The diode pumped solid-state (DPSS) laser use a 
semiconductor diode laser as pump source to pump a doped laser crystal. Rather than giving off 
the fundamental laser frequency of the lasing medium, the second harmonic generated by the 
doubling crystal is transmitted as the final laser beam.
198
 DPSS lasers produce stable and narrow 
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laser beam with good mode quality throughout the visible spectrum at a relative low cost. 
Meanwhile it also possesses characteristics of a diode laser, such as a compact size and high 
optical efficiency.
198
 A DPSS cw laser produced by CrystaLaser (Reno, NV) was chosen as the 
illumination source. It is equipped with an adjustable power supply controller. Table 2 lists some 
of the main parameters for this laser obtained from the manufacturer. The output power for our 
system is adjustable from 0 mW to 20 mW. A Gaussian 20 mW beam focused to a 1 µm radius 
spot size will produce a peak irradiance of over 10
6 
W/cm
2
 and in real operation the irradiance 
should be held to a value less than 10
5
 W/cm
2
 to eliminate saturation and possible 
photodegradation in fluorescence detection.
167
 Thus output power range of 0 to 20 mW suffices 
for our system. 
Table 2. Main parameters of BCL-020-405-CL2005 DPSS laser  
Parameters Values 
Wavelength 403.1 nm 
Output Power Up to: 20 mW 
Transverse Mode TEM00 mode, M
2
 = 1.2 
Longitudinal Mode Several longitudinal modes 
Beam Diameter (1/e
2
) 1 mm 
Beam Divergence 0.6 mrad (full angle) 
Output Stability 1% over 24 hours 
Noise (rms) < 0.5% 
Operation Voltage 90 to 250 VAC 
Dimension (mm) 30 x 30 x 120 
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2.1.2 Microscope objective 
The microscope objective is one of the core optical components in a confocal LIF system. In a 
confocal setup, the objective will be used to focus the laser beam into a tiny spot onto the sample 
in the microfluidic channel and to collect the fluorescence signal generated by the sample and 
transmits it into the following optical path. There are several key parameters that determine the 
performance of an objective.  
Numerical aperture (N.A.) is defined as the refractive index (n) of the immersion medium 
times the sine of the angle made by the marginal ray with the optical axis. It is closely related 
with the light collection efficiency as shown in Eq. 5 
167
  
                            
       
    
  
 
  (5) 
Therefore a lens of high N.A. is required to obtain high collection efficiency. For 
example, without special immersion medium, a lens with N.A. of 0.6 will collect 10% of the 
emitted light, while a lens with a N.A. of 0.1 will only collect 0.3%. Objectives with higher 
magnification usually have greater N.A.  
 Optical aberrations occur in various forms for objectives, which include spherical 
aberration, chromatic aberration and other geometrical aberrations. Expensive objectives usually 
have higher level of correction than the inexpensive ones. In a confocal LIF system, the 
excitation source is a single wavelength laser beam and the fluorescence signal has a narrow 
band width. Therefore, it is not necessary to use objectives with highest correction level. Most 
transmitted light objectives are designed to image specimens that are covered by a cover glass. 
The thickness of this small cover slip is standardized at 0.17 mm for most applications. General-
purpose objectives are designed for this thickness. However, some special objectives have a 
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correction collar adjustment of the internal lens elements to compensate for the variation in 
thickness of the cover glass. Because the thickness of the base glass has a thickness of 1.0-1.1 
mm, it is important to choose an objective with higher allowance for the thickness of the cover 
glass. The working distance (W.D.) is the distance between the front objective pupil lens and the 
closest surface of the cover glass when the specimen is in focus. In most cases, the W.D. is 
inversely related to the magnification of the objective. It is safer to have an objective with 3 mm 
or longer W.D due to the mechanical platform for the microfluidic devices. 
A LUCPLFLN 40x objective from Olympus (Center Valley, PA) has been selected to use 
in our confocal LIF system. It belongs to the UIS2 (infinity-corrected) series and is a plan- 
fluorites objective with a cover glass correction collar from 0-2 mm. The W.D. for this objective 
is between 2.7-4 mm, which is also within the safe distance for our system. The light collection 
efficiency is also acceptable under a N.A. of 0.6. Table 3 includes some of the main parameters 
for this objective obtained from the manufacturer. A LUCPLFLN 20x objective with focal length 
of 9.0 mm and W.D. of 6.6-7.8 mm is also used in some of the experiments mentioned below to 
test the performance of the system.  
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Table 3. Main parameters of LUCPLFLN 40x objective 
Parameters Value 
Focal Length (mm) 4.5 
N.A. 0.6 
W.D. (mm) 2.7-4 
F.N. 22 
Cover Glass Thickness (mm) 0-2 
Immersion No 
Correction Ring Yes 
Ultra Wide Anti-reflection Coating Yes 
Bright field Excellent 
Dark field Good 
DIC Excellent 
Polarized Light Good 
Fluorescence (B, G Excitation) Excellent 
UV Fluorescence (at 365nm) Excellent 
 
2.1.3  Photon detector 
Fluorescence signals generated by the sample must be converted into electrical signals for 
post-processing, analysis and storage. Photon detectors are sensors of light or other 
electromagnetic radiation that are capable of translating optical signals into electrical signals. 
Photoemissive devices, such as vacuum phototubes and photomultiplier tubes, form one of the 
major classes of photo detectors. For a vacuum phototube, photocurrent will be generated upon 
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the strike of photons towards the photocathode with energy larger than the threshold energy of 
photosensitive material. The anodic current will cause a voltage drop across the load resister, 
which can be measured and recorded. The photomultiplier tube (PMT) is a type of vacuum 
phototube with additional dynodes, which can provide electron multiplication or gain. The 
operating voltage for PMTs is usually between 500 V to about 1200 V with gains of 10
6
.
152, 199
 
pn-Junction devices, such as photodiodes (PDs), are another class of photon detectors. 
The main component of PDs is the pn-junction diode. Under reverse bias, a limiting current 
directly proportional to the incident radiant power can be measured when the production rate of 
the charge carrier induced by light largely exceeds that which results from thermal processes. 
PDs are simple, very small in size and have excellent linearity over six to seven decades of 
incident radiant power. However the responsivity (the ratio of the rms signal output to the rms 
incident radiant power evaluated at a particular wavelength and incident power) of PDs is 
typically much lower than that of PMTs due to the lack of the internal gain.
152
 Avalanched 
photodiodes (APDs) can be viewed as PDs with gain, which are typically operated in the reverse 
breakdown region of the pn-junction diodes and provide best signal to noise (S/N) performance 
with an internal gain between 200-1000.
200
 Typically, APDs have a high responsivity unmatched 
by PDs and excellent performance at 650 nm unmatched by PMT.
152, 200
 
To choose a suitable detector for a certain application, important factors such as gain, 
quantum efficiency (QE) or responsivity, S/N, wavelength region, response time and cost must 
be considered.
152, 201
 As mentioned above, the internal gain of APD is much smaller than that of 
PMT. PMT usually has a smaller QE value (the ratio of the number of photoelectrons ejected to 
the number of incident photons, this value can be converted from responsivity) than that of APD 
and PD. For example, a gallium-arsenide-phosphide (GaAsP) cathode found in the most sensitive 
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PMTs has QEs of 40% compared to the 85% peak QEs offered by APDs.
152, 200
 PMT has peak 
responsivity around 300-400 nm and the maximum detection range of 800 nm while PD and 
APD maintain high responsivity in the range of 400-1100 nm and are widely used in the red or 
near infrared range.
200
 Most PMTs provide little responsivity in the NIR spectral region (beyond 
850 nm), but APD and PD are sensitive up to 1100 nm.
201
 At high signal level, APD and PMT 
have similar S/N in the visible spectral range.
200
 APD has better S/N at wavelengths longer than 
650 nm due to high QE in the long wavelength region.
200
 At low signal level, PMTs offer a better 
S/N than PD and APD with an amplifier, where PMT is operating in the shot-noise limit while 
S/N of APD and PD is limited by the amplifier and dark noise.
200, 201
 The rise times for both 
PMT and APD are all very short (1-10 ns) and they are applied in experiments requiring fast 
responses.
152
 In general, PMT is widely used at very low light level while APD is used where the 
light level is too low for a standard PD but too bright for a PMT or when a magnetic field is 
present.  
In our case, the emission light has a peak wavelength around 500 nm; meanwhile the 
signal from the confocal LIF system is relatively weaker than that in normal fluorescence 
detection. Based on the above discussion, a head-on metal package PMT module H5784-01 from 
Hamamatsu Photonics (Bridgewater, NJ) was selected as the photon detector of the system. 
Some of the main parameters for this PMT module provided by the manufacturer are listed in 
Table 4.  
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Table 4. Main parameters of H5784-01 PMT module 
Parameters Value 
Cathode Type Multi-alkali 
Peak Sensitivity Wavelength (nm) 400 
Spectral Response (nm) 300-850 
Frequency Bandwidth (kHz) DC to 20 
Max. Output signal Voltage 10 V 
Current-to-Voltage Conversion Factor (V/μA) 1 
Sensitivity Adjustment Range 1:10
4
 
Cathode: Radiant Sensitivity (mA/W)
*1
 60 
A
n
o
d
e 
Radiant Sensitivity (V/nW) 
*1*2
 30 
Voltage Output Depending on PMT Dark  
Current (mV) 
*2,*3
 
0.4 (typ.) 
4 (max.) 
Settling Time (s) 
*4
 2 
Rise Time (ns) 0.78 
Gain
*2
 4 x 10
5
 
Effective Area: diameter Ф (mm) 8 
Dimension (mm) 22 x 22 x 60 
Ripple Noise (peak to peak) (mV)
 *2,*5
 2 (max.) 
 
*
1: Measured at the peak sensitivity wavelength; 
*
2: Control voltage is +0.8 V; 
*
3: After 30 minute storage in darkness; 
*
4: The time required for the output to reach a stable level following a change in the control voltage from +1.0 
V to +0.5 V; 
*
5: Cable RG-174/U, Cable length 450 mm, Load resistance = 1 MΩ, Load capacitance = 22 pF. 
There are several major advantages of using this PMT as the detector. First, our desired 
wavelength of 500 nm is near the peak sensitivity wavelength of this PMT. Second, the dark 
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current and the ripple noise of this module are very low. Third, it is quite compact and includes a 
low-power consumption high-voltage power supply and a low noise amplifier together with a 
metal package photomultiplier tube. Fourth, the head-on type has a circular input window with a 
diameter of 8 mm, which is much easier than a side-on module during beam alignment. Last but 
not least, the rise time for this module is fast, which fits for detection following separation 
carried out in the microchannels. 
2.1.4 Filter set, lens and mirrors 
There are two kinds of filters in our detection system, spatial filters and spectral filters. A pinhole 
can be used as the spatial filter of the system. The diameter of the aperture depends on the area of 
the sample we want to analyze. The smaller the area of the sample we want to analyze, the 
narrower the aperture should be, and therefore less noise from the background would pass 
through the pinhole. Several pinholes with various fixed aperture diameters ranging from 50 μm 
to 600 µm were tested to optimize the aperture size. The selection of spectral filter set largely 
depends on the light source used and the excitation and emission spectra of the analyte (see Fig. 
8). A set of spectral filters usually includes an excitation filter, a dichroic filter and an emission 
filter. An excitation filter is placed after the light source, which is used to block light with 
unwanted wavelength from entering the system. A dichroic filter not only reflects the laser beam 
but also allows the passage of fluorescence signal collected by the objective while effectively 
reflecting other light with wavelength below the cut-on wavelength of the dichroic filter.  An 
emission filter can be a long pass filter or a band pass filter depending on the actual experiment. 
A band pass filter serves to capture the most specific energy from the analyte rather than to 
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capture the entire spectral region. Therefore, a filter with narrow bandwidth is effective in 
reducing potential background artifacts.  
 A XF2040 (435DRLP) filter and a 3
rd
 470-520 nm band pass filter as were selected as the 
dichroic filter and the emission filter in the confocal system, respectively, both of which were 
obtained from Omega Optical, Inc. (Brattleboro, VT). The diameter of the dichroic filter is 22 
mm. The transmission spectrum of this 435DPLP is shown in Fig. 8. The 50% peak transmission 
is at 435 nm, and the transmission at 403 nm and 500 nm are around 0.19% and 96.8% 
respectively. This is compatible to wavelength of DPSS laser and the emission spectrum of the 
analyte. The key parameters for the emission filter are listed in Table 5. The 3
rd
 millennium band 
pass filter applies Alpha technology and has very sharp edge steepness. It also applies a special 
coating assembly aimed at eliminating auto-fluorescence, improving transmitted wave front and 
lengthening filter life. Transmission range of this filter covers the emission peak of our analyte 
with the peak transmission of 83%. The excitation filter was not added because the 
monochromaticity of the DPSS laser source is very good and the reflected laser line would be 
eliminated by the dichroic and emission filter before reaching the detector.  
 Because the fluorescence collected by the infinity corrected objective will travel as 
infinity parallel rays after it passes through the objective, it is necessary to have a lens after the 
objective to focus the fluorescence signal to the pinhole. The focal length of this lens depends on 
approximate location of the pinhole in the system. An achromat doublet (G063215000, Linos 
Photonics, Inc, Milford, MA) with a focal length of 120 mm and clear aperture of 25.4 mm was 
selected for the system. It consists of a convex crown glass lens with low dispersion and a 
concave flint glass lens with a high dispersion to correct for both spherical and chromatic 
aberrations.  
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Another important optic component in the system is the front surface mirror used to 
redirect the light path 90° to another channel. A silver elliptical plane mirror (G340523000, 
Linos Photonics, Inc., Milford, MA) with a size of 22.4 x 31.5 mm was selected for our system. 
It has the highest reflection (>95%) for 450 nm to 12 µm wavelength and a surface flatness of 
1/10 λ. 
Table 5. Main parameters of the emission filter 
Parameters Value 
Cut-On (nm) 470 
Cut-Off (nm) 520 
Average Transmission (%) 83 
Edge Tolerance (nm) ±3 
Attenuation Range (nm) UV-1.3 x Cut-Off 
Attenuation (OD) >>5 
Diameter (mm) 25 
2.2 DESIGN AND ASSEMBLY OF AN OPTO-MECHANICAL SYSTEM  
In order to reduce noise from vibration, the whole opto-mechanical assembly was built upon a 
19˝ x 23˝ composite breadboard (NT54-252, Edmund Optics Inc., Barrington, NJ). We adopted a 
parallel mode in assembling the laser and collection optics, where the laser beam and 
fluorescence signal entering the detector are parallel with each other as indicated in Fig. 9. 
Arranging the laser (5), the optical tower and the stage C for the pinhole (6), the emission filter 
(7) and the PMT (8) on a single rail with engraved scales eased beam alignment. This linear 
arrangement also saved a lot of space for stage A.  
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Figure 9. Schematic view of the confocal LIF system 
 
Stage A was used to hold and control the location of the microfluidic device and the cell 
dish. It is composed of an aluminum platform and an x, y, z-translational stage mounted on a 
heavy duty rod. This 3D stage allowed the adjustment of as low as 1 µm in each dimension. The 
design of the aluminum platform on stage A is shown in Fig. 10 and is drawn to scale. An 
aperture with a size of 40 mm x 15 mm was located close to the center of this platform, which 
had a trapezoidal cross section and provided an easy access for the objective to the bottom of the 
microfluidic devices. Four plastic slide bars were fixed around the aperture by screws to hold the 
device in position.  The aluminum platform was fixed to the x, y, z-linear translational stage 
through the connector located on the top right corner of this platform. Five circular wells with a 
diameter of 35 mm served as holders for cell dishes.    
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Figure 10. Top view of aluminum platform of stage A 
 
The main part of stage B was a small tilt table sitting on the optical rail. The laser head 
was mounted on top of it horizontally with output of the beam directed towards the dichroic filter. 
The angle of the beam could be finely adjusted by turning three spring thumbscrew adjusters at 
the bottom. The height of the beam could be regulated by the height of the post below the table.  
 Stage C had an x-linear stage attached to the opposite side of the rail. It assembles three 
optical components together, the pinhole, the emission filter and the PMT. Fig. 11 is a platform 
of this stage. A square holder with a 33 mm x 33 mm through hole in the middle was attached to 
the left side of the platform. This holder was used to mount the pinhole positioner on one side 
and the emission filter holder on the other side. The size of this holder was specially calculated to 
make sure the pinhole and emission filter was closely attached to each other in order to avoid 
miscellaneous light coming from the environment. The head of the PMT was right against the 
holder of emission filter and the centers of the pinhole, emission filter and PMT photon sensitive 
surface were adjusted to the same height.     
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Figure 11. Top view of the platform of stage C 
 
The other important part of the system is the optical tower standing in the middle of the 
rail. It was composed of three 40 mm cube frames piled on top of each other. The top of the 
tower held the objective (1), which was mounted on top of the first cube with an adaptor. The 
dichroic filter (2) was fixed on a beam-steering mirror holder and mounted inside the first cube. 
It reflected the incoming laser beam parallel to the rail toward the objective perpendicular to the 
rail. The front surface mirror (4) was fixed on a second mirror holder and resided in the second 
cube. It reflected the focused signal by the lens (3) mounted in a plate between the first and 
second cubes and directed it towards the pinhole. This two steering mirror holders had three 
thumbscrew adjusters for fine adjustment of the angle and the position of the mirror. A 
photograph of the confocal LIF detector is given in Fig. 12.  
 44 
 
Figure 12. Photograph of the confocal LIF detector 
2.3 DEVELOPMENT OF A CONTROL PROGRAM USING LABVIEW 
The control program, named “Microfluidic Analysis System (MAS LAB)” used to control the 
detection system was developed using LabVIEW (version 8.2 National Instruments, Austin, TX), 
which is commonly used for data acquisition, instrument control, and industrial automation. 
Based on the functions to be achieved in real experiments, the control program can be divided 
into four modules: (1) data acquisition (analog input); (2) control and monitoring of high voltage 
power supply (HVPS) (analog input/output and digital I/O); (3) control of PMT sensitivity 
(analog output and digital I/O); (4) control of electrokinetic sampling (digital I/O). Two 
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multifunction data acquisition (DAQ) devices (NI PCI-6221 and a NI PCI-6733), two CB-
68LPR I/O connector blocks, one SHC68-68-EPM cable, one SH68-68-EP cable and a RTSI Bus 
Cable were obtained from National Instruments to cooperate with the program. 
  Data acquisition is the main function of the control program. Current signals from the 
PMT were first converted into voltage by its internal amplifier and then were transferred to the 
DAQ device. A digitizer on the device applied an accurate internal sample clock to determine the 
sampling rate (up to 250 kS/s) and converted the input signal to digital values. These data were 
temporarily stored in a buffer region allocated by the program, then averaged and plotted on a 
chart in the front panel (user interface) during the experiment. Meanwhile, data would also be 
recorded in a user specified file and could be exported for analysis. The main parameters that can 
be controlled by user on the front panel are listed in Table 6.  
Table 6. Main parameters for data collection 
Parameters Value 
Channel 
Max. (V) 10  
Min. (V) -10  
Sampling Rate (kS/s) 0-250 
A
v
er
ag
in
g
  
Type Linear/ Exponential 
Time (ms) 10/20/50/100 
Windows for DC and RMS 
(linear only) 
Rectangular  
Hanning 
Low Side Lobe 
Output Function 
DC only 
RMS only 
DC and RMS 
File/Process Control Save/Run/Stop 
 
The state and voltage of two high voltage power supply (HVPS) racks, each of which had 
four positive or negative output channels, were controlled by using twenty-four digital 
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input/output (DIO) channels and eight analog output channels of two DAQ devices. There were 
three states for each individual output channel, namely “disable/float”, “output” and “GND”, 
which could be accomplished by the cooperation of three DIOs. Fig. 13 and Table 7 show how 
three DIOs are capable of controlling two HV relays (relay 1 and relay 2) and an enable/disable 
switch of the output channel to achieve three different states. Users could control the states and 
output voltage of these eight HV channels with the option of presetting the experiment time. All 
channels were automatically disabled after the completion of the experiment. There were 
additional four charts on the front panel, which served as monitors of voltage and current for one 
positive HV channel and one negative HV channel. 
 
Figure 13. Setup of three DIOs and two HV relays for a single HV output channel 
 
Table 7. Connection between levels of DIOs and the state of the state of the electrode 
Level of DIOS 
State of HV channel 
DIO1 DIO2 DIO3 
1 0 1 Output 
0 0 0 Disable/Float 
0 1 0 GND 
 
The PMT module used in our system had a built-in low-power consumption (±15 V) high 
voltage power supply and a low noise amplifier. It also had an additional pinout to adjust the 
PMT sensitivity using an external low voltage. One of the analog output channels on PCI-6221 
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was assigned to adjust this control voltage ranging from 0.25 V to 0.9 V. In an experiment, users 
could adjust the value of the control voltage and had the option to lock this voltage at a certain 
value.  
Electrokinetic gated sampling was performed on the microfluidic chip for continuous 
injecting sample into separation channel for analysis.  In an experiment, users had the options to 
select “single gated mode” or “double gated mode”. In the “single gated mode”, one 32-bit 
counter of PCI-6221 controlled either a positive output channel or a negative output channel to 
generate an output signal switching between “float (injection)” and “GND” or “output” (analysis) 
based on the parameters specified by the user, which included “initial delay”, “interval”, 
“sampling time” and “repeat”. In the “double gated mode”, two 32-bit counters could 
simultaneously control two individual channels using specified parameters by the user. The 
program also had a synchronization option, which allowed the gated sampling to start at the same 
time as the data acquisition.  
Finally, the program had a safe “SHUT DOWN” button. If anything unusual happened in 
the middle of an experiment, the user could disable all HV output channels, gated sampling, 
PMT control voltage, data acquisition and reinitialize everything into its default value by 
clicking this button. Screenshots of the user interface are given in Fig. 14.  
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(a) PMT signal acquisition 
 
(b) Monitoring of gated sampling, HV current and voltage  
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(c) Controlling of electrokinetic gated sampling  
 
(d) Controlling of HVPS racks 
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(e) Controlling of PMT sensitivity and data averaging 
 
Figure 14. Screenshot of the user interface of “MAS LAB” 
2.4 SYSTEM OPTIMIZATION AND PRELIMINARY EXPERIMENTS 
2.4.1 Beam alignment 
After the stage A, B, C and optical tower were assembled with optical components as shown in 
Fig. 12, beam alignment was performed to optimize the light path for best detection. A plain 
glass slide (25 mm x 75 mm, 1 mm thickness) with a fluorescent label on one side was used to 
assist the alignment of the laser beam. The cover glass was placed on the stage A at the location 
where the aperture was. After turning on the power supply, the laser beam was reflected 90° by 
the dichroic filter towards the objective and formed a bright fluorescent spot on the glass slide. 
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The diameter of the spot became larger when the glass slide was moved away from the focal 
plane by adjusting the height of the stage A, which could be used to test the location of the focal 
plane. Meanwhile, the shape of the fluorescent spot could be used to identify the direction of the 
laser beam. Three thumbscrews on the beam-steering mirror holder were adjusted so that the 
shape of the fluorescent spot was round, which indicated that laser beam was positioned along 
the light path of the objective and perpendicular to the platform of stage A. An eclipsed spot 
appeared when the beam hit the inner barrel of the objective lens.   
After the excitation beam had been optimized, the glass slide was replaced by a simple 
test microfluidic chip as shown in Fig. 15. The bottom glass of the chip had a thickness of 1.0-
1.1 mm. The diameter and the depth of the big round reservoir on the chip were about 6.7 mm 
and 1.8 mm, respectively. The depth of the channel on the chip was around 20 μm. About 50 μL 
of freshly prepared solution of ThioGlo-1 (0.5 µM) and GSH solution (0.1 µM) were loaded into 
the reservoir. A piece of fluorescent label would be placed in front of the pinhole facing the front 
surface mirror at a distance of ~ 10 cm. The height of the stage A was adjusted so that the laser 
beam was focused on the middle of the solution and a bright spot ( ≈ 1 mm) could be detected 
on the fluorescent label. The thumbscrews of the dichroic filter holder were then finely adjusted 
so that three distinguished spots appeared on the fluorescent label and were clearly separated 
from each other. Among them, two spots were the images formed by a very small portion of 
laser beam reflected by the objective and the bottom glass of the microfluidic chip and only one 
of them was the true image of the fluorescence signal from the sample. The real signal image 
could be distinguished from the other two by changing the fluorescent label into a plain white 
paper. The image formed by the fluorescence signal had a unique color close to cyan, while the 
other two images formed by the reflection light had a color close to indigo like the color of the 
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laser beam. The image of the fluorescence signal must be separated from the images of the 
reflected light to prevent a noisy optical background.  
 
Figure 15. Sketch of the microfluidic chip for simple tests 
 
In order to make sure that the focused fluorescence signal beam was in parallel with the 
rail, two iris diaphragms with the minimum aperture diameter of 1 mm were used to facilitate the 
alignment. A sketch of this setup is presented in Fig. 16. The emission filter was temporarily 
removed from stage C and placed between the front surface mirror and the paired iris 
diaphragms. The iris diaphragm A was placed at 10 cm away from the center of the front surface 
mirror. Iris diaphragm B was in parallel with A and the distance between them was about 2.5 cm. 
The height of diaphragms A and B were carefully adjusted so that the centers of both iris 
diaphragms were at the same level as the pinhole on stage C. A fluorescent label was placed 
between two iris diaphragms, both of which were closed down. Three thumbscrews on the beam 
steering holder of front surface mirror were finely adjusted so that a light spot was formed on the 
fluorescent label. Then, the label was removed and placed after iris diaphragm B. The angle of 
the mirror was further adjusted so that the focused signal beam could pass through the second 
diaphragm and formed a light spot on the label.        
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Figure 16. Setup of two iris diaphragms in the parallel alignment 
 
After the focused beam was aligned in parallel with the rail, a 400 µm pinhole, the 
emission filter and the PMT would be fixed on stage C as shown in Fig. 12. The position of the 
pinhole would then be finely adjusted with the thumbscrews on the pinhole positioner, so that the 
focused beam was aimed at the center of the pinhole. After turning on the control program and 
PMT, fluorescence signals could be read on the chart on the front panel. The positions of stage A 
and the pinhole would be further tuned until a maximum signal could be detected. 
2.4.2 Laser beam profile measurement 
In the confocal LIF system, the laser beam is focused by the objective onto the sample inside the 
microchannel. It is useful to have a full picture of the intensity profile of the focused laser beam 
in order to optimize the dimension of the channel and other related parameters. Ideally, a laser 
beam can be depicted as a Gaussian intensity profile, which theoretically has a TEM00 mode. In 
the following experiment, a simple method is presented for measuring the laser beam intensity 
profile. The result will be further compared to that from theoretical calculation. 
The setup used to measure the laser beam profile is presented in Fig. 17. A thin blade 
with a small aperture (red) in its center was bonded to a plain glass slide with a thickness of 1 
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mm. The collar ring on the 40x LUCPLFLN objective was adjusted to the corresponding 
position to compensate for the thickness of the glass slide. The platform of stage A was 
temporarily removed and the holder in Fig. 15 was fixed on the heavy-duty rod, so that the 
aperture on the blade was directly above the objective installed on the optical tower. A low 
power detector (818-UV, Newport, Irvine CA) with an active diameter of 1.13 cm was also fixed 
on the rod at a height just above the blade with its active surface facing the aperture on the blade. 
The distance between the detector and the front objective pupil lens was fixed to be about 2.8 cm. 
The adjustment factor for the power meter (1815-C, Newport, Irvine CA) connected to the 
detector was set to be 3.81x10
3
 W/A for 400 nm wavelength measurements.  
 
Figure 17. Setup for the laser beam profile measurement  
 
At the beginning of the experiment, the height of the glass slide was slowly decreased 
until the bottom of the glass slide was just in contact with the front surface of the objective pupil 
lens. The reading of the z-axis micrometer drive was recorded. The glass slide was then lifted up 
~2 mm above the objective and the reading of z-axis micrometer drive was recorded again. The 
actual distance between the surface of pupil lens and the bottom of the glass slide, DZ (z is the 
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propagation direction of the focused laser beam), was calculated from the difference between 
two readings of the micrometer drive at different heights. When the height of the glass slide was 
fixed, the y-axis linear stage was adjusted so that the laser beam passed through the center of the 
aperture on the blade. After that, the micrometer drive on the x-axis was turned to a position 
where the laser beam was fully blocked by one side of the blade and the reading on the power 
meter was 0.00 mW. The x-axis drive was then turned back slowly step by step until the reading 
on the power meter reached its maximum. Readings of the power meter and the micrometer drive 
in each step were recorded for further analysis. This whole process was repeated when the height 
of the glass slide was changed to other values in z-axis. 
The relationship between the laser beam power readings and x-axis positions at different 
DZ, (2.507 mm (a1), 3.250 mm (b1), 4.030 mm (c1)) are plotted in Fig. 16. Each step in our 
experiment along the x-axis can be treated as a definite integration of the laser beam power 
unblocked by the blade. The results therefore could be differentiated and fitted to the Gaussian 
intensity profile of a theoretical TEM00 mode according to Eq. 6.  
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Where y0, xc, w and A are the offset, center, width and area of the Gaussian distribution, 
respectively. In an irradiance distribution of the Gaussian TEM00 beam, the beam intensity can 
be expressed by
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Here, z is the distance the wave has propagated from the plane where the wavefront is flat (z = 0 
is the location of a Gaussian waist); w(z) is the beam width defined as the radius of 1/e
2
 contour 
after the beam has propagated a distance z; w0 is the beam width of the waist defined as the 
radius of the 1/e
2
 contour at the Gaussian waist; I0 is the beam intensity of 1/e
2
 contour at the 
Gaussian waist; P is the total beam power; and r is the radical distance from the center of the 
beam. Comparing Eq. 6 and Eq. 7, it is not difficult to find out that the y0, xc, w and A in Eq. 6 
obtained from experiments correspond to the offset for the power density, beam center, beam 
width (radius of the 1/e
2
 irradiance contour) and total beam power, respectively. The fitting 
constants for three runs are listed in Table 8. It is obvious from the Fig. 18 that the power density 
(mW/mm) of the laser beam in run b is much larger than that in run a or c. The Dz in run b is 
3.250 mm, which falls into the listed W.D. range of this objective (2.7-4 mm).  
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Figure 18. Results from laser beam profile measurements at different DZ 
a1 = 2.507 mm; b1 = 3.250 mm; c1 = 4.030 mm; The results are then differentiated and fitted to Gaussian 
distribution and plotted in a2, b2, c2, respectively. Three Gaussian fits are plotted together in plot d for comparison. 
 
Table 8. Gaussian fitting results for three measurements 
Run # 
DZ  
(mm) 
A 
(mW) 
xc 
(mm) 
w 
(mm) 
y0 
(mW/mm) 
Peak density 
(mW/mm) 
R
2
 
a 2.507 1.85 1.389 0.057 0.223 25.9 0.973 
b 3.250 1.97 1.391 0.006 3.84 280 0.867 
c 4.030 2.24 1.394 0.066 0.528 27.0 0.996 
 
When Gaussian beam propagates through a simple lens, the output beam will still have a 
Gaussian intensity profile. Therefore, it is reasonable to fit our results by using the propagation 
equation for a laser beam. In practice, a beam quality factor, M
2
, is generally used to describe the 
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deviation of a real laser beam from an ideal Gaussian beam. The radius of the 1/e
2
 contour after a 
real beam has propagated a distance z,      , can be expressed by Eq. 8
203
 
             (
   
    
       )
 
       (8) 
Where λ is the wavelength of the beam; w0r is the radius of the 1/e
2
 irradiance contour of a real 
beam at the beam waist and z0 is the location of the beam waist along the direction of wave 
propagation. In our experiment, Dz can be related with z by 
               (9-a) 
              (9-b) 
Where d is the thickness of the glass slide and Dz0 is the distance between the front objective 
pupil lens and the bottom glass slide when the beam waist is located at the top surface of the 
glass slide (ignoring any effect caused by the finite thickness of the blade in our experiment). 
Replacing z and z0 with Dz and Dz0 will give 
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     (10) 
The parameters and results from nonlinear curve fitting based on Eq. 10 are given in Table 9 and 
Fig. 19.  
Table 9. Equations and parameters for nonlinear curve fitting of the beam width and DZ 
Known variable 
λ = 403.1 x 10
-6
 mm 
M
2 
= 1.2 
Dependent Variable WR (width of the Gaussian distribution from Table 9) 
Independent Variable DZ (see Table 9) 
Results 
Parameters 
w0r (μm) 
Value 
1.9 
Error 
0.04 
DZ0 (mm) 3.204 0.013 
R
2
 0.99724 
 
 60 
 
Figure 19. Nonlinear curve fitting of the beam width to DZ 
 
Table 9 gives two important parameters obtained from nonlinear curve fitting. One is the 
radius of the beam waist, w0r, which is around 1.9 μm. The other is the W.D. of this objective 
with a 1 mm thick glass slide, DZ0, which is 3.205 mm (Strictly speaking, W.D. ≠ DZ0, but they 
are very close to each other in our case.) 
Meanwhile, it is possible to calculate the radius and the location of the beam waist after a 
spherical Gaussian beam passes through a train of lenses by using method developed by S. A. 
Self in 1983.
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  If the waist of the input beam represents the objective and the waist of the output 
beam represents the image, the relationship between the objective distance s, image distance s˝, 
and focal length of the lens under paraxial conditions is given by Eq. 11: 
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Where zR is the Rayleigh range (the distance over which the beam radius increased by a factor of 
√  or the distance from the waist at which the wavefront curvature is a maximum) of the input 
beam defined by Eq. 12 
    
    
 
 
 (12) 
The magnification, m, is given by  
   
   
 
   
 
 
√{                       }
 (13) 
where w0r˝ is the width of a real output beam waist. In most cases, the beam waist is designed to 
be very close to the output surface of the laser. Therefore we can assume that the w0r is 0.5 mm 
and s is ≈130 mm for our setup. The focal length for 40x objective is 4.5 mm. zR, s˝ and w0r˝ can 
be calculated from Eq. 11, 12, 13 are 1947 mm, 4.501 mm and 1.391 μm, respectively, which 
indicates that the waist of the output beam is not exact at the focal plane of the objective, but 1 
μm away. However, the beam width at the focal plane is very close to that of the beam waist 
based on the fitting results obtained in Fig. 19. The results from the beam profile experiments are 
consistent with what we got from the theoretical calculation.  
2.4.3 Noise experiments and system performance testing  
2.4.3.1 Noise sources 
Identification of the dominant noise sources is of vital importance for optimizing experimental 
variables systematically and improving the instrumental design to obtain a better S/N.  The total 
noise observed in a measurement may arise from several sources, among which one or two noise 
sources are dominant. For a photoluminescence measurement, the total signal, Et, equals to the 
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summation of the analytical luminescence signal ES and the blank signal Ebk, where Ebk includes 
contributions from the background luminescence signal, the dark current and scattering. 
Similarly, the rms noise in the total signal, σt, has contributions from analytical signal noise (σS) 
and the blank signals noise (σbk). σS is mainly due to analytical signal shot noise, (σS)s and flicker 
noise (σS)f. σbk is originated from noise in the background signal noise, σB, and the total dark 
current noise, σdt. Furthermore, σB can be divided into background signal shot noise, (σB)s and 
flicker noise (σB)f. On the other hand, σdt includes the actual noise in the dark current, σd, and the 
amplifier-readout noise, σar. Finally, σd is contributed from the dark current shot noise, (σd)s, and 
the excess noise, (σd)ex. The rms noise from different sources can be added up quadratically if all 
of them are assumed to be totally uncorrelated. The affiliation among all these various noise 
sources is summarized in Fig. 20. It can be concluded that there are three primary noises sources 
existing in the analog signal processing: the noise in the analytical signal, the noise in the 
background signal, and the noise from the dark current and amplifier-readout system.
152
 
 
Figure 20. Various rms noise sources for a photoluminescence measurement 
 
S/N is an important parameter of the system. Mathematically, it is defined as  
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 (14) 
For a confocal LIF system with a PMT as fluorescence signal monitor, the main sources of (σS)s 
are shot noise, including the quantum noise and PMT multiplication noise. (σS)f is mainly due to 
the variation in laser radiance resulted from the fluctuation in the electrical power, temperature 
or vibrations. Besides, the vibration of the whole setup, especially the sample stage also 
contributes to the flicker noise in analytical signal. σB mainly comes from background scattering 
and luminescence noises, such as the noise of scattering light from the wall of the microchannel, 
and noises of light from computer monitor or other additional light sources in the room. It is 
worth to notice that laser flicker noise is also related with σB, because just like the analytical 
fluorescence, the background fluorescence and scattering signals are also proportional to the 
radiant power of excitation source and will be affected equivalently as the analytical signal by 
the source flicker noise. σdt is relatively weak compared with other noises mentioned above 
according to the listed values provided the manufacturer.
152
 
2.4.3.2 Identification of different noise sources  
Several experiments were designed to test the rms noises from different sources and identify the 
dominant one(s) in the system. The first experiment mainly was designed to test the 
environmental noises such as the luminescence from computer monitor and a weak ceiling lamp. 
The laser power was set to be 3.0 mW and PMT control voltage was 0.556 V. No cover glass 
was placed on the sample stage and stage C was not shielded with light tight cover. The sampling 
rate was 10 Hz. A LUCPLFLN 20 x objective is used in the system. The results of this 
experiment are summarized in Table 10. 
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Table 10. Environmental noises experiment 
Parameters Only monitor on Only lamp on 
Monitor On and  
 Lamp On 
Monitor off and 
Lamp off 
σbk (mV) 2.460 2.165 3.338 0.428 
Ebk (mV) 0.494 7.578 8.674 0.206 
Laser power is 3.0 mW; PMT control voltage is 0.556 V; 20x objective; Sampling rate is 10 Hz; No cover glass on the stage; 
sample is not loaded; no light tight cover over the stage C. 
 
It is indicated by the Table 10 that the main blank signal and noises (without chip) in this 
experiment were resulted from background luminescence of the computer monitor and ceiling 
lamp. The dark current and amplifier readout contributed only a very small portion of the blank 
signal and noise with values of only 0.206 mV and 0.428 mV, respectively. As the noise from 
the computer monitor, σM, ceiling lamp, σL, and total dark current noise, σtd, are independent, 
they can be added quadratically as follows 
     √  
    
     
  (15) 
Based on Eq. 15 and the data in Table 10, the rms noises and signal from different 
sources and their contribution (%) can be calculated as in Table 11. It is obvious that ceiling 
lamp contributed 93.7% of the background signal. Meanwhile noises from computer monitor and 
ceiling lamp accounted for 55.6% and 42.7% of the total noises, respectively. Therefore, it was 
necessary to turn off the ceiling lamp and shield the stage C with a light tight cover during the 
experiments to minimize these background noises. 
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Table 11. rms noise from different background sources 
Parameters 
Monitor Only 
(Calc.) 
Lamp Only 
(Calc.) 
Total Dark Current 
(Expt.) 
Monitor, Lamp and total dark current 
Calc.
 *1
 Expt.
 *2
 
σbk (mV) 2.422 2.122 0.428 
3.248 3.338 
% 55.6 42.7 1.74 
Ebk (mV) 0.288 7.372 0.206 
7.866 8.674 
% 3.66 93.7 2.62 
*1 Obtained by adding the values in the first three columns. 
*2 Obtained from Table 10 under the conditions when computer monitor and ceiling lamp are both on. 
 
The following experiment was designed to study the noises from the scattering and 
reflecting light from the cover glass. Most of the basic parameters for this experiment were same 
with that in the first experiment, except that a cover glass of 1 mm thickness was placed on the 
sample stage and the laser power was increase to 7.4 mW. Ceiling lamp was kept off for all the 
experiments discussed below. The total signal and rms noise from scattering light are 
summarized in Table 12.  
Table 12. Scattering experiment 
Parameters Scattering Expt. 
Total dark current 
(from Table 10) 
Scattering light 
(Calc.) 
σbk (mV) 0.662 0.428 0.505 
Ebk (mV) 0.485 0.206 0.279 
Laser power is 7.4 mW; PMT control voltage is 0.556 V; 20x objective; Sampling rate is 10 Hz; with cover glass on the stage; 
sample is not loaded; both computer monitor and ceiling lamp are off, no light tight cover over the stage C. 
 
Compared with σdt in the first experiment, the result in the scattering experiment where 
computer monitor was off showed a little increase in its value. This was due to the noise of 
scattering light from the cover glass. Assuming that σdt was the same for both experiments, the 
contribution of signal and noise from the scattering light could be estimated to be 0.279 mV and 
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0.505 mV, respectively, which were relatively weak compared with the noise from the computer 
monitor and ceiling lamp. 
In the third experiment, the laser head and PMT were temporarily removed from the 
system and lined up with several neutral density filters between them. The heights of the PMT 
and laser were adjusted so that laser beam was just aimed at the active surface of the PMT. The 
goal of this experiment was to test the noise contributed by the laser and PMT together. Like the 
scattering experiment, the sampling rate for this experiment was 10 Hz and the experiment was 
carried out when the ceiling lamp and computer monitor were both off. Results and main 
parameters of this experiment are listed in Table 13.  
Table 13. Laser beam and PMT stability analysis 
Run # 
Laser Power 
 (mW) 
Neutral Density Filter  
(OD) 
σt  
(V) 
Et  
(V) 
S/N 
(Et/σt) 
1 3.00 4 0.014 5.861 413 
2 10.0 5 0.007 1.538 220 
3 15.0 5 0.008 2.418 286 
Sampling rate is 10 Hz; ceiling lamp and computer monitor are both off; PMT control voltage 0.375 V. 
 
In this experiment, the laser beam could be treated as the analytical signal. The noise 
sources in this experiment composed of the shot noise of PMT and laser flicker noise.  Based on 
the results from the first noise experiment, total dark noise only accounted for a small portion of 
the total noise. Table 13 shows that the total rms noise from PMT and laser increased when the 
analytical signal was enhanced. Linear fitting of lg(Et/σt) against lg(Et) in Fig. 21 shows that S/N 
was directly proportional to (Et)
0.46
, which further demonstrates that the shot noise was the 
dominant source of noise as the exponent was close to 0.5. 
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Figure 21．Relationship between Et/σt and Et when noises are contributed by laser and PMT  
 
Finally, the real sample was tested when the stage C was shielded with a light tight cover. 
The ceiling lamp was kept off throughout the experiment, but the computer monitor was not 
turned off, which was required to monitor and control the experiments. A 40x objective was 
installed in the system. Newly prepared sample solution, which contained 0.50 mM ThioGlo-1 
and 0.10 mM GSH in 50 mM Tris-HCl buffer (pH=7.0), was loaded into the large reservoir on 
microfluidic chip shown in Fig. 15. The sample was then introduced into the channel by applying 
vacuum at the other end of the channel. The level of the stage A was finely adjusted so that the 
laser beam was focused onto the solution inside the channel. PMT control voltage was set to be 
0.5 V and the laser power was fixed at 3.0 mW. The total rms noise was 0.084 V, while the total 
signal was 6.896 V (Table 14). Fig. 22 is a picture of microfluidic chip with sample in reservoir 
taken during the experiment. Compared with the rms noise in the previous experiments, it is 
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8
2.30
2.35
2.40
2.45
2.50
2.55
2.60
2.65  Experimental data
 Linear fitting
lg
(E
t/
t)
lgE
t
lgE
t
/
t
=2.26+0.46lgE
t
R
2
=0.996
 68 
obvious that analytical signal shot noise and flicker noise accounted for a large percentage of the 
total noise. 
 
Figure 22. Photograph of the microfluidic chip during the experiment 
2.4.3.3 Noise reduction  
Three different methods will be applied to reduce the noise in our system, averaging and 
low pass filter, reduction of stage vibration. As we already know that the analytical and 
background shot noise, (σS)s, is a fundamental noise is due to the random emission of photons 
from a source and the random fluctuation in the PMT gain due to the random nature of secondary 
emission of electrons in the dynodes. The probability of photon counts in a certain integration 
time can be described with the Poisson probability distribution with a well-defined mean and 
variance. As the magnitude of the shot noise power is independent of frequency, it belongs to 
white noise (or Gaussian noise).
152
 When the expected value of noise is zero, after performing 
signal averaging, the expected value of the output signal is statistically close to the mean. While 
the expected value of the rms noise will be reduced to 1/√  of the original rms noise based on 
the error propagation formula and quadratic addition (additive variances) property, where n is the 
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number of points used in the averaging. Therefore, the S/N will be enhanced to √  of the value 
before signal averaging is performed. It must be noticed that signal averaging doesn’t correct for 
pink noise or interference noise. In addition, proper correction must be done before it is applied 
to signal with a time-dependent drifting characteristics.
205
  
When applying averaging in experiments, attention must be paid to some practical limits, 
such as the sample clock rate of the DAQ device, the processor’s speed, buffer size. Besides, all 
samples taken for averaging should come from a range of time where the real signal varies little 
in amplitude compared with the error that you are trying to eliminate. In other words, it is 
necessary to know the maximum frequency component of a signal. In our system, the resolution 
is acceptable when using a sampling rate of 20 Hz (50 ms/point) for a peak with a standard 
deviation of 0.1 s (about 10 points per signal peak (5σ)). If we set the sample clock rate of the 
DAQ device to be 10000 Hz and the number of averaged points to be 100, the temporal 
resolution for the system will remain to be 10 ms (100 Hz). Because the number of averaged 
points in one period will be 100 and the rms noise will decrease to 1/10 of its original value.  
Averaging is simply achieved by using “averaging function” in control program. The 
averaging time was fixed to be 50 ms, but the sample clock rate was changed from 20, 100, 1000, 
10000 and 100000 Hz. In this case, the temporal resolution (50 ms or 20 Hz) was maintained at a 
same level for all the experiments while different numbers of points, n, were averaged. PMT 
control voltage was adjusted to be 0.5 V and the laser power was set to be 3.0 mW. Sample 
solutions, which contained 0.50 mM ThioGlo-1 and 0.10 mM GSH in 50 mM Tris-HCl buffer at 
pH 7.0, was introduced into the microchannel of the microfluidic chip shown in Fig. 15 by 
applying vacuum at the other end of the channel. A 40x objective was used to focus the laser 
beam into the center of the channel. The results are shown in Table 14 and Fig. 23. 
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Table 14. Signal averaging experiment
 
Sample Clock Rate Averaged Points Averaged time (ms) Et (V) σavg(V) S/N (Et/σavg) 
20 1 50 6.896 0.084 82 
100 5 50 6.916 0.030 227 
1000 50 50 6.889 0.014 492 
10000 500 50 6.863 0.013 531 
100000 5000 50 6.852 0.011 614 
Laser power is 3.0 mW; PMT control voltage is 0.5 V; 40x objective; averaging time is 50 ms (sampling rate 20 Hz); ceiling 
lamp is off and computer monitor is on; light tight cover over the stage C; laser is focused to the center of the channel. 
 
 
Figure 23.  Results from signal averaging experiment 
(a) PMT signals obtained when different averaged points (pts) are applied; (b) linear fitting of averaged rms noise to 
the number of averaged points in the log plot. 
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phenomenon implies that there are some other noise sources with certain frequencies in our 
system, which cannot be removed by performing signal averaging. Those noises must be 
removed by applying other methods. 
The function of an electronic low pass filter is to restrict the bandwidth of the input signal 
so that the aliases caused by the noise with frequency higher than Nyquist frequency can be 
removed. Nyquist frequency is defined as half of the sampling frequency in a sampling system. 
Aliasing exists when the frequency of a signal or noise is higher than the Nyquist frequency. 
When the highest frequency component of interest in the measurement is higher than the Nyquist 
frequency, the signal of interest will be under sampled and the sampling rate will generate an 
incorrect low frequency alias. Meanwhile, the actual signal usually contain noises with 
frequencies that is higher than the Nyquist frequency, aliases of these frequencies will be added 
to the signal of interest, distort the otherwise correct signal and generate a noisy background.
206
 
 The alias frequency fa of a signal or noise with high frequency equals to the minimum 
absolute value of the difference between the frequency of the input signal, f, and the closest 
integer multiple of the sampling rate, Nfs, as given by Eq. 16 
    |     |    (16) 
It can be deduced from the above equation that signal must be sampled at a rate no less than 
twice the highest frequency component of interest in the signal (fs>2f) in order to capture the 
highest frequency component of interest and prevent aliasing.
207
 In practice, the sampling rate 
must be set high enough (about 5 to 10 times the highest frequency components in the signal) to 
obtain accurate measurements in the output data. Meanwhile, to prevent aliasing of noises with 
high frequencies, it is often necessary to add a low pass filter to attenuate frequencies higher than 
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the Nyquist frequency and restrict the bandwidth of the input signal before the analog-to-digital 
converter (ADC) in the DAQ device.   
In the following experiment, a Wavetek 852 dual Hi/Lo variable filter (Willtek, Germany) 
was added between the signal output end of PMT and DAQ device. PMT control voltage was 
adjusted to be 0.5 V and the laser power was set to be 3.0 mW. Newly prepared sample solutions 
containing 0.50 mM ThioGlo-1 and 0.10 mM GSH in 50 mM Tris-HCl buffer at pH 7.0 was 
loaded into the big reservoir of the microfluidic chip shown in Fig. 15. A 40x objective was used 
to focus the laser beam into the center of the reservoir. The sample clock rate was kept at 1000 
Hz throughout the experiment and no averaging was performed. The cut off frequency of the 
filter was changed from 10 Hz to 5000 Hz. Under each specific frequency, the experiment was 
repeated for 10 runs and each lasted for ~15 s. Before using with Fast Fourier Transform (FFT) 
to extract the character frequency of the noise, all data sets were treated with the methods 
described by Morgan and Weber.
207
 Briefly, a smoothed curve was obtained for each run by 
using adjacent averaging. This smoothed curve was then subtracted from each original curve, 
respectively. The resulted data sets were finally treated with FFT and averaged. The results after 
adding a low pass filter is summarized in Table 15 and Fig. 24. It can be seen from the data that 
the analytical signal is accompanied by noises with several characteristic frequencies around 20 
Hz, 30 Hz, 45 Hz and 60 Hz. When the cutoff frequency of the low pass filter is decreased, noise 
with frequencies higher than the cut-off frequency disappears and the total rms noise level goes 
down, too. Besides, the frequencies of the noise are concentrated below 100 Hz, therefore when 
the cut off frequency is higher than 100 Hz, the low pass filter has no obvious effect for 
decreasing the total rms noise.  
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Table 15. Low pass filter experiment 
Cut Off Freq. (Hz) Et (V) σt (V) S/N (Et/σt) 
No filter 5.449 0.049 111 
5 5.313 0.006 864 
50 5.530 0.037 150 
500 5.548 0.035 159 
5000 5.520 0.037 150 
Laser power is 3.0 mW; PMT control voltage is 0.5 V; 40x objective; sample clock rate is 1000 Hz; ceiling lamp is off and 
computer monitor is on; light tight cover over the stage C; laser is focused to the center of the reservoir. 
Channel A of the dual Hi/Lo filter is used with 0 dB gain and flat amplitude. 
 
 
 
Figure 24. FFT results showing the effect of low pass filter with different cutoff frequency 
(a) No filter; (b) 5 Hz; (c) 50 Hz. 
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Further experiments proved that some of the noises with frequencies lower than 100 Hz 
were caused by the vibration of the lab bench (and the building) to the sample stage. In the 
following experiments, a rubber layer was placed under the platform of stage A and all the steal 
screws on this platform were replaced with plastic ones to dampen and mitigate the 
transference of vibrations from the bench to sample platform. Fluorescence signals from newly 
prepared ThioGlo-1 (0.50 mM) and GSH (0.10 mM) mixture loaded inside the big reservoir of 
the same microfluidic chip (Fig. 15) were collected with or without four racquetballs added 
under the optical breadboard. According to the results (see Table 16 and Fig. 25), there is a 
distinguishable change in the noise intensity, which proves that the sources for these noise are 
related with vibration. 
  Table 16. Vibration experiment 
With racquetballs? Et (V) σt (V) S/N (Et/σt) 
Yes 6.712 0.024 282 
No 6.583 0.051 128 
*1 laser power is 3.0 mW; PMT control voltage is 0.4 V; 40 x objectives; light tight cover over the stage C; sampling rate is 1000 
Hz, no averaging and low pass filter; laser is focused to the center of the reservoir. 
 
 
Figure 25. FFT results showing the effect of racquetballs in the vibration experiment 
(a) No racquetballs; (b) with racquetballs under the breadboard. 
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To further reduce the noises and increase the S/N, a heavy-duty aluminum frame stage 
was specially designed and made to accommodate the confocal LIF detection system. The whole 
breadboard, on which the detection system was built, was hanged in the air with four elastic 
ropes fixed to the roof of the frame stage. Black light tight curtains were installed on four sides 
of the frame stage to minimize the light from environment. In addition, the platform of stage A 
was supported from below with a spring tension rod to dampen the vibration and give addition 
support. Beam alignment was performed after the detection system was installed into the frame 
stage. 
The following experiments showed the effects of averaging and low pass filter on the 
new system where transference of vibrations from the bench to sample platform was effective 
blocked. Sample containing 10.7 µM GSH and 50 µM ThioGlo-1 was loaded into the big 
reservoir of the same microfluidic chip as before. The control voltage of PMT was set at 0.5 V 
while the laser beam of 3.0 mW was focused on the center of the reservoir by a 40 x objective. 
The results from averaging experiment for the new system were summarized in Table 17 and Fig. 
26. Compared with the results for the old system (Table 14, Fig. 23), it is clearly that the 
fluorescence response of the new system is much better than the old system. Fluorescence signal 
of a 10 times diluted sample in the new system is as high as one third of the signal of an 
undiluted sample in the old system using the same PMT control voltage and laser power. 
Meanwhile, the best S/N obtained from averaging in the new system is three times higher than 
that of the old system. Fig. 26 shows that, unlike that in the old system, data averaging 
effectively decreases the rms noise until the number of the averaging points reaches 500 for a 
system. This is consistent with the fact that averaging will be most effective when flick noise 
generated by vibration is pre-removed from the system and white noise becomes the dominant 
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noise source. The results from Low pass filter experiment are summarized in Table 18 and Fig. 
27. The S/N values shown in Table 18 are also better than that in Table 15. The best S/N 
obtained under 5 Hz cut-off frequency for the new system is 2.6 times higher than that for the old 
system. Fig. 27 indicates that the noise power is decreased by two orders of magnitude for the 
new system compared to that of the old system. The special frequencies below 100 Hz in Fig. 24 
(a) disappear in Fig. 27 (a). By applying a low pass filter with 5-500 Hz cut-off frequency, the 
rms noise is further decreased as shown in the power spectrum. It must be pointed that although 
the low pass filter is effective in reducing the aliases of noises with high frequency, noises at 
frequencies of 10 Hz, 60 Hz and 180 Hz can be introduced into the system by the low pass filter 
as shown in Fig. 27 (c) and (d). Frequencies at 60 Hz and 180 Hz are most likely picked up from 
the power line hum and its harmonics. Based on these results, a low pass filter with 50 Hz cut-off 
frequency and 500 points data averaging will be applied in the further experiment unless 
otherwise specified.  
Table 17. Effect of signal averaging for the new system
 
Sample Clock Rate Averaged Points Averaged time (ms) Et (V) σavg(V) S/N (Et/σavg) 
20 1 50 2.408 0.0248 97 
100 5 50 2.211 0.010 214 
1000 50 50 2.333 0.004 648 
10000 500 50 2.167 0.001 1477 
100000 5000 50 2.265 0.001 1878 
Laser power is 3.0 mW; PMT control voltage is 0.5 V; 40 x objective; averaging time is 50 ms (sampling rate 20 Hz); no low 
pass filter; the whole system is covered with light tight curtains; laser is focused to the center of the reservoir. 
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Figure 26.  Effect of averaging for the new system 
 
Table 18. Effect of the low pass filter for the new system
 
Cut Off Freq. (Hz) Et (V) σt (V) S/N (Et/σt) 
No filter 2.186 0.024 92 
5 2.110 0.001 2255 
50 2.137 0.002 1083 
500 2.126 0.004 505 
5000 2.164 0.012 184 
Laser power is 3.0 mW; PMT control voltage is 0.5 V; 40 x objective; sample clock rate is 1000 Hz; no averaging is performed; 
the whole system is covered with light tight curtains; laser is focused to the center of the reservoir; only channel A of the dual 
Hi/Lo filter is used with 0 dB gain and flat amplitude. 
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Figure 27. FFT results showing the effect of low pass filter with different cutoff frequency  
(a) No filter; (b) 5 Hz; (c) 50 Hz; (d) 500 Hz. 
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fluorescence responses and PMT control voltage/laser power and the linearity of the signal 
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loaded into the big reservoir on microfluidic chip in Fig. 15. The averaging time was set to be 50 
ms when the sample clock rate was 1000 Hz. The cutoff frequency of the low pass filter was 
adjusted to 10 Hz. The laser beam with a power of 3.0 mW was focused on the sample with a 
40x objective. Fig. 28 (a) indicates an optimal range of PMT control voltage where Et/σt reached 
its highest level. The experiment conditions in laser power experiment were similar to those in 
PMT control voltage experiment, except that the control voltage for PMT was fixed at 0.5 V 
while laser power varied in different runs. Fig. 28(b) shows that the fluorescence from the 
analyte would not increase boundlessly when the power of laser was enhanced. This is mainly 
because the optical saturation of the absorbance transition for the analyte will arrive finally under 
a high irradiance of the beam. A significant fraction of the analyte will be raised to the excited 
state and the number of photons absorbed per second approaches the spontaneous emission rate 
under the first approximation. The increase in the laser power thereafter will only lead to photo 
degradation of the sample.
167
  
Sample solutions with different concentration of ThioGlo-1 and GSH were also used to 
test the linearity of fluorescence response to the analyte concentration. All other conditions were 
same as the previous experiments. Results from linearity experiments are given in Fig. 27. When 
the PMT control voltage was set at 0.5 V and laser power was adjusted to 3.0 mW, the linear 
range for GSH ([GSH]: [ThioGlo-1] = 1:5) for the current setup spanned from 0-49.7 μM 
(analyte with higher concentration was not tested under the current condition, as the high optical 
intensity would cause the saturation and damage of the PMT). The detection limit was estimated 
to be 1.45 nM (Eq. 17) with the mass detection limit as low as 10
-18
 mol: 
     
    
     
 
           
       
         (17) 
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Figure 28. Relationship between the fluorescence intensity and (a) PMT control voltage and (b) laser power 
 
Figure 29. Linearity between fluorescence signal and analyte concentration  
Note: due to the existence of photobleaching, data collected in the first 50 s was not used in the calculation. 
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3.0  ON-CHIP MONITORING OF THE REDUCTION OF OXIDIZED 
GLUTATHIONE BY GLUTATHIONE REDUCTASE  
Part of the following work has been published in Analytical Chemistry 2010, 82(17):7267-7273 
A microfluidic chip has been designed, which integrates the precolumn derivatization, 
continuous flow gated sampling, separation and detection on a single device. We validated this 
device for monitoring GSH level by studying the kinetics of glutathione reductase (GR, EC 
1.8.1.7), an enzyme that catalyzes the reduction of GSSG to GSH in the presence of β-NADPH 
(β-nicotinamide adenine dinucleotide phosphate, reduced form) as a reducing cofactor. We 
demonstrate here that the fluorogenic, thiol-specific reagent, ThioGlo-1, reacts rapidly enough 
for efficient precolumn derivatization. The second order rate constant for the reaction of GSH 
and reagent (pH 7.5, room temperature) is 2.1 x 10
4
 M
-1
s
-1
. During the experiment, GSH being 
generated in the enzymatic reaction was labeled with ThioGlo-1 as it passed through a mixing 
channel on the microfluidic chip. Derivatization reaction products were introduced into the 
analysis channel every 10 s using flow gated injections of 0.1 s. Baseline separation of the 
internal standard, ThioGlo-1, and the fluorescently labeled GSH was successfully achieved 
within 4.5 s in a 9 mm separation channel. Relative standard deviation of the peak area, peak 
height, and full width at half maximum (FWHM) for the internal standard were 2.5%, 2.0%, 
1.0%, respectively with migration time reproducibility for the internal standard of less than 0.1% 
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RSD in any experiment. The GSH concentration and mass detection limit were 4.2 nM and ~10
-
18
 mol, respectively. The Michaelis constants (Km) for GSSG and β-NADPH were found to be 40 
± 11 μM and 4.4 ± 0.6 μM, respectively, comparable with those obtained from UV/Vis 
spectrophotometric measurements. Our system is capable of integrating derivatization, injection, 
separation and detection for continuous GSH determinations. 
3.1 INTRODUCTION 
The ubiquitous tripeptide, GSH acts as an anti-oxidant in cells.
28
 It is particularly important for 
its ability to react with reactive oxygen species (ROS) directly or indirectly making it a principal 
component of an organism’s antioxidant response.3 Compared with other organs, brain is 
especially vulnerable to ROS because it is rich in lipids with unsaturated fatty acids.
4, 208
 
Oxidized glutathione, GSSG, is reduced to GSH by the NADPH-dependent enzyme GR. 
Alterations in this energy (NADPH)-redox (GSH/GSSG) “axis” occur in aging, and are thought 
to be responsible for the progress of neurodegenerative diseases.
209, 210
 Efflux rates of GSH from 
astrocytes through hemichannels can be gated by changes in the concentration of extracellular 
Ca
2+
,
60
 and hypoxia-ischemia.
211
 Thus, there is an interest in continuous monitoring of GSH, and 
related thiols in the extracellular space of tissues, including brain with good temporal 
resolution.
3, 60, 212
 Both electrochemical
213, 214
 and fluorescence detection
215, 216
 of GSH and other 
thiols has been used with high performance liquid chromatography and capillary electrophoresis. 
Determination of GSH and related thiols on microfluidic chips has been performed using UV,
217
 
and electrochemical detection.
189
 Laser induced fluorescence (LIF) detection
179, 180, 190
 on 
microfluidic chips used offline derivatization of GSH and other thiols. Despite the need for the 
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derivatization, LIF is widely applied for its robust nature and consistent calibration compared to 
electrochemical detection. Also, labeling of the thiol group reduces its reactivity during the 
analysis, protecting it from degradation.
93
 Qin
182
 and Ling
97
 et al. briefly mentioned the use of 
2,3-naphthalene dicarboxaldehyde (NDA) for on-column derivatization of GSH by simply 
including the fluorescent tag in the electrophoresis buffer. However, as the derivatization process 
was carried out simultaneously with separation, this approach is not optimal. The goal of this 
work is to improve the analysis platform for thiols, including the speed of the separation, the 
detection limit of the determination, using a derivatizing reagent that is thiol-specific, and doing 
continuous analysis.   
The published reaction times for fluorogenic labeling of thiols are fairly long, which 
commonly range from several minutes to an hour.
218-222
 Some of them even require heating for a 
fast and complete derivatization.
219, 222
 We and others have used a commercial fluorescent tag, 
ThioGlo-1
223
 (N-(2-carbomethoxy-9-methoxy-3-oxo-3H-naphtho [2,1-b] pyran-10-yl) 
maleimide) for labeling thiols in intact cells,
224-226
 cell homogenates or supernants.
225, 227
 Others 
have shown the potential of ThioGlo reagents for labeling thiols before HPLC analysis.
228
  These 
derivatizations were performed offline with a 20-minute reaction time. In this work, we 
determined the reaction rate at pH 7.5 for the derivatization of GSH by ThioGlo-1 and 
demonstrated the feasibility of using ThioGlo-1 for online derivatization of GSH.  
GR is a flavoprotein that catalyzes the β-NADPH-dependent reduction of GSSG to GSH 
and maintains a suitable intracellular thiol/disulfide redox potential for an organism.
229, 230
 
Maintaining an adequate level of reduced cellular GSH over GSSG is especially important for 
cells to fight against oxidative stresses and xenobiotics.
10, 26
 The kinetics and mechanism of the 
GR catalyzed reactions have been studied.
229-232
 The most widely used tool to analyze the 
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kinetics and mechanism of GR is UV/Vis absorbance as described by Racker,
233
 which relies on 
the decrease in the absorbance at 340 nm of NADPH. Transferring the enzyme reaction from the 
traditional cuvette or well plate to microchannels with LIF detection not only reduces the 
consumption of samples and reagents, but also has much higher sensitivity compared with that of 
UV/Vis absorbance detection. Meanwhile, interferences caused by other chemicals that coexist 
with the target compound, such as enzyme, by product, unreacted substrates would be eliminated 
from the detection by separation, which ensures more reliable results.  
In the following research, we used the reaction catalyzed by GR as a model system to 
validate the online derivatization, multiple injection, separation and detection of GSH with good 
temporal resolution on an integrated microfluidic platform. GSH concentration in the enzyme 
reaction mixture was measured using an online precolumn derivatization and a 4.5 s 
electrophoretic separation. In any given experiment, the reproducibility of the migration times of 
the internal standard was excellent, less than 0.1% relative standard deviation. The obtained 
kinetic constants for GR are comparable with those obtained through traditional methods. 
3.2 EXPERIMENTAL SECTION 
3.2.1 Chemicals and reagents 
ThioGlo-1 was purchased from Calbiochem (San Diego, CA). Proflavine hemisulfate salt 
hydrate (PFH), sodium hydroxide, tris(hydroxymethyl) aminomethane, hydrochloric acid, GR 
from baker’s yeast (suspended in 3.6 M ammonium sulfate, 168 units/mg protein, containing  0.1 
mM dithiothreitol, pH=7.0), dimethyl sulfoxide (DMSO), GSH, GSSG disodium salt, β-
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nicotinamide adenine dinucleotide phosphate, tetrasodium salt hydrate, and 1,6-diaminohexane 
were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO) and used without 
purification. 
Stock solutions of GR, GSSG and β-NADPH were prepared using 20 mM Tris-HCl 
buffer (pH = 7.5). The concentrations of these solutions were 3.33 units /mL, 13.2 mM, and 2.41 
mM, respectively. The stock solutions of PFH and ThioGlo-1 were prepared using Milli-Q water 
(Millipore Co., Billerica, MA) and DMSO with the final concentrations of 4.74 mM and 2.5 
mM, respectively. Stock solutions were aliquoted into small vials and stored at -20 °C and 
diluted serially to the desired concentrations on the day of experiment. All working solutions 
were kept on ice during the experiment when not in use. The running buffer for microfluidic chip 
electrophoresis was 20 mM Tris-HCl buffer (pH = 7.5) with 0.1 mM 1, 6-diaminohexane, unless 
otherwise specified. All buffers were prepared using Milli-Q water, filtered through Nylon 0.22 
μm filter and degassed by ultrasonication prior to use. 
3.2.2 Design and fabrication of the microfluidic chip 
The microfluidic chip used in our experiments was fabricated using traditional lithography 
techniques. Briefly, borofloat glass (1.1 mm) coated with chromium and AZ 1500 photoresist 
(Telic, Valencia, CA) was exposed to UV light through a negative film mask (Pixels, 
Charlottesville, VA) containing the design of the channels to be etched. Following development 
and removal of the underlying chrome, the glass was etched in HF solution containing nitric acid 
(HF/HNO3/H2O:20/14/66) to a depth of 20 µm. The remaining photoresist and chromium was 
then removed and the glass cleaned and dried. Uncoated borofloat cover glass was drilled using 
1.1 mm diameter diamond tipped drill bits (Kingsley North Inc., Norway, MI) to provide access 
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holes at the end of each channel. Cover plates were cleaned and aligned with the etched glass 
plate and the two pressed together to form an initial bond. The device was permanently bonded 
by thermal annealing at 675 C for 3.5 hours. The layout of the microfluidic chip and the voltage 
scheme are shown in Fig. 30. RR, SR, BR, and WR represent reagent reservoir, sample reservoir, 
buffer reservoir and waste reservoir, respectively. The channels were determined to be ~30 μm 
wide at the bottom and ~70 μm wide at the top, with a depth of ~20 μm. The total length of the 
precolumn reaction channel was ~46.3 mm. The detection point (DP) was located 9 mm from the 
injection cross. Platinum electrodes were placed into all reservoirs to serve as electrical contacts 
to the high voltage power supply. During each run, the electrodes in reagent reservoir and sample 
reservoir were kept at ground, while the electrode in waste reservoir was connected to a single 
channel negative high voltage power supply (UltraVolt, Inc., Ronkonkoma, NY). Sample 
injection was by a gated approach, which has advantages in shortening the analysis cycle, 
enhancing the temporal resolution and reducing contamination between reservoirs.
234, 235
 The 
electrode in buffer reservoir could be switched between “GND” and “floating” to achieve the 
flow gated sampling. In the “sampling” stage, the electrode in buffer reservoir was set to “float” 
for a very short period allowing a small segment of the reaction mixture to be directed into the 
separation channel. In the “separation” step, this electrode was switched back to ground, 
resulting in electrophoretic separation of the components in the injected aliquot. These steps 
were computer controlled and repeated automatically to achieve continuous sampling and 
analysis. 
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Figure 30. Layout of the microfluidic chip used for enzyme analysis 
3.2.3 Reaction between ThioGlo-1 and GSH 
A SpectraMax M2 from Molecular Devices (Sunnyvale, CA) was used in measurement of the 
reaction between ThioGlo-1 and GSH at 25°C. The excitation and emission wavelengths were 
set at 403 nm and 495 nm, respectively. The reaction between 29.7 μM GSH and 15 μM 
ThioGlo-1 were monitored in a series of 50.1 mM Tris-Acetate buffers at different pH value 
ranging from 4 to 9 for optimizing the reaction condition of online precolumn derivatization. The 
measurement was started right after two reactants were well mixed. The kinetic parameters of the 
reaction between GSH and ThioGlo-1 in 20 mM Tris-HCl buffer at pH 7.5 were also measured. 
In order to accurately record the start point of the reaction and establish the baseline, the 
fluorescence reading was started before GSH and ThioGlo-1 was mixed. At the beginning of the 
experiment, the cuvette contained only ThioGlo-1 dissolved in 20 mM Tris buffer solution at pH 
7.5. The addition of GSH stock solution into the cuvette followed by mixing using a pipette for 
2-4 s caused a sharp increase of fluorescence intensity, which marked the start point of the 
reaction.  
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3.2.4 Enzyme kinetics measurement 
The home-made confocal LIF detection system described in Chapter 2 was used to detect the 
analyte in the microfluidic experiments. The PMT control voltage was set at 0.5 V and the laser 
power was adjusted to 3.0 mW. Before each run, mixtures of β-NADPH and GSSG at the desired 
concentrations were prepared using 20 mM Tris-HCl buffer (pH = 7.5) and transferred into the 
sample reservoir. Derivatizing reagent, which contains 50 μM ThioGlo-1 and 1.9 μM PFH as 
internal standard, was prepared using 20 mM Tris-HCl buffer (pH = 7.5) with 0.1 mM 1,6-
diaminohexane then added into reagent reservoir. Buffer reservoir and waste reservoir were both 
filled with running buffer. The enzyme catalyzed reaction was initiated by the addition of 10 μL 
of GR solution into the substrate mixture in sample reservoir to achieve a final concentration of 
7.93x10-4 unit/mL unless otherwise specified. The final volume of solution in each reservoir was 
200 μL. Immediately after addition of GR, -6000 V was applied to waste reservoir, while reagent 
reservoir and sample reservoir were kept at ground and buffer reservoir was switched between 
two states, “GND” and “floating”. Typically, the sampling time was 0.1 s and the separation time 
was 9.9 s unless otherwise stated. There were usually 40-50 repeat injections for each sample per 
run. Before changing to the next sample, the channels were rinsed and reconditioned in sequence 
with 0.1 M NaOH and running buffer each for 5 minutes by applying -6000 V at waste reservoir 
and keeping all other reservoirs at ground. All experiments were carried out at room temperature. 
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3.3 RESULTS AND DISCUSSIOIN 
3.3.1 Derivatization of GSH with ThioGlo-1 
ThioGlo-1 is selected as a fluorescent derivatizing reagent of GSH based on its distinctive 
properties compared to other widely used reagents mentioned in Section 1.2.2.  ThioGlo-1 is a 
maleimide derivative of naphthopyranone fluorophore.
223
 It has very low quantum yield before 
reacting with thiols, while adduct of ThioGlo-1 and GSH has a high quantum yield. The stock 
solution of ThioGlo-1 in DMSO is very stable and the hydrolyzed products are all inactive with 
thiol group and have low quantum yield. The hydrolysis rate of the ThioGlo-1 is slower than 
most other maleimide reagent. Most important, the reaction between ThioGlo-1 and GSH is very 
fast in buffer solution at pH 7.0.
236
  
 
Figure 31. Reaction between ThioGlo-1 and thiols 
 
The reaction between GSH and ThioGlo-1 shown in Fig. 31 was monitored using a 
commercial spectrofluorometer to test its suitability and optimize the reaction conditions for 
online precolumn derivatization. Fig. 32 shows the change of the fluorescence intensity (relative 
fluorescence unit, RFU) with time at different pH value. The fluorescent signal is directly 
proportional to the concentration of the fluorescent adduct. When pH value is lower than 7, the 
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reaction between GSH and ThioGlo-1 is relatively slow compared with solutions with higher pH 
value. Besides, there is a small decrease in the fluorescence intensity when pH value reaches 9, 
which may due to the fast oxidation of GSH to GSSG at high pH value. Based on this result, Tris 
buffer at pH 7.5 is selected as the buffer solution for the derivatization of GSH with ThioGlo-1.  
 
Figure 32. pH effect on the reaction of ThioGlo-1 and GSH 
 
It has been observed that the reaction of GSH and ThioGlo-1 at pH above 7 will be 
completed in seconds. The complete time course of the reaction between GSH and ThioGlo-1 in 
20 mM Tris buffer solution at pH 7.5 shown in Fig. 33 indicates that it takes about 14 s to 
generate a fluorescent signal equivalent to 95% of the signal intensity at equilibrium when the 
initial concentrations of GSH and ThioGlo-1 are 5 μM and 25 μM, respectively. Based on this 
fact, it is reasonable to assume that under the similar conditions the precolumn derivatization in 
the reaction channel will be nearly complete as long as the online derivatization reaction lasts 
longer than 14 s. 
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Figure 33. Change of RFU with time for the reaction of ThioGlo-1 and GSH 
 
To obtain the kinetic parameters for the reaction between GSH and ThioGlo-1 in a 20 
mM Tris buffer solution at pH 7.5, seventeen complete time courses of the reaction between 
GSH with initial concentrations ranging from 0 μM to 15 μM and ThioGlo-1 with a fixed 
concentration of 5 μM were recorded. Fig. 34 (a) shows nine out of the seventeen time progress 
curves with the initial GSH concentrations of 0.5 µM, 1 µM, 2 µM, 3 µM, 4 µM, 5 µM, 6 µM, 8 
µM and 15 µM. These curves were adjusted so that they shared a common starting point at t = 0 
s for better comparison.  The fluctuation of the fluorescence intensity right after t = 0 s was 
caused by mixing using a pipette and these two to three data points will be removed in the 
following data treatment. The average fluorescence intensities of the product at equilibrium are 
plotted against various initial concentrations of GSH in Fig. 34 (b). Data points at each 
concentration are mean ± 2× standard deviation (SD) based on 50 or more fluorescence 
measurements after equilibriums were reached. It can clearly that when ThioGlo-1 is in excess, 
the fluorescence intensity of the product is directly proportional to the initial concentration of 
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GSH. A linear curve fitting (black dash-dot line) gives an R
2
 of 0.9982 for the data when the 
initial GSH concentrations range from 0-5 μM. The equilibrium fluorescent adduct 
concentration, Peq (M) and the initial GSH concentration, G0 (M) and ThioGlo-1 concentration, 
T0 (M), can be mathematically related according to the definition of equilibrium constant, K (M
-
1) as shown in Eq. 18. Meanwhile, Peq is directly proportional to the equilibrium fluorescence 
intensity, Ieq (RFU) according to Eq. 19 with coefficients, α (M/RFU) and β (M). Nonlinear 
fitting (red solid curve) of the data shows K is on the order of 10
8 M-1. 
 
  
   
                
 (18) 
                   (19) 
       
Figure 34. Kinetic experiments for GSH and ThioGlo-1 
(a) Time progress curves of the reaction taking place in 20 mM Tris buffer solution at pH 7.5; (b) relationship of the 
equilibrium fluorescence intensity and the initial GSH concentration. 
 
Based on this approximate equilibrium constant, it is reasonable to assume that the rate 
constant of the reverse reaction, k-1(s
-1), is much smaller than the rate of the forward reaction 
rate, k1(M
-1s-1), when the concentrations of GSH and ThioGlo-1 are in the low micromolar range. 
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Under this assumption, a linear relationship can be derived as indicated in Eq. 20 and 21, with Pt 
(M) and It (RFU) as the concentration and the fluorescence intensity of fluorescent adduct at time 
t, respectively. 
   
     
     
   
  
  
     
   𝑡 
(20) 
           (21) 
A linear global fitting of the seventeen sets of kinetic data is given in Fig. 35. The value 
of the slope, k1, is 2.1x10
4
 M
-1
s
-1
 with a standard deviation of 2.2x10
2
 M
-1
s
-1
. Based on the above 
results, k-1 can also be estimated, which is on the order of 10
-4
 s
-1
. Although the reaction between 
thiols and maleimide is reversible,237 under our experimental conditions, the reverse reaction 
does not factor into the detection. Therefore, ThioGlo-1 is suitable for online precolumn 
derivatization of GSH and quantitative analysis. 
 
Figure 35. Global linear fitting of the data from seventeen kinetic curves 
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3.3.2 Microfluidic capillary electrophoresis 
Utilizing flow gated injection,
238
 the microfluidic chip operates in a continuous 
sampling/separation mode, which allows continuous monitoring of the changing concentration of 
the analyte GSH. Another advantage of flow gated injections is that the analyte, reagent, and 
buffer reservoirs are all kept isolated throughout the experiment. Therefore dilution or 
contamination of analytes by the other reagents and buffers is reduced compared to a pinched 
injection, which enables more repeatable and reliable results. Although the flow gated injector is 
time dependent and electrophoretically biased,
239, 240
 it is possible to use an internal standard to 
eliminate these problems. The sample volume loaded by the flow gated valve is determined by 
both the short period of time when the potential at buffer reservoir is floating and the flow rate of 
the sample streams. The operation of the high voltage relay was controlled by the onboard clock 
on the data acquisition device, which provided precision in the floating time. However, the flow 
rate of the sample streams can be affected by changes in the zeta potential, the conditions in the 
microfluidic channels, differences in the relative liquid levels between buffer reservoir and waste 
reservoir, and fluctuations of the pH in each reservoir during continuous analysis. To mitigate 
any effect of the variability in the injection volume, an internal standard, PFH, was added to the 
reagent reservoir. PFH has an excitation maximum of 445 nm and emission maximum of 511 nm 
at neutral pH, both of which are suitable for our LIF detector.
241
 Moreover, it is positively 
charged under the separation conditions and should migrate before the analyte to avoid 
additional analysis time. Fig. 36 (a) shows the separation of PFH (internal standard, IS), 
unreacted ThioGlo-1 (dye) and the ThioGlo-1 labeled GSH in the microfluidic chip using 20 mM 
Tris-HCl buffer (pH = 7.5) as the carrier buffer and running buffer. Sample reservoir was filled 
with 3 μM GSH and reagent reservoir was filled with 50 μM ThioGlo-1 and 1.9 μM PFH. 
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Sampling and separation times were 0.1 s and 9.9 s, respectively. Potential applied at waste 
reservoir was -6000 V, while the reagent and sample reservoir were kept at ground and buffer 
reservoir was switched between two states, “GND” and “float”.  
Although the resolution of the IS and Dye peaks reaches 4.0 in Fig. 36 (a), the IS peak is 
tailing. This may be caused by electrostatic interactions between the cationic PFH and the 
negatively charged inner wall of the channel. Supporting this idea, when PFH was used, the 
channels became clogged, even if the microfluidic chip went through a conditioning step 
between runs. PFH is relatively insoluble in water, and adsorbed PFH may nucleate precipitation. 
The addition of aliphatic diamines, especially 1,4-diaminobutane, to the running buffer to 
neutralize the negative charges on the wall has been investigated by several groups.
242, 243
 For 
these experiments, 1, 6-diaminohexane was chosen since it is less toxic than other diamines with 
shorter aliphatic chains. While it will compete for surface adsorption sites with PFH, it will also 
change the zeta potential at the microchannel wall. Fig. 36 shows a decrease in the mobilities of 
PFH (IS), unreacted ThioGlo-1 (dye), and ThioGlo-1-GSH adduct (GSH*) as the concentration 
of 1, 6-diaminohexane in the running buffer varied from 0 mM to 1.0 mM, which is the evidence 
of a reduced zeta potential and electroosmotic flow rate. Based on these results, a concentration 
of 0.1 mM 1, 6-diaminhexane was chosen for further experiments based on the separation time 
needed for the analysis.  
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Figure 36. Effect of 1, 6-diaminohexane on the separation of PFH, ThioGlo-1 and GSH* 
Sample reservoir was filled with 3 μM GSH in 20 mM Tris-HCl buffer (pH = 7.5) and reagent reservoir was 
filled with 50 μM ThioGlo-1 and 1.9 μM PFH in the same Tris-HCl buffer. The concentration of 1, 6-
diaminohexane in the buffer and waste reservoir varied from (a) 0 mM; (b) 0.1 mM; (c) 0.5 mM; (d) 1.0 mM. 
 
To test the effect of 1, 6-diaminohexane in the reaction channel, electropherograms were 
obtained with and without 0.1 mM 1, 6-diaminohexane in the reagent reservoir during 
continuous analysis of GSH produced in the sample reservoir by the enzyme reaction. In this 
experiment, sample reservoir contained 25 μM GSSG and 50 μM β-NADPH. Reagent reservoir 
contained 300 μM ThioGlo-1 and 9.5 μM PFH. Experiment was started once GR was mixed with 
the substrate solution at a final concentration of 5.29x10
-3
 unit/mL in sample reservoir. Sampling 
and separation times were 0.1 s and 9.9 s, respectively. Potential applied at waste reservoir was -
6000 V. It is clear from Fig. 37 that the repeatability is significantly improved from using the 
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additive. Fig. 37 (c) shows the fluctuation in the FWHM of the GSH-ThioGlo-1 reaction product 
(GSH*) peaks in both cases. The RSD of the FWHM for GSH* peaks was 2.2% when 0.1 mM 1, 
6-diaminohexane was included in reagent reservoir. However, this value increased to 12.8% 
when 1, 6-diaminohexane was excluded from reagent reservoir. Adding 1, 6-diaminohexane to 
both the derivatizing reagent and running buffer was helpful for improving the resolution of the 
separation, reducing the adsorption of PFH and stabilizing the quantitative measurements, 
especially in continuous sampling. To avoid any interference with the enzyme reaction, 1, 6-
diaminohexane was not added to sample reservoir. Applying the above optimized conditions for 
the separation, the concentration and mass limit of detection for GSH were determined to be 4.2 
nM and 10
-18
 mol using ThioGlo-1 as the derivatizing reagent. The repeatability of the 
continuous injections was evaluated by measuring the peak parameters for the internal standard. 
The relative standard deviation of the peak area, peak height, FWHM and migration time for the 
internal standard were found to be 2.5%, 2.0%, 1.0% and less than 0.1%, respectively. 
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Figure 37. Effect of 1, 6-diaminohexane in reagent reservoir on the enzyme kinetic analysis 
(a) No 1, 6-diaminohexane; (b) 0.1 mM 1, 6-diaminohexane; (c) FWHM of the GSH* peaks in both experiments. 
Sample reservoir contained 25 μM GSSG and 50 μM β-NADPH. Reagent reservoir contained 300 μM ThioGlo-1 
and 9.5 μM PFH. Experiment was started once GR was mixed with the substrate solution at a final concentration of 
5.29x10-3 unit/mL in sample reservoir. 
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3.3.3 Enzyme kinetic study 
GR is a well-studied flavoenzyme, which catalyzes β-NADPH-dependent reduction of GSSG to 
maintain a healthy cellular ratio of [GSH]/[GSSG] as shown by the equation below.229, 244  
                          (22) 
Numerous studies have demonstrated that in the absence of product inhibition, the double 
reciprocal plot (Lineweaver-Burk plot) of the reaction rate against one of the two substrates, the 
other being held constant and saturating, will give a straight line.
232, 244-248
 Thus if we obtain two 
linear Lineweaver-Burk plots, each of which yields a correct Michaelis constant for the non-
saturating substrate, then we know that the derivatization, injection, separation and detection of 
GSH on this microfluidic platform are reliable. 
We utilized the microfluidic chip, and the conditions just developed, to measure the 
initial forward rate as a function of concentration of one substrate while the concentration of the 
other substrate was kept at a saturating concentration. As the initial rate was to be measured, 
inhibition caused by the product was assumed to be negligible. The reaction rate in this case 
depends only on the concentration of the enzyme–substrate complex, assumed to be nearly 
constant, therefore; a linear conversion of the substrate to product is predicted. Fig. 38 (a) shows 
the series of electropherograms obtained for a rate measurement when the initial concentration of 
GSSG and β-NADPH were 1000 μM and 100 μM GSSG. The electropherograms for all of the 
injections in this experiment are replotted in parallel in Fig. 38 (b).  
The electropherogram in Fig. 38 (a) can be divided into three regions based on the 
detected peaks. In the first region (0–40 s), no peaks are observed. This is the time needed by the 
compound with the highest mobility to pass through the reaction and separation channels before 
being detected. In the second region, located between 40 and 130 s, the IS peaks come out 
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steadily and the dye peaks start to arrive and gradually become stable. No GSH* peak is detected 
in this region. GSH* peaks begin to be detected in the third region beginning at approximately 
130 s. Calculations based on Ohm’s and Kirchoff’s laws show that it takes about 106 s for GSH 
to traverse the reaction channel, i.e., the reaction time is about 106 s. Based on the rate constant 
determined above, the ThioGlo-1 concentration in the reaction channel, and assuming a pseudo-
first order reaction (ThioGlo-1 in excess) the time required to achieve 95% conversion of GSH to 
GSH* would be 5 s. The time for a complete mixing of dye and GSH in aqueous solution is 
estimated to be ~2 s, based on the diffusion coefficient of GSH, D = 6.7 × 10
−10
 m
2
/s,
249
 and the 
channel width, 50 µm. Thus, conversion of GSH to GSH* is virtually complete. Comparison of 
relative peak areas for the online reaction and offline reaction (5 minutes) shows that the reaction 
is, in fact, complete. For evaluation of enzyme kinetics, data points were collected once the later 
peaks demonstrate the expected constant signal (ThioGlo-1 and IS) and a linear increases in the 
height and area of the GSH* peak due to the enzyme reaction was observed. The first several 
peaks of GSH* were excluded in the calculation of the initial forward rate. The relative peak area 
of the GSH* (compared to that of IS) was converted to the concentration of GSH* based on the 
calibration curve (Fig. 39) obtained under the same conditions as those applied in the enzyme 
kinetic experiments except that the solution in the sample reservoir contained GSH at known 
concentrations.  
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Figure 38. Electropherograms for on-chip enzyme kinetic study 
(a) Series of electropherograms obtained in a microfluidic chip with continuous flow gated injection. The 
concentrations of GSSG and β-NADPH were 1000 μM and 100 μM, respectively. The inset magnifies one set 
of peaks from an injection made between 300 and 309 s. The small valley, GI, around 300.5 s resulted from the 
flow gated injection. ‘IS’, ‘Dye’ and ‘GSH*’ represent PFH, unreacted ThioGlo-1 and ThioGlo-1-GSH adduct, 
respectively. (b) Reconstructed plot of PMT reading vs time for all injections in this series. 
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Figure 39. Calibration curve established based on the relative peak area of GSH* 
Experimental conditions were same as that in enzyme analysis, except that only GSH was included in sample 
reservoir. Data are plotted as mean ± SD for at least 17 injections. 
 
For the enzyme kinetic studies, the concentration of GR was fixed at 7.93x10
-4
 unit/mL; 
this concentration was chosen to allow the steady state phase of the enzyme catalyzed reaction to 
last long enough to collect sufficient data while also giving a detectable change in GSH. The 
appropriate forms of the rate equations for the initial rates are 
231, 250 
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In the above equations, υi is the initial forward rate obtained under different initial 
substrate B concentrations, [B]0. [A]0 is the fixed concentration of substrate A. KmA and KmB are 
the Michaelis constant of substrate A and B, respectively, and Vmax is the maximum rate. If 
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substrate A is kept at saturating concentration, [A]0 would be much large than KmA. Therefore, 
the term KmA/[A]0 can be neglected and Eq. 24 would be further simplified to  
  
  
 
   
    
 
    
 
 
    
 (25) 
A Lineweaver-Burk plot based on Eq. 25 is shown in Fig. 40. The relationship between 
the initial rate of the forward reaction of GR (the rate at which the GSH concentration changes) 
and the initial concentration of β-NADPH (1-100 μM) at a saturating concentration of GSSG 
(1000 μM)247 is demonstrated in Fig. 40 (a). The corresponding plot showing the initial rate 
versus the initial concentration of GSSG (10-1000 μM) at a saturating concentration of β-
NADPH (100 μM)247 is shown in Fig. 40 (b). The initial concentrations of both GSSG and β-
NADPH were chosen to be evenly distributed in the inverse plot. The initial forward rates were 
obtained by performing linear regression of the GSH concentration vs. time. The apparent Km of 
β-NADPH and GSSG for GR obtained from the Lineweaver-Burk plots were 4.4 ± 0.6 μM and 
40 ± 11 μM, respectively. Vmax values calculated from each plot were close to each other; it was 
11.0 ± 1.3 nM/s when the concentration of GSSG was fixed and 10.8 ± 2.6 nM/s when the 
concentration of β-NADPH was fixed. Errors are the standard error of the mean (SEM). 
The Km values of GSSG and β-NADPH for GR (baker’s yeast) measured by Massey et 
al. were 55 μM and 3.8 μM, respectively.229 Mavis et al. reported similar Km values of 61 μM 
and 7.6 μM for GSSG and β-NADPH.251 The apparent Km values of GSSG and β-NADPH we 
obtained using an integrated microfluidic method for evaluation of GR kinetics are comparable 
with these values.  
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Figure 40. Lineweaver-Burk plots to determine the enzyme kinetic parameters 
(a) The initial rate of the forward reaction of GR is plotted against concentration of β-NADPH at 1000 μM GSSG; 
(b) the initial rate of the forward reaction of GR is plotted against concentration of GSSG at 100 μM β-NADPH. 
Error bars are ± SD (n = 14). Note that the initial reaction rate is the expressed as the rate at which GSH 
concentration changes. 
3.4 CONCLUSIONS 
We have demonstrated the use of ThioGlo-1 as an online derivatizing reagent for 
quantitative determinations of GSH. The reagent derivatizes GSH more rapidly than had been 
thought to be the case. This knowledge was then utilized to develop an integrated microfluidic 
method for evaluation of enzyme kinetics employing on-chip precolumn derivatization. For the 
gated separation analysis, PFH as an internal standard minimized variable injection volume 
effects without added analysis time and 1, 6-diaminohexane addition resulted in stabilization of 
the peak parameters from GSH, especially during continuous analysis. The sensitivity of the 
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determinations is excellent with a GSH concentration and mass detection limit of 4.2 nM and 10
-
18
 mol. The combination of the simple microfluidic chip with well-chosen chemistry has led to an 
integrated system capable of continuous monitoring of GSH concentrations.  
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4.0  AN IN SITU MEASUREMENT OF EXTRACELLULAR AMINOTHIOLS 
IN OHSCS BY INTEGRATION OF ELECTROOSMOITIC SAMPLING AND 
MICROFLUIDIC ANALYSIS  
Part of the following work has been published in Analytical Chemistry 2013, 85(6):3095-3103 
We demonstrate an all-electric sampling/derivatization/separation/detection system for the 
quantitation of thiols in tissue cultures. Extracellular fluid collected from rat OHSCs by 
electroosmotic flow through an 11 cm (length) x 50 μm (ID) sampling capillary is introduced to 
a simple microfluidic chip for derivatization, continuous flow-gated injection, separation and 
detection. With the help of a fluorogenic, thiol-specific reagent, ThioGlo-1, we have successfully 
separated and detected the extracellular levels of free reduced CSH, Hcy and Cys from OHSCs 
within 25 s in a 23 mm separation channel with a confocal LIF detector. Attention to the 
conductivities of the fluids being transported is required for successful flow-gated injections. 
When the sample conductivity is much higher than the running buffer conductivities, the 
electroosmotic velocities are such that there is less fluid coming by electroosmosis into the cross 
from the sample/reagent channel than is leaving by electroosmosis into the separation and waste 
channels. The resulting decrease in the internal fluid pressure in the injection cross pulls flow 
from the gated channel. This process may completely shut down the gated injection. Using a 
glycylglycine (Gly-Gly) buffer with physiological osmolarity but only 62% of physiological 
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conductivity and augmenting the conductivity of the running buffers solved this problem. 
Quantitation is by standard additions. Concentrations of CSH, Hcy and Cys in the extracellular 
space of OHSCs are 10.6 ± 1.0 nM (n = 70), 0.18 ± 0.01 μM (n = 53) and 11.1 ± 1.2 μM (n = 
70), respectively. This is the first in situ quantitative estimation of endogenous CSH in brain. 
Extracellular levels of Hcy and Cys are comparable with other reported values. 
4.1 INTRODUCTION 
The coupling of sample collection and microfluidic analysis addresses the critical problems that 
arise in handling small amounts of liquid samples.
135
 Several groups have devised useful 
approaches to transport samples from cells, tissues, or living animals directly to a microfluidic 
chip for online analysis.
153, 252-254
 But to the best of our knowledge all the published methods 
require extra vacuum/pressure pumps for transporting the samples either from a push-pull 
perfusion probe
252
 or a microdialysis probe
153, 253, 254
 to the microfluidic chip for further analysis. 
The addition of these pumps increases the total cost and the complexity of the system.  
Electroosmosis is the natural and dominant driving force in CE and microfluidic chips
.255, 
256
 Electroosmosis requires no mechanical pumps but can generate accurate flow rates in the 
domain of less than one to tens of nL/s depending on the cross sectional area of the conduit.
257
 In 
addition, the plug shaped electroosmotic flow creates less solute dispersion than that of parabolic 
flow in a pressure-driven system. Under an external electric field, solvated cations in the diffuse 
layer will migrate towards the cathode, dragging the bulk solution. The potential at the shear 
boundary of the fluid defines the ζ-potential that governs the EOF. Under physiological 
conditions, the cell surface is naturally negatively charged like that of the wall in a fused silica 
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capillary or a microfluidic channel.
258
 We have reported that OHSCs have a ζ-potential of -22.8 
mV,
259
 therefore the EOF generated with an electric field can be used to pump the extracellular 
fluid out of the tissue for analysis. Our lab has developed an electroosmotic sampling method to 
extract extracellular fluid from OHSCs into a fused silica capillary. In that work, the sample 
inside the capillary was then collected for offline HPLC analysis.
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Cys, Hcy and CSH are three related aminothiols that exist in tissues and body fluids at 
low levels.
1, 88
 Although Cys is neurotoxic,
78
 it is a rate-limiting synthetic precursor of 
glutathione in neurons. The latter plays a critical role in defending cells against oxidative stress.
10
 
In brain, neuronal glutathione synthesis relies on Cys that arises from extracellular hydrolysis of 
GSH exported from astroglia by γ-glutamyl transpeptidase and aminopeptidase N. This interplay 
results in an intensive metabolic exchange with astrocytes.
31
 The Cys concentration in plasma is 
estimated to be in the range of 8-10 µM,
23
 while the concentration of Cys in the extracellular 
space of rat caudate nucleus and striatum determined by microdialysis is round 2 µM.
29, 260 
Hcy 
is an important endogenous molecule in the metabolism of methionine, and it connects the 
methionine and Cys metabolic cycles.
1
 Only trace amounts (0.05-0.3 µM) of free Hcy (1-2% of 
total Hcy) exist in its reduced form in plasma.
87
 Changes in the levels of Cys/Hcy or their 
oxidized forms in biological systems usually indicate dysfunctions of related metabolic cycles or 
cellular processes. Specifically, cystinosis is due to accumulation of abnormal amounts of cystine 
in lysosomes.
76
 The Hcy level in plasma/serum is considered to be a biomarker of clinical 
disorders, such as Alzheimer’s disease and cardiovascular disease.1 Due to their importance, 
numerous methods have been developed to detect and quantify free or total cysteine and 
homocysteine in body fluids such as plasma,
222, 261, 262
 urine,
262, 263
 tissue homogenates,
264
 while 
fewer studies have been done on the extracellular space of tissues
29, 260
 through microdialysis. 
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The dominant quantitation methods are HPLC or capillary electrophoresis equipped with UV, FL 
or mass spectrometry detectors.
114, 265
  
Although CSH is a decarboxylated form of Cys, it is widely believed to be the active 
terminal product of the synthesis and degradation of CoA in the Cys metabolic cycle.
68
 Albeit at 
a very low concentration in the tissue,
69
 the oxidation of CSH is believed to be an indispensable 
pathway for  taurine synthesis, the second most abundant amino acid in mammalian tissues.
70
 
CSH has many other remarkable roles and biological functions. As an FDA-approved drug for 
treating cystinosis, CSH can cross the lysosome membrane, react with the cystine to form a 
mixed disulfide which can be transported out of the lysosome.
266
 In addition to its potent radio-
protective action on DNA-induced radiation damage, CSH, as well as its oxidized form 
cystamine (CSSC), have been considered as potential neuroprotective agents. Both compounds 
have shown significant beneficial properties in treating models of neurodegenerative disease, 
such as Huntington’s and Parkinson’s diseases.71 Measuring the CSH concentration in biological 
samples is vital for understanding its metabolic mechanism and fate. Endogenous CSH levels in 
different tissue homogenates (brain, liver, kidney, etc),
72-74, 267-270 
urine and plasma
74, 262, 271
 have 
been reported using HPLC-electrochemical detection
73, 268, 269
/FL
72, 74, 268, 270, 271
, CE-LIF
262
. The 
published values cover a very wide range, which is most likely due to the inadequate 
methodology and species differences.
69, 73
 Several workers report that the endogenous 
concentration of free CSH in brain tissue homogenates is very low and below the detection limits 
of the most sensitive detection methods( <10 nmol/L).
69, 72-74
 We are unaware of measurements 
in vivo or in in vitro preparations such as acute or cultured brain slices. 
In this work, we integrated online electroosmotic sampling and microfluidic analysis 
coupled to confocal LIF detection to evaluate the endogenous free Cys, Hcy and CSH 
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concentrations in the extracellular space of OHSCs. Compared with publications cited above, the 
method described here is faster, more sensitive; and to the best of our knowledge for the first 
time simultaneously evaluates the endogenous Cys, Hcy and CSH in the extracellular space of 
any tissue.  
4.2 EXPERIMENTAL SECTION 
4.2.1 Chemicals and reagents 
Tris (hydroxymethyl)aminomethane (Tris base), 1,3-bis[tris(hydroxymethyl)methylamino] 
propane (Bis-Tris propane), hydrochloric acid, sodium hydroxide, dimethyl sulfoxide anhydrous 
(DMSO), D-(+)-glucose, Gly-Gly, L-Cys, DL-Hcy, CSH hydrochloride, Gey’s balance salt 
solution (GBSS) and nitric acid (70%) were purchased from Sigma-Aldrich Chemical Co. (St. 
Louis, MO). Hydrofluoric acid (48-50%) was from Fisher Scientific (Pittsburgh, PA). Sodium 
chloride, potassium chloride and methanol were obtained from Avantor Performance Materials 
(Center Valley, PA). Potassium phosphate monobasic and calcium chloride dihydrate were from 
EM Science (Gibbstown, NJ).  Opti-MEM, horse serum, Hank’s balanced salt solution (HBSS) 
with phenol red and propidium iodide (PI) were from Life Technologies (Grand Island, NY). 
ThioGlo-1, sodium bicarbonate and magnesium sulfate anhydrous were purchased from EMD 
Millipore (Billerica, MA).  
Stock solutions of CSH, Hcy, Cys, GSH, γ-Glu-Cys and Cys-Gly were prepared no more 
than two days before experiments using degassed Milli-Q water (EMD Millipore) and stored at -
20 °C. The stock solution of ThioGlo-1 was prepared using anhydrous DMSO with the final 
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concentration of 2.5 mM. Stock solutions were diluted serially to the desired concentration 
during the experiments and kept on dry ice when not in use. The artificial cerebrospinal fluid 
(ACSF) was composed of 128 mM NaCl, 3 mM KCl, 2 mM CaCl2, 1.2 mM MgSO4, 0.4 mM 
KH2PO4, 25 mM NaHCO3 and 10 mM D-glucose.
272
 Gly-Gly modified ACSF (ggACSF) was 
prepared by replacing 75 mM NaCl in ACSF with 125 mM Gly-Gly and keeping all other 
components unchanged. Both solutions were adjusted to pH 7.4 using NaOH. GBSS used during 
sampling experiments was fortified with 2.7 mM MgSO4 and 0.5% D-(+)-glucose. The term 
GBSS used below means “fortified GBSS” unless otherwise specified. PI solution was prepared 
using GBSS to a final concentration of 0.35 mM and was stored in the freezer. For optimization 
of the separation conditions, Tris-HCl buffers and Bis-Tris propane buffers at various 
concentrations and different pH values were used as the running buffer to test their effects in the 
separation of aminothiol mixture in the microfluidic channel. In some experiments, 1, 6-
diaminohexane were also used as an additive of the running buffer. For online sampling 
experiments, the running buffer of the microfluidic capillary electrophoresis was 40 mM Bis-Tris 
propane buffer with 15 mM NaCl (pH 8.5) unless otherwise specified. Tris-HCl buffer (20 mM, 
pH 7.5) was used as the derivatizing buffer for the thiol analytes. All buffers were filtered 
through 0.1 μm polyethersulfone membrane (EMD Millipore) and degassed by ultrasonication 
prior to use.  
4.2.2 Design of a microfluidic chip coupled with electroosmotic sampling 
The fabrication of microfluidic chip was similar as described previously in Section 3.2.2 with 
some modifications. Briefly, after UV exposure, development and removal of the underlying 
chromium layer, the AZ 1500 photoresist coated borofloat glass plates was etched in HF solution 
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(HF/HNO3:200/30 (v/v)) to a desired depth. The photoresist and chromium remaining on the 
plate were then removed completely. The etched glass plate was carefully aligned with another 
uncoated borofloat cover plate pre-drilled with liquid access holes. Permanent bonding between 
two plates was achieved by annealing at 655 ºC for 8 hours. The mask width for all channels is 
30 μm and the etching depth is 20 μm. Fig. 41 shows the layout and the photograph of the 
microfluidic chip coupled with electroosmotic sampling. The total length of the reaction channel 
from the mixing junction to the injection cross is ~46.3 mm. The detection point (DP) is about 23 
mm away from the injection cross. R1, R2, R3 and R4 represent derivatizing reagent reservoir, 
buffer reservoir, waste reservoir and auxiliary reservoir, respectively. An 11 cm (length) x 50 μm 
(ID)/360 μm (OD) fused silica capillary tube (Polymicro Technologies, Phoenix, AZ) was 
connected to the R5 through a NanoPortTM assembly (IDEX Health&Science LLC, Oak Harbor, 
WA). The free tip of the capillary was positioned by a Sutter MP-285 micromanipulator system 
(Sutter Instrument Company, Novato, CA) near the surface of an OHSC. Platinum electrodes 
(0.5 mm diameter, Goodfellow Corporation, Oakdale, PA) made electrical contact with solutions 
in all reservoirs and the Petri dish (35x10 mm, BD, Franklin Lakes, NJ). During the experiment, 
the electrodes in R1 and the Petri dish were connected to positive power supplies (UltraVolt, 
Inc., Ronkonkoma, NY). The electrode in R3 was connected to a negative power supply, while 
the one in R4 was kept at ground (GND). Flow-gated sampling was achieved through the 
switching of electrode in R2 between the “GND” (separation) and “floating” (injection) states. 
The microfluidic chip shown in Fig. 41 can also be used in on-chip experiments by temporally 
replacing the sampling capillary with reservoir R5. In these experiments, R1 and R5 (or R4) will 
be connected to positive power supplies, while R4 (or R5) will be disabled. The potential settings 
in other reservoir will be the same as that in the electroosmotic sampling. Extra caution is 
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required when working with high voltage power supplies. All voltages were controlled remotely 
by computer. 
 
 
Figure 41. Layout of the microfluidic chip and single capillary electroosmotic sampling  
(a) Sketch view of the system; (b) Photograph of the single capillary electroosmotic sampling 
4.2.3 Instrumentation 
Detection in the microfluidic experiments was achieved through a home-made confocal LIF 
detector detection system described in Chapter 2. The PMT control voltage was set at 0.5 V in 
the optimization experiments and 0.6 V in the online analysis of aminothiols from OHSCs. The 
laser power was maintained at 3.0 mW. A locally written program in LabView 8.2 (National 
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Instruments, Austin, TX) was used to control two four-channel high-voltage power supplies, the 
flow-gated sample introduction, the control voltage of the PMT and the signal collection. An 
inverted fluorescent microscope IX71 (Olympus, Center Valley, PA) was used to characterize 
OHSCs. This microscope was equipped with an Olympus U-MWIG2 mirror unit (ex: 520-550 
nm; em: 580IF nm; dichroic: 565 nm), an Olympus UPLANAPO 4x objective and a Hamamatsu 
ORCA-ER digital CCD camera. Laser safety goggles should be worn in the presence of the laser 
beam. 
4.2.4 Optimization of the separation conditions for aminothiols  
The separation conditions for microfluidic analysis of aminothiols were optimized using the 
microfluidic chip shown in Fig. 30. Standard mixture of aminothiols was added into the sample 
reservoir while ThioGlo-1 solution was transferred into the reagent reservoir. The derivatization 
of aminothiols was achieved in 20 mM Tris-HCl at pH 7.5 in the reaction channel. Different 
running buffers were added into the gated reservoir and waste reservoir to test their capability in 
separating aminothiols. The detection point was located at 27 mm from the injection cross. In the 
experiments, the electrodes in reagent reservoir and sample reservoir were kept at ground, while 
the electrode in waste reservoir was connected to -6000 V. The gated reservoir was switched 
between “GND” and “Floating” to achieve multiple injections with an injection time of 0.1 s. 
The microfluidic channels were rinsed with NaOH and buffer solutions successively to prevent 
contamination between runs.  
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4.2.5 OHSCs preparation and characterization  
The procedure for OHSC preparation is adapted from Gogolla’s protocol273 and has been 
approved by the IACUC of the University of Pittsburgh. Briefly, the hippocampus of a 7 days 
postnatal Sprague-Dawley rat was removed and sliced (McIIwain tissue chopper, Mickle 
Laboratory Engineering Co. Ltd., UK) into 350 μm thick transverse sections. After cold 
incubation, slices with the right morphology were selected and transferred onto the Millicell 
standing inserts (hydrophilic PTFE membrane, 0.4 μm, EMD Millipore) in a 6-well tissue culture 
plate (Sarstedt Inc., Newton, NC) containing culture medium (50% Opti-MEM, 25% HBSS with 
phenol red, 25% horse serum, 0.45% D-(+)-glucose). The OHSCs were usually cultured in the 
incubator for 6-8 days before any sampling experiments were carried out.  
An inverted fluorescent microscope IX71 (Olympus, Center Valley, PA) was used to 
characterize OHSCs. This microscope was equipped with an Olympus U-MWIG2 mirror unit 
(ex: 520-550 nm; em: 580IF nm; dichroic: 565 nm), an Olympus UPLANAPO 4x objective and 
a Hamamatsu ORCA-ER digital CCD camera.Tissue viability was assessed before a set of 
experiments. PI was added to the culture medium to a final concentration of ~7 μM. The OHSCs 
were then cultured overnight. The PI-containing medium was replaced with pre-warmed and 
gassed GBSS before the fluorescence images were taken. Cell death was assessed by acquiring 
fluorescence images using the same exposure time as the auto-exposure time for an intentionally 
killed 100% death control.
105
 After that, the GBSS in the 6-well plate was replaced with normal 
culture medium and OHSCs were taken back to the incubator for future experiments. The 
assessment of cell death in OHSCs following sampling was also carried out as described above.         
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4.2.6 Measurement of extracellular aminothiols in OHSCs using single capillary mode 
R2 and R3 contain running buffer. R1 contains ThioGlo-1 2.7 μM in 20 mM Tris-HCl buffer (pH 
= 7.5). R4 and the sampling capillary were filled with 20 mM Tris-HCl buffer (pH = 7.5) with 60 
mM NaCl. The final liquid volume in each reservoir was 300~310 μL. OHSCs on culture inserts 
were transferred from the incubator to a Petri dish containing 1.2 mL pre-warmed and gassed 
GBSS. Immediately before sampling, an OHSC on an insert was transferred to another Petri dish 
containing 1.2 mL of ggACSF alone or spiked with the standards at their desired concentrations 
before the sampling. The free end of the sampling capillary was lowered perpendicularly towards 
the tissue until it made contact with a thin layer of liquid on the tissue surface (CA3 region) by a 
Sutter MP-285 micromanipulator system (minimal resolution 0.04 µm). The tip was then raised 
up 20 μm so that the tissue surface and the capillary tip were connected through a thin layer of 
liquid. The process was monitored using a Fisher Scientific Stereomaster zoom microscope. 
Every sampling experiment was started with a pre-sampling step. In this step, +3000 V 
were applied to the Petri dish while R4 was grounded. All other reservoirs were floating. This 
step preserves derivatizing reagent and running buffer while electroosmotically transporting 
extracellular fluid into the sampling capillary. Six minutes later, the microfluidic chip was 
switched to the measuring mode. Data collection was initiated and +300 V and -4500 V were 
applied to R1 and R3, respectively. The voltage on R4/Petri dish was not changed. R2 was 
switched between two states: “floating” (injection, 0.5 s) and “GND” (separation, typically 24.5 
s) to obtain a continuous sequence of separations as described previously.
274
 The time during 
which the system is in the online measuring mode varies, but is typically in the 800-1000 s 
range. This corresponds to 32-40 injections and separations per run. The appearance of the first 
peaks from the extracellular space typically occurs in the 17th electropherogram. Therefore, we 
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obtain 16-24 electropherograms corresponding to 6.7-10 minutes of sampling from the tissue. 
Between each run, the microfluidic chip and the sampling capillary were flushed and 
reconditioned with NaOH and buffer solutions successively to prevent contamination. All 
experiments were carried out at room temperature. To prevent byproducts from the oxidation 
reactions at the Pt electrode in the culture dish from altering the composition of the extracellular 
space, the Pt electrode was kept 15-20 mm from the sampling region. 
4.2.7 Electroosmotic sampling from OHSCs using dual-capillary 
Dual capillary setup mode was tested as a comparison of single capillary electroosmotic 
sampling from OHSCs. Fig. 42 shows the difference between these two sampling modes. In dual 
capillary mode, the capillary holder has two parallel grooves which can fit two capillaries at the 
same time. The inner distance between two capillaries is determined by the distance of the 
grooves, which is 180 µm. Before the experiment, one end of the inlet capillary (15 cm x 50 µm 
ID) would be immersed into a small glass vial which contains ggACSF buffer only or spiked 
with GSH and a platinum electrode connecting to a positive power supply. The other end of the 
inlet capillary would be lowered towards the tissue together with one end of outlet capillary (11 
cm x 50 µm ID) until the tip of outlet capillary just made contact with a thin layer of liquid on 
the tissue surface (CA3 region) by the manipulator. The capillary holder was then raised up 20 
μm so that the tissue surface and the outlet capillary were connected through a thin layer of 
liquid. In this process, it was important to make sure that the tip of inlet capillary also connected 
with the surface liquid on the tissue. The other end of the outlet capillary will be connected to the 
microfluidic chip in the same way as that in a single capillary experiment. There is no electrode 
in the Petri dish in the dual capillary mode. It must be noticed that there is limited freedom to use 
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only one manipulator to control two capillary at the same time. The relative height of the two 
capillaries may result in two cases as shown in Fig. 42 (c). Although the distances between the 
tip of outlet capillary and tissue surface are kept the same in both cases, the distance between the 
tip of inlet capillary and tissue surface may varies. In case A, the tip of inlet capillary is much 
closer to the tissue than that of outlet capillary. In case B, the tip of inlet capillary is at the same 
height as that for the outlet capillary. During the dual capillary sampling experiment, the voltage 
setup was same as that for the single capillary analysis, except that +3000 V positive potential 
used to apply to the Petri dish was now switched to the glass vial with a value of +7000 V. Inlet 
capillary was prefilled with the same solution as in the glass vial and outlet capillary was 
prefilled with 20 mM Tris-HCl buffer (pH = 7.5) with 60 mM NaCl as in single capillary 
experiment. Petri dish contained 1.2 mL pre-warmed and gassed GBSS. For comparison purpose, 
all the solutions contained in the reservoirs are the same as those in single capillary experiment. 
Similarly, every sampling experiment included a six minutes pre-sampling step, where +7000 V 
were applied to the Petri dish while R4 was grounded. All other reservoirs were floating. 
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Figure 42. Schematic views of single and dual capillary modes in the electroosmotic sampling 
(a) Single capillary mode; (b) dual capillary mode; (c) two different cases in dual capillary mode: Case A, inlet 
capillary lower than outlet capillary; case B, inlet capillary is at the same height as the outlet capillary. 
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4.3 RESULTS AND DISCUSSIOIN 
4.3.1 Optimization of separation conditions of aminothiols for microfluidic analysis 
The separation conditions of aminothiols in microfluidic channel were optimized for later online 
analysis. Tris buffer has been used as the running buffer in the separation of ThioGlo-1 and 
fluorescent derivatized GSH in the glutathione reductase experiments (Section 3.3.2). However, 
the separation capacity of this solution was not good for aminothiols mixture including Hcy, Cys, 
GSH, γ-Glu-Cys and Cys-Gly. Fig. 43 shows the separation of aminothiols using 20 mM Tris-
HCl at different pH values. At pH 7.5, unreacted ThioGlo-1, fluorescent labeled Hcy, and Cys 
peaks were overlapped, while fluorescent labeled GSH, γ-Glu-Cys and Cys-Gly migrated 
together as a single peak. Although, increasing the pH to 8.0 decreased the average signals for all 
the peaks, there was a baseline separation of Cys from that of Hcy and ThioGlo-1.  
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Figure 43. Separation of aminothiols mixtures using 20 mM Tris-HCl buffers at pH 7.5 and 8.0 
The concentration of Hcy, Cys, GSH, γ-Glu-Cys and Cys-Gly in the sample reservoir were all 1.0 µM and the 
concentration of ThioGlo-1 in reagent reservoir was 5.0 µM. The labeled peaks belong to the aminothiols 
derivatized with ThioGlo-1. Hereafter, the names of the aminothiols will be used to mark the peaks of 
ThioGlo-1 labeled aminothiols. 
 
Bis-Tris propane is another widely used chemical substance in buffer solution with a 
wider buffering range (pH 6.0 to 9.5) than that of Tris buffer (pH 7.1 to 9.0). The separation 
performances of Bis-Tris propane buffer solutions at different pH for aminothiols were tested 
and summarized in Fig. 44. At pH 7, a baseline separation of GSH, Cys-Gly and γ-Glu-Cys were 
achieved. However, the separation of Hcy, Cys and ThioGlo-1 is not acceptable as indicated by 
the inset of Fig. 44 (a).  The resolutions for peaks of ThioGlo-1, Hcy and Cys are improving 
together with much shorter migration times for all the peaks as the pH of the running buffer 
increases. The resolutions for GSH, γ-Glu-Cys and Cys-Gly decreases first when pH of the 
running buffer varies from 7.0 to 8.0, and then increases a little at pH = 9.0, where Cys-Gly is 
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baseline separated from the overlapped peaks of GSH and γ-Glu-Cys. The concentration Bis-Tris 
propane buffer will also affect the separation performance. Fig. 45 indicates that as the 
concentration of buffer solution is enhanced, the separation of peaks improves with longer 
migration time. The trends in the change of migration time with pH and concentration are 
constant with what is predicted by the Debye-Huckel approximation.
117
 The effect of 1, 6-
diaminohexane to the separation of aminothiols was also examined and shown in Fig. 46. The 
increment in the additive concentration in the running buffer results in an improved separation 
performance at the cost a longer migration time. The actual separation conditions for the online 
analysis will be determined by the analytes of interest presenting in the samples and the 
requirement of analysis time to achieve good temporal resolution. 
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Figure 44. Separation of aminothiols mixtures using 20 mM Bis-Tris propane buffers with various pH  
The concentration of each analyte in sample reservoir was 1 µM each. The concentration of ThioGlo-1 in 
reagent reservoir was 5 µM. 
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Figure 45. Effect of Bis-Tris propane concentrations on the separation of aminothiols mixtures at pH 8.0 
The concentration of each analyte in sample reservoir was 1 µM each. The concentration of ThioGlo-1 in 
reagent reservoir was 5 µM. 
 
Figure 46. Effect of 1, 6-diaminohexane on the separation of aminothiols mixtures 
The concentration of each analyte in sample reservoir was 1 µM each. The concentration of ThioGlo-1 in 
reagent reservoir was 5 µM. Running buffer is 30 mM Bis-Tris propane buffers at pH 8.0. 1, 6-DAH: 1, 6-
diaminohexane. 
0 10 20 30 40 50 60
-0.02
0.00
0.02
0.04
0.06
40 mM
P
M
T
 r
e
a
d
in
g
 (
V
)
Time (s)
Bis-Tris propane: 20 mM
60 mM
80 mM
100 mM
ThioGlo-1
Hcy
Cys
GSH
-Glu-Cys
Cys-Gly
0 10 20 30 40 50
-0.02
0.00
0.02
0.04
0.06
P
M
T
 r
e
a
d
in
g
 (
V
)
Time (s)
No 1,6-DAH
0.5 mM 1,6-DAH
1.0 mM 1,6-DAH
1.4 mM 1,6-DAH
1.8 mM 1,6-DAH
ThioGlo-1 GSH
Cys
Hcy -Glu-Cys
Cys-Gly
 125 
4.3.2 Microfluidic analysis of samples with high conductivity 
Initial experiments drawing ACSF into the chip led to difficulties such as significant Joule 
heating, gas bubble formation,
275
 reduced electrophoretic separation efficiency,
276
 and fast 
consumption of buffer seen by others. Methods to deal with this problem include reducing the 
sample conductivity, or diluting samples, and decreasing the electric field strength or applying ac 
electric fields with dc offsets.
275
 In our experiments, Gly-Gly, widely used in biochemistry with a 
buffering range that complements phosphate and bicarbonate (7.5-8.9 at 25 
◦
C), was used as a 
substitute for some of the NaCl in the ACSF that the OHCSs imbibe. In the following 
experiments, 75 mM of the NaCl in ACSF was replaced with 125 mM Gly-Gly in ggACSF and 
the final pH value of 7.4 was adjusted using NaOH solution. The osmolarity for the ggACSF was 
calculated to be the same as that of the ACSF. The ggACSF’s conductivity is 9.6 mS/cm while 
the conductivity of ACSF is 15.4 mS/cm. We assessed the potential for tissue damage from brief 
exposure of OHSCs to ggACSF. Fig. 46 (c1) and (c2) show the fluorescence and bright field 
images of an OHSC which was placed in a Petri dish containing ggACSF for 10 min. By 
measuring the grey level of the experimental OHSC in Fig. 47 (c1) and comparing it with that of 
the 100% death control in Fig. 47 (a1) and a live control in Fig. 47 (b1), the percentage of cell 
death can be calculated according to the Eq. 26.
105
    
 death  =
experimental OHSC  live control
                          
 100  (26) 
The results indicate that the death% for the CA3 region (sampled region) was below 1%. 
Therefore, ggACSF is an effective substitute for the ACSF in electroosmotic sampling. 
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Figure 47. Viability assessment for OHSCs 
(a1) fluorescence and a2 bright field are for the 100% death control. (b1) and (b2) are for a live control, which was 
handled in the same way as the experimental OHSCs, except that it was neither sampled nor exposed to ggACSF. 
Image (c1) and (c2) are for an OHSC placed on the same culture insert as the sampled OHSC (d1/d2) in a Petri dish 
containing the ggACSF. The electroosmotic sampling was carried out by applying +3000 V at the Petri dish and 
GND at R4 for 10 min. The arrows indicate the location where the sampling capillary tip was positioned. 
4.3.3 High sample conductivity affects flow-gated sample injection analysis of samples  
Normally, the conductivities of the fluids inside the channels during a microfluidic analysis are 
similar. We found that when the conductivity of the stream from the reaction channel (which 
contains the sample) is much higher than that of the running buffer (from R2 and R3), flow-gated 
sample injection will fail. To investigate this, we used a simplified version of the setup shown in 
Fig. 41 in which the capillary and fitting were removed from R5. An electrode and an 
appropriate buffer solution were placed in the reservoir thus created. There is no analyte flowing 
in from the sample branch (from R5). We use the peak from the ThioGlo-1 reagent, which has a 
very low but non-zero quantum yield in the absence of thiols, as a flow marker. Fig. 48 shows a 
series of flow-gated injection experiments where the analyte-free sample stream in R5 has the 
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same (a) or higher (b) conductivity than that of the running buffer. The period from 0 to about 80 
s in Fig. 48 (a) and (b) represents the time needed for changes made in the reservoirs to show up 
at the injection cross.  When the conductivity of the solution in R5 was 1.4 mS/cm (20 mM Tris, 
pH = 7.5) which is the same buffer as in R1, R2, and R3, continuous flow-gated injection 
generated reproducible ThioGlo-1 peaks. When the low conductivity buffer in R5 was replaced 
by ACSF (15.4 mS/cm), and following the 80 s period in which the conductivity in the reaction 
channel changes, the ThioGlo-1 peaks disappear as shown in Fig. 48 (b). To validate that the 
failure of flow-gated sample introduction is due to the mismatch of the conductivities around the 
injection cross, the running buffers in R2 and R3 were both replaced with 20 mM Tris-HCl 
augmented with 60 mM NaCl (pH = 7.5), which increased the conductivity inside the separation 
channel to 7.3 mS/cm. We estimate the conductivity in the reaction channel to be 4.2 mS/cm 
with R5 at 15.4 mS/cm and R1 at 1.4 mS/cm. This estimation depends on the conductivies of the 
fluids as well as the mixing ratio of fluids from R1 and R5 as they enter the reaction channel. 
Estimation of the mixing ratio accounts for the relevant channel lengths, applied voltages, and 
channel wall -potentials (which take into account the local ionic strength).  When the reaction 
channel conductivity (~4.2 mS/cm) is lower than that of R2/R3 (7.3 mS/cm), reproducible flow-
gated injection behavior is recovered as shown in Fig. 48 (c).  
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Figure 48. Effect of buffer conductivity on the flow-gated injection 
+200 V, +200 V and -4500 V were applied to R1, R5 (no capillary was connected) and R3, respectively. R2 was 
switched between “GND” (0.5 s) and “floating” (14.5 s) continuously, while R4 was disabled. R1 was filled with 3.4 
μM ThioGlo-1 in 20 mM Tris-HCl (pH = 7.5). (a) R2, R3, and R5 have 20 mM Tris-HCl (pH = 7.5). (b) R2 and R3 
as in (a), R5 has ACSF (pH = 7.4). (c) R2/R3 has 20 mM Tris-HCl containing 60 mM NaCl (pH = 7.5), R5 same as 
(b). 
 
To understand this phenomenon better, we simulated it using Comsol v4.3 (COMSOL, 
Inc., Burlington, MA). The channel lengths, applied voltages, and sample injection time were 
simulated at 1/10 of their laboratory values. This increases computing efficiency while leaving 
the critical feature, electric field, equal to the field applied in the laboratory. To avoid confusion, 
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from 1.4 mS/cm to 15.4 mS/cm, while the conductivities of the solutions in all other reservoirs 
were kept constant at 1.4 mS/cm. In Fig. 49, the injections cross has the same orientation as that 
in Fig. 41. Fig. 49 shows that the conductivity in R5 has a significant influence on the velocities 
at the cross. Importantly, at high conductivity, floating R2 does not result in an injection. This 
can be explained qualitatively as follows.  
In the injection step (R2 floating) the current from the reaction (r) channel passes in about 
equal proportions into the waste (w) and separation (s) channels. As the cross sectional areas are 
all the same, the current density in the separation and waste channels is about half that of the 
reaction channel. As the electric field is proportional to the product of current density and 
resistivity, when the resistivities are the same in all channels, the electric field in the reaction 
channel Er is nearly twice as large as that of the separation channel (Es) or that of the waste 
channel (Ew). For incompressible liquid, according to the law of the conservation of mass, the 
total volumetric flow rate (m
3
/s) into the cross is equal to that out of the cross which can be 
expressed as follows: 
           (     ) (27) 
where A is the area (m
2
) of the channel cross sections,   ,   ,   , and    are the flow speeds 
(m/s) in the separation, waste, gated and reaction channels, respectively. Each flow speed is 
contributed by two terms, the electroosmotic flow and the pressure driven flow. According to 
Hagen-Poiseuille law, the mean flow speed caused by the pressure drop is inversely proportional 
to the length of the channel given the same pressure drop between the inlet/outlet of a channel 
and injection cross. As the channel lengths for the separation, waste and reaction channels are 
much longer than the gated channel, the contribution from the pressure driven flow is negligible 
for   ,   , and    in comparison with that for   . When R2 is floating, there is no electric field in 
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the associated channel,    is contributed only be pressure driven flow. According to the above 
discussion, the flow speeds in reaction, separation and waste channel are proportional to the 
electric fields,    is equal to      . Combining the mass balance expressed as Eq. 27,    is 
zero. This is seen in the simulation, Fig. 49 (c1). Therefore, the sample stream from the reaction 
channel enters the separation channel when R2 is floating and the injection is successful (Fig. 49 
(a1)).  
If we keep the conductivities of solutions in R1/R2/R3 unchanged while increasing that 
of solution in R5, after a certain time the concentrations of the solutions in all channels will reach 
a new steady state. The conductivities in the waste and reaction channels will be similar and 
higher than that of the separation channel, which is approximately unchanged. As the parallel 
waste and separation channels have different conductances, their currents are no longer the same. 
The current in the waste channel becomes larger than that in the separation channel. 
Furthermore, as the current in the reaction channel provides the current passing through both the 
waste and separation channels, and the waste channel has the majority of the current beyond the 
cross, the ratio of the current in the reaction channel to that in the waste channel is now less than 
two. As the current densities define the fields, the fields suffer the same change in ratio. Thus, 
when R2 is floating, Es and Ew are each greater than one-half of Er (See Appendix A for detailed 
equation deduction). Consequently, the mass flow rate leaving the cross is greater than the mass 
flow rate provided by the reaction channel:  
            (28) 
In order to meet the requirements of Eq. 27 and 28 simultaneously,    must be larger than 
zero. Therefore, during the sample injection step, there is fluid flow from the gated channel 
through the injection cross due to the decrease in the internal fluid pressure at the cross, even 
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though R2 is set at “floating” and the contribution of this fluid flow from EO flow is zero (Fig. 
49 (c2-4)). A direct result of this flow during the injection step is the reduction in the amount of 
sample being introduced into the separation channel (Fig. 49 (c2/3)). When the mismatch of the 
conductivity becomes large, sample introduction will be completely shut down (Fig. 49 (a4)). 
Fig. 49 (d) simulates the profiles of the ThioGlo-1 peaks along the separation channel at 0.025 s 
in the separation step after injection of the sample stream for 0.05 s. It is clear that when the 
conductivity in R5 increases to 11.9 mS/cm, no more samples will be introduced into the 
separation channel.  
In order to keep the conductivity of the solution in R2 balanced with that of the sample 
stream, the 40 mM Bis-Tris propane buffer (pH = 8.5) was augmented with 15 mM NaCl, which 
increased the conductivity of the running buffer in R2 to 4.2 mS/cm, comparable to that of 
sample stream from OHSCs mixed with derivatizing reagent. Another way that may circumvent 
the flow-gated problem described above is by switching the relay to a negative voltage instead of 
“floating” for a sample introduction. We have not explored this.  
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Figure 49. Concentrations, conductivities and velocities during injection 
Snapshots of the ThioGlo-1 concentration (a1-4), the buffer conductivity (b1-4) and the velocity of the fluid 
(c1-4) after 0.05 s of sample injection are for different R5 conductivities. The concentration profiles of the 
ThioGlo-1 at 0.025 s in the separation step are plotted against the length of the separation channel (d). The 
peak concentration of ThioGlo-1 is plotted against the R5 conductivity in the inset of (d). 
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4.3.4 The function of an auxiliary channel in integrating electroosmotic sampling and 
microfluidic analysis 
Controlling the flow rate by adjusting potentials applied to reservoirs is critical to obtaining a 
reproducible signal. If the sampling step and the microfluidic analysis are directly connected to 
each other, the potential drop in one process will dramatically affect the following steps. To 
circumvent this, an auxiliary channel with an additional R4 was added to the microfluidic chip 
(Fig. 41). By setting R4 to “GND”, the electric field across the sampling capillary is controllable 
without dramatically affecting the derivatizing reaction. Moreover, it expands the usable 
potential range that can be applied on the sampling capillary and provides an option to split the 
sample flow to R4.  
To demonstrate the effectiveness of the auxiliary channel, we simulated the effect of 
changing the potential in the Petri dish on the concentration of the derivatizing reagent in the 
reaction channel with and without an auxiliary channel (Fig. 50). In this simulation, we again 
rescaled the capillary length, and the applied voltages to one tenth of their actual values but kept 
the width of the channel unchanged. Again, voltages stated here are those that would be used in 
the laboratory. The ThioGlo-1 concentrations at the end of the reaction channel relative to 
ThioGlo-1 concentration in R1 were recorded, while the potential at the Petri dish was swept 
from 0 to +10000 V and that at R1 was kept constant at +300 V. It is clear from Fig. 50 that with 
a grounded auxiliary channel, changing the potential in the Petri dish (x-axis) has much less 
effect on the relative ThioGlo-1 concentration (y-axis) in the reaction channel than that in the 
case without the auxiliary channel. At virtually all applied voltages without the auxiliary 
channel, the reagent concentration is less than its value in R1. With the auxiliary channel, 
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however, at voltages up to about 3000 V there is little change in the reagent concentration. Thus, 
we chose to use 3000 V in these measurements. 
 
Figure 50. Effect of auxiliary channel on the relative ThioGlo-1 concentration 
ThioGlo-1 concentration is sampled at the end of the reaction channel. X-axis is the voltages at the Petri dish 
(sample). 
4.3.5 The effect of electroosmotic sampling conditions on OHSCs  
Unlike the offline sampling method,
106
 online experiments require continuous transport of the 
collected sample through the whole sampling capillary before it can enter into the microfluidic 
chip for analysis. Parameters, such as capillary ID, length, and potential applied at the Petri dish 
should be adjusted to obtain an appropriate flow rate. We finally selected an 11 cm x 50 μm (ID) 
capillary with +3000 V applied to the cell dish after trial and error. Also, exposure to the field 
and current can be damaging.
105
 To evaluate the damage that the electroosmotic sampling may 
cause to CA3, we first did a viability assessment for OHSCs after applying 3000 V to the Petri 
dish while R4 was at GND for 10 min. All other conditions were the same as that for the pre-
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sampling step described in the experimental section. The fluorescent (PI) and bright field images 
are shown in Fig. 47 (d1/2). According to Eq. 26, the %death of the tissue after sampling is ~ 
10%, which we believe is acceptable in sampling from OHSCs.
105
  
4.3.6 Evaluation of the extracellular Cys, Hcy, and CSH concentration in OHSCs  
Results from online single capillary sampling experiments indicated that there was no detectable 
GSH, γ-Glu-Cys or Cys-Gly in the samples collected from electroosmotic sampling. GSH was 
evident in electropherograms when sampling directly from the surface of the hydrophilic PTFE 
membrane of the standing insert on which the culture sits (when glutathione is present in the 
medium below), however it was not evident when sampling from tissue. We believe that there 
are two contributions to this. One is that GSH reacts very rapidly with Gly-Gly in the 
extracellular space due to the presence of the ectoenzyme γ-glutamyl transpeptidase.277 The other 
is the electrophoretic bias in sampling. It takes longer for anions to be transported from tissue to 
the chip than for neutrals or cations under the sampling conditions. In the extreme case, the 
electroosmotic sampling method may fail to sample out small and highly negatively charged 
molecules that have electrophoretic mobility equivalent or larger than that of electroosmotic flow 
with opposite direction. This is mainly due to the relative small -potential of the tissue (-22.8 
mV)
259
 compared with that of the fused silica capillary (-50 mV) and low permeability of the 
tissue (~10-15 m2),
278
 even the pressure driven flow induced by the stepwise change in the -
potentials at the interface of tissue and sampling capillary will not compensate the difference 
between the electrophoretic mobility of small negatively charged analytes and electroosmotic 
mobility in the extracellular space of the tissue.  
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Based on the analyte of interest presenting in the sample and the requirement of analysis 
time for a single assay, 40 mM Bis-Tris propane buffer with 15 mM NaCl (pH 8.5) was used as 
the running buffer in the online analysis. Fig. 50 (a) shows an electropherogram from 
electroosmotic sampling of an OHSC with ggACSF in the Petri dish. Fig. 51 (b), (c), (d) were 
obtained using the same conditions, but the ggACSF (Petri dish) was spiked with 99.2 nM CSH, 
65.8 μM Cys and 575 nM Hcy. ThioGlo-1 derivatized peaks of CSH, Hcy, and Cys were 
identified by comparing the migration times with those of standards. A reconstructed plot of 
PMT reading vs time for all injections in one run is given in Fig. 52.  
 
Figure 51. Electropherogram of analytes from electroosmotic sampling of OHSCs 
Electroosmotic sampling from an OHSC with (a) ggACSF in the Petri dish, (b) 99.22 nM of CSH in ggACSF, (c) 
65.81 μM of Cys in ggACSF, (d) 574.8 nM of Hcy in ggACSF. 
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Figure 52. Reconstructed plot of PMT reading vs time for all injection in one run 
Electroosmotic sampling was performed on an OHSC with only ggACSF in the Petri dish. Peaks with migration 
time from 20-25 s are impurities from derivatizing reservoir R1 containing ThioGlo-1. 
 
Some comments on the separation/detection are warranted. The “dye” peak is from the 
neutral ThioGlo-1, thus it acts as a marker for the electroosmotic velocity in the separation 
channel. Hcy and Cys are nominally zwitterionic, but in fact at pH 8.5, each has a small negative 
charge (pICys = 6.31;
279
 pIHcy = 6.54,
279
 estimated without considering the pKa of –SH) consistent 
with their positions, with respect to each other as well as with respect to the neutral marker, in 
the observed electropherogram. Finally, we were surprised to see Gly-Gly in the 
electropherogram. It turns out that amines are reactive with maleimides, though at a much lower 
rate than thiols.
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In order to convert the output signals to values with a unit of concentration, a calibration 
curve must be established. In our situation, it is inappropriate to establish standard curves by 
sampling directly from free solutions containing analytes at various concentrations. The 
resistance of an OHSC is significantly different from free solution.  Alterations in the voltage 
and current distribution on the chip will lead to different sample-reagent mixing ratios and thus 
different fluorescent signals for the same analyte concentration. To solve this problem, a 
calibration curve was created by adding known quantities of the analyte to the ggACSF in the 
Petri dishes of a series of tissue cultures. To determine the basal concentration of CSH, Hcy and 
Cys, analyses were carried out on 5-8 tissues for each compound. Three tissues in each group 
had no added analytes, while the rest had added analyte. As discussed in a previous paper,
274
 
there is a delay from the appearance of the first analyte peak in each analysis until the peak 
magnitude in the electropherogram reaches a steady value (Fig. 53). Once the steady state is 
reached, all of the peak heights are taken. Each analysis results therefore include fifty or more 
determinations. For example, a single reported concentration may result from measurements on 
six tissue cultures, three with no added analyte and three with different concentrations of analyte 
in the Petri dish. If ten electrophoretic peaks are used from each of six tissue cultures, then the 
number of data going into the measured concentration is sixty. A linear regression on these data 
points leads to a slope for peak height versus concentration. The y-intercept and the slope are 
used to calculate the resting concentration of that analyte in OHSCs. Standard deviations of the 
basal concentrations were calculated through propagation of error (see Appendix B for detail 
information related with the standard addition method). In this way, the measured endogenous 
concentration of CSH, Hcy and Cys were calculated to be 10.6 ± 1.0 nM (n = 70), 0.18 ± 0.01 
μM (n = 53) and 11.1 ± 1.2 μM (n = 70), respectively, where n is the number of data points used 
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in the linear fitting. Errors are the SEM. We also calculated the detection limit based on the RMS 
noise in 3 second sections of baselines and the slope of the calibration curve. This would be 
appropriate for deciding if a particular feature in a single electropherogram was actually a peak. 
The values (S/N = 3) are 5.4 nM, 25 nM and 1.4 μM for CSH, Hcy and Cys, respectively. 
Averaging electropherograms would improve these values. This method is capable of 
determining CSH in the extracellular space of rat OHSCs. Other methods do not have the 
requisite low detection limit.
73, 74
 The concentrations for Hcy and Cys are comparable with the 
published extracellular values of Hcy and Cys.
29, 87, 260
  
 
Figure 53. Hcy peak height vs injection # in a single run 
Record of the injection number started from the detection of the first Hcy peak in the electropherogram. 0.575 μM of 
Hcy was added into ggACSF buffer in the Petri dish before the start of electroosmotic sampling from an OHSC. 
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No new method should go without a thorough consideration of potential confounding 
issues. It is well known that accurate calibration of a method that samples (or measures directly 
in) the extracellular space is very difficult, e.g., microdialysis and in vivo voltammetry. A 
primary source of uncertainty in the current method might be the local uptake and exchange of 
the aminothiols inside the tissue during sampling, especially when the spiked analytes have 
concentrations comparable to the basal levels in OHSCs. Cell damage near the sampled region 
may add uncertainty. On the latter point, we note that the electric field inside the tissue along the 
sampling direction is highest near the tip of the sampling capillary. Cells near the capillary tip 
may be electroporated
281
 adding intracellular material to the sample. However, the actual 
measurements are taken after the signal reaches a steady state. Material from electroporated cells 
near the tip of the capillary will be present at the early stages of the measurement prior to 
establishing the steady state. Finally, electroosmotic sampling will suffer a sampling bias based 
on solute charge and size. With proper calibration, this need not be a problem, but there are some 
molecules (small and highly negatively charged) that may not be suitable for this method based 
on the current experimental setup and conditions. 
4.3.7 Comparison of single and dual capillary modes in electroosmotic sampling 
It has been discussed in Chapter 1 that the synthesis of neuronal GSH relies on the releasing of 
GSH from the neighboring astrocytes. The concentration of extracellular GSH in brain has been 
reported to be in the low micro molar range. However, from the online single capillary sampling 
experiments, there is no detectable GSH shown in the electropherograms. In order to further 
explore this problem, a dual capillary sampling mode is applied in electroosmotic sampling from 
OHSCs as a comparison to single capillary sampling. To find out the migration behavior of GSH 
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under the current separation condition, the microfluidic chip in Fig. 41 was first operated in on-
chip mode. Fig. 54 (a) was obtained when the sample reservoir R5 contained ggACSF spiked 
with 1.234 µM GSH. There was an additional peak just before the location for the peak of Gly-
Gly. To further confirm the identities of these peaks, in the following experiment, the analyte of 
Tris-HCl buffer with 60 mM NaCl and 1.234 µM GSH was added into R4. Fig. 54 (b) showed 
that there was an obvious decrease in the Gly-Gly peak and an increase in the GSH peak. In the 
next experiment, we would like to test whether the membrane of the standing insert became an 
obstacle of electroosmotic sampling of GSH. In this experiment, the tip of the single sampling 
capillary was lowered down until it made contact with the membrane. The ggACSF buffer 
solution under the membrane was spiked with 62.24 µM GSH. All other conditions were the 
same as that described in Section 4.2.6. Fig. 55 proved that GSH could be sampled out 
successfully without any problem through the membrane. 
There are several possibilities that will result in no detectable GSH in extracellular fluid 
collected through single capillary electroosmotic sampling in CA3 region as shown in Fig. 52. 
First, the basal concentration of GSH is too low to be detected using this method. Second, the 
electrophoretic bias of this sampling method may result in much longer migration time for anions 
like GSH to be transported from tissue to the chip than that for neutrals and cations, or in the 
worst case, this method may fail to collect GSH due to both the low -potential and low 
permeability of the tissue. Third, the conversion rate of GSH to CysGly by γGT may increase at 
the presence of a high concentration of Gly-Gly in ggACSF buffer. To exclude the concentration 
factor, GSH was added into the ggACSF buffer to a final concentration of 62.24 µM. There was 
still no GSH peak observed in a ~ 30 minutes online electroosmotic sampling as shown in Fig. 
56, which suggested that it may require much longer sampling time for the GSH to reach the 
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injection cross and the mobility of GSH may be comparable with that of the electroosmotic flow 
but with opposite direction. Based on the migration time of ThioGlo-1 and GSH shown in Fig. 
43 and 44, the electrophoretic mobility of GSH-ThioGlo-1 adduct can be estimated to be -
1.22×10
-8
 m
2
/(V·s) at pH = 7.5. The electrophoretic mobility of GSH would be more negative 
than its ThioGlo-1 adduct. According to the reported value of -potential for OHSCs, -22.8 
mV,
259
 the electroosmotic mobility of tissue would be 1.78×10
-8
 m
2
/(V·s). The difference 
between these estimated mobilities is not large.     
 
Figure 54. Electrophoretic behavior of GSH 
Microfluidic chip shown in Fig. 41 were used. R1: 20 mM Tris-HCl at pH 7.5 with 2.688 µM ThioGlo-1; R2/R3: 40 
mM Bis-tris propane buffer with 15 mM NaCl at pH 8.5; R4: 20 mM Tris-HCl buffer spiked with 60 mM NaCl and 
1.234 µM GSH at pH 7.5; R5: ggACSF with 1.234 µM GSH. Voltage settings in experiments: (a) R1/R5: 300 V; R2 
(GND/floating: 24.5 s/0.5 s); R3: -4500 V; R4: disable; (b) R1/R4: 300 V; R2 (GND/floating: 24.5 s/0.5 s); R3: -
4500 V; R5: disable. 
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Figure 55. Single capillary sampling through membrane of the standing insert placed in the Petri dish 
Petri dish contained 1.2 mL ggACSF spiked with 62.24 µM GSH. All other conditions were same as the single 
capillary sampling experiment described in Section 4.2.6. 
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Figure 56. Single capillary sampling from CA3 of OHSCs 
 Petri dish contained ggACSF spiked with 62.24 µM GSH. All other conditions were same as sampling experiment 
described in Section 4.2.6. (a) Waterfall plot of all injections in a single run of 1200 s (there was an additional six 
minutes pre-sampling step) (b) rotated view of the waterfall plot; (c) Comparison of the electropherograms obtained 
from injection at 950.525 s of this experiment and that of Fig. 54 (a).  
 
The dual capillary sampling was first tested when both tips of the parallel inlet capillary 
and 2 were immersed into ggACSF in a Petri dish. Inlet capillary and glass vial were prefilled 
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60 mM NaCl at pH 7.5.  In the pre-sampling step and at the beginning of the online analysis, 
+3000 V was applied to the glass vial. All other parameters were same as the single capillary 
sampling experiment described in Section 4.2.6. At about 626 s, the potential in R1 was 
decreased to 80 V, which decreased the ratio of the derivatizing reagent in the mixing channel. 
At about 975 s, the potentials at the glass vial and R1 were increased to +7000 V and +300 V, 
respectively, so that the electric field applied on the two capillaries was similar to that in the 
single capillary sampling experiment. GSH appeared finally in the electropherogram as shown in 
Fig. 57. It must be pointed out that concentration of the GSH in the sample stream is determined 
by the actual tip-to-tip distance of the two capillary and the mobility of GSH in inlet and outlet 
capillaries.  
 
Figure 57. Dual capillary sampling directly from solution in Petri dish 
Petri dish contained 1.2 mL ggACSF buffer. Glass vial and inlet capillary contained ggACSF buffer spiked with 
62.24 µM GSH. At beginning, 3000 V was applied to the glass vial; +300 V was applied to R1; at 626 s, the 
potential at R1 was decreased to 80 V; at 975 s, the potential at R1 was increased to 300 V and potential at the glass 
vial was increased to +7000 V. All other experiment conditions were described in Section 4.2.7.  
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It has been discussed in Section 4.2.7 that there are two situations in the dual capillary 
sampling experiment as shown in Fig. 42 due to the limited freedom in controlling positions of 
two capillaries simultaneously with only one manipulator. Fig. 58 shows that the 
electropherograms for these two cases were quite different. In this experiment, glass vial and 
inlet capillary were filled with ggACSF buffer spiked with 62.24 µM GSH, all other conditions 
were described in Section 4.2.7. The relative distance between the tip of outlet capillary and 
tissue surface was kept the same as that in the single capillary sampling experiment, while the tip 
of inlet capillary was much closer to the tissue surface than that of outlet capillary (case A) or at 
the same height as that for the outlet capillary (case B). In case A, there is no additional peak 
migrates before Gly-Gly peak (Fig. 58 (a1/2)). However, in case B, the GSH peak appears in the 
electropherogram next to the Gly-Gly peak (Fig. 58 (b1/b2)). The overlay of selected 
electropherograms for these two cases is given in Fig. 58 (c). In another dual capillary sampling 
experiment, all experimental conditions were same as that for Fig. 58 (b1/b2) except that no 
GSH was in the glass vial or inlet capillary, however, we still observed an additional peak before 
the peak of Gly-Gly (Fig. 59 (a)). By comparing the migration time of this peak with that of GSH 
(Fig. 59 (b)), this additional peak was assigned to basal extracellular GSH of OHSCs with a 
concentration of ~ 10 µM. A possible reason that may explain the difference in the appearance of 
GSH on the electropherogram in both cases is that in case A when the inlet capillary is very close 
or touching the tissue surface, electric circuit between two tips of the capillaries is completed by 
a segment of tissue. Buffer solution from the inlet capillary has to pass through this segment of 
tissue before being collected by the outlet capillary. As discussed before, GSH has similar 
electrophoretic mobility as the electroosmotic mobility of the tissue but with opposite direction. 
The time it requires to collect anions from tissue may be much longer than for neutrals or cations 
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under the sampling conditions and this time may be longer than the current sampling time. 
Therefore, there is no GSH observed in the electropherogram in Fig. 58 (a1/2). On the contrary, 
in case B, the tip of the inlet capillary is at the same height at that of the outlet capillary, the 
electric circuit between two capillary tips is completed by a parallel circuit composed of a 
segment of liquid on the tissue surface and a segment of tissue. Due to the low conductivity and 
permeability of the tissue in comparison to the free solution, most of the buffer solutions from 
the inlet capillary flows on top of the tissue and then enters the outlet capillary rather than 
passing through the tissue. Although the electroosmotic mobilities are same on the tissue surface 
and inside the tissue, the pressure driven flow caused by the mismatch of the -potentials of the 
capillary and tissue will dramatically increase the velocities of the anions like GSH in the free 
solution on top of the tissue, which explain the existence of the GSH peaks on the 
electropherogram in Fig. 58 (b1/b2). However, the low permeability
278
 of the tissue largely limits 
the pressure driven flow inside the tissue and thus has little help in speeding up the velocity of 
GSH. The endogenous GSH in the extracellular space which diffused into the liquid layer on top 
of the tissue can also been collected by the dual capillary sampling as shown Fig. 59 (a). It is 
anticipated that by applying the dual capillary electroosmotic sampling in a mode that the inlet 
capillary is at the same height or higher than the outlet capillary, it is possible to obtain 
information of the analytes in the extracellular space of OHSCs and metabolic data when specific 
substrate flows on top of tissue.    
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Figure 58. Comparison of two cases in dual capillary electroosmotic sampling from OHSCs 
Sampling was performed in CA3 region. Glass vial and inlet capillary were filled with ggACSF buffer spiked with 
62.24 µM GSH. The dual capillary setups in a1 (a2, rotated view) and b1 (b2 rotated view) were based on case A 
and case B shown in Fig. 43, respectively. (c) Comparison of the electropherograms obtained from injection at 
475.525 s in case A and injection at 481.525 s in case B. Other conditions were described in Section 4.2.7. 
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Figure 59. Dual capillary electroosmotic sampling from OHSCs 
Sampling was performed in CA3 region. Glass vial and inlet capillary contained ggACSF buffer only. (a) 
Electropherogram shows the basal GSH. (b) Comparison of the electropherograms obtained from injection at 
631.925 s in this experiment and injection at 481.525 s in case B of Fig. 58. 
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4.4 CONCLUSIONS 
We have interfaced electroosmotic sampling and a microfluidic chip-based determination for 
thiols. High conductivity biological samples lead to many practical problems during microfluidic 
analysis. We explored the issues of high conductivity samples and the failure in flow-gated 
injection due to mismatch in conductivities of flows at the injection cross and provided solutions 
to these problems. The partial replacement of NaCl in the ACSF in the tissue culture dish with 
Gly-Gly resulted in a 38% decrease in the conductivity and caused negligible damage to OHSCs. 
Further, the increase of the conductivity of the running buffer using NaCl not only recovered the 
flow-gated injection but also retained the separation resolution for three aminothiols, CSH, Cys, 
and Hcy in 15 s. Finally, the incorporation of an auxiliary channel plays a key role in integrating 
electroosmotic sampling with microfluidic analysis. It expanded the usable range of the electric 
field across the sampling capillary in comparison to when there is no auxiliary channel. We 
demonstrated the successful separation of common aminothiols in the microfluidic channel and 
the coupling of single capillary electroosmotic sampling with a microfluidic chip to achieve in 
situ measurement of the extracellular CSH, Hcy, and Cys in OHSCs. Compared with other 
reported works, our method has high selectivity, sensitivity and analysis speed. This technique 
can be applied to monitoring the change of aminothiols level in the extracellular space and 
measuring the activity of related ectoenzymes in OHSCs. We also compared the single capillary 
and dual capillary in electroosmotic sampling of OHSCs and found that it is possible to sample 
the spiked or endogenous GSH out of tissue if tips of the capillaries in a dual capillary mode are 
connecting the tissue through a thin layer of liquid. The dual capillary sampling mode is a 
promising technique to study anionic analytes in the extracellular space and other biological 
information and metabolic process on the tissue surface.  
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5.0  TRACKING THE METABOLISM OF TWO DURG COMPOUNDS AND COA IN 
OHSCS  
CSH is the last product of CoA biodegradation. The current knowledge about the formation rate 
of CSH in mammalian tissues is limited, which hinders the estimation of taurine flux through the 
CSH pathway. Owing to their ability to generate CSH, cystamine (CSSC) and pantethine (PSSP) 
are two well-known drug compounds in treating cystinosis. The difference in their effectiveness 
and side effects can be tracked back to their distinct metabolic behaviors at cellular level. CoA, 
as an essential cofactor for about 4% of all known enzymes, participates actively in the oxidation 
of carbon substrates and the synthesis of cellular structural components. Currently, little is 
known about CoA biodegradation and even less is known about the regulation and kinetic 
characteristics for this sequential multi-enzyme reaction. We have developed a technique, which 
integrates electroosmotic sampling with online microfluidic analysis that is capable of tracking 
the metabolism of CSSC, PSSP and CoA in the extracellular space of organotypic hippocampal 
slice cultures (OHSCs). In this research, the percentage yields of CSH from CSSC and PSSP 
after ~55 s exposure time to the OHSCs were 91% ± 4% and 0.01%-0.03%, respectively, which 
can be used to explain the reported differences in the effectiveness and toxicity of these two 
drugs. Error represents the standard error of the mean. Besides, the kinetic parameters of enzyme 
reaction catalyzed by pantetheinase were also determined to be KM,C/α = 4.4 ± 1.1 mM and 
Vmax,C = 29 ± 3 nM/s, where α is the percentage yield of PSSP to pantetheine through disulfide 
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exchange. The degradation of CoA in extracellular space was also observed and based on the 
formation rate of CSH in the OHSCs, we obtained the overall apparent Michaelis constant and 
maximum reaction rate for the sequential extracellular CoA degradation in an in situ 
environment, which are K’M = 16 ± 4 μM, V’max = 7.1 ± 0.5 nM/s. Kinetic parameters obtained 
in situ, although difficult to measure, are better representations of the biochemical flux in the 
living organism than those from an isolated enzyme in vitro. Using these kinetic parameters for 
the CoA biodegradation is helpful to understand and solve the current challenges related with 
CoA degradation.  
5.1 INTRODUCTION 
Endogenous CSH exists at a relatively low concentration in the tissue.
69
 It is the terminal 
metabolite in CoA degradation.
65, 68, 88
 and also a vital source for taurine.
70
 Beside their 
therapeutical functions as radio-protective and anti-viral agents, CSH and its disulfide form 
CSSC are potential neuroprotective candidates in treating neurodegenerative diseases such as 
Parkinson’s disease and Huntington’s disease.71, 282, 283 CSH and CSSC are also used in the 
treatment of cystinosis, an autosomal recessive genetic disease.
284, 285
 Cystine trapped inside the 
lysosome reacts with CSH following the latter’s transport across the lysosomal membrane by a 
specific yet unidentified membrane transporter to form the CSH-cysteine mixed disulfide, which 
can leave the lysosome with the help of lysosomal lysine transporter.
76
 The disulfide form of 
pantetheine, PSSP, is also capable of reducing accumulated cystine inside the lysosome but with 
fewer side effects and lower toxicity in comparison to CSH or CSSC.
285-288
 The ability of PSSP 
in treating cystinosis relies on the formation of pantetheine from disulfide exchange reaction 
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with endogenous thiols (e.g. GSH) and then the metabolism of PSH to CSH via 
pantetheinases.
285, 289
  
CoA is an essential cofactor for about 4% of all known enzymes and is actively involved 
in more than one hundred different synthetic and degradative reactions  
65, 68
. CoA participates in 
the oxidation of major carbon substrates for energy production and  the synthesis of many 
cellular structural components 
68
. In brain, CoA also plays an essential role in the production of 
the neurotransmitter acetylcholine 
68
. Due to its role in energy metabolism, the tissue 
concentration of total CoA, including both free CoA and esterified CoA, is especially high in 
metabolically active tissues such as heart, liver, kidney and brain.
65, 68, 290, 291
 In the intracellular 
space of animal tissues, CoA is distributed mainly in cytosol, mitochondria and peroxisome with 
estimated concentrations of 0.02-0.14 mM, 2.2-5 mM and 0.7 mM, respectively.
65
 The 
biosynthesis of CoA is accomplished in cytosol through five well-established steps with the aid 
of enzymes starting from three substrates, pantothenic acid (also known as vitamin B5), ATP, 
and cysteine 
65, 68, 89, 292
. However, very little is known about CoA degradation and even less is 
known about the regulation of this process as well as its turnover rate 
1, 65, 68, 88
. Currently, the 
pathway for CoA degradation is poorly understood. Based on the current information related 
with identified enzymes that can catalyze this process, there are several proposed routes for CoA 
biodegradation as shown in Fig. 60. In route I, CoA is first dephosphorylated to dephospho-CoA 
by acid phosphatase (EC 3.1.3.2) located inside the lysosome and then degraded to 4’-phospho-
PSH by the ecto-nucleotide diphosphatase (EC 3.6.1.9) located on the plasma membrane 
65, 68, 293
. 
CoA has also been reported to be a direct substrate of nucleotide diphosphatase with the products 
of 3’, 5’-ADP and 4’-phospho-PSH through route II 65, 68, 294. In route III, a peroxisomal nudix 
hydrolase (EC 3.6.1.13) is capable of converting CoA to 4’-phospho-PSH and shows very low 
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activity with dephospho-CoA as the substrate 
65, 294-296
. After further dephosphorylation of 4’-
phospho-PSH by acid phosphatase, the product PSH is then degraded to pantothenic acid and 
CSH, which is catalyzed by membrane-bound extracellular pantetheinase (EC 3.5.1.92) 
65, 68, 88
. 
 
Figure 60. Proposed CoA biodegradation pathways 
H2O in each step is omitted. 
Measuring CSH concentration in biological samples and the rate of CSH formation are 
crucial for evaluating taurine production through the CSH-dependent pathway and better 
understanding the CoA metabolic turnover rate and mechanism.
88
 It will also clarify the 
mechanism underlying the differences in the toxicity and beneficial effects of CSSC and PSSP at 
the molecular level. Currently, there is little knowledge about the rate of CSH formation in 
mammalian tissues due to the relatively low endogenous concentration of this molecule in tissues 
and also the technical difficulty in measuring it.
69, 88
 We have reported integrating electroosmotic 
perfusion with a microfluidic chip for online analysis of fluid perfused through the extracellular 
space of OHSCs.
297
 Conveniently, under the influence of an electric field extracellular fluid in 
the tissues can be drawn into a capillary by the same natural driving force, electroosmotic flow, 
as that used in the microfluidic chip. The coupling of perfusion, sample transport and 
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quantitative analyses solves many practical problems. Samples transported directly to a 
microfluidic device for analysis are more representative of the fluid in the tissue being sampled 
than samples that undergo several handling steps. This is especially true when the samples 
volumes are nanoliters or smaller volumes.  
The integration of a tissue culture with a micro-analytical system has an added advantage. 
In intact biological systems, numerous enzyme reactions occur simultaneously with complex 
inhibiting and activating regulation and feedback among them.
298
 Therefore, analyzing a 
metabolic process in an in situ model provides a representation of the process that is distinct 
from and complementary to the determination of the physicochemical properties of the enzymes 
involved in the process.  
In this work, we perfused OHSCs with two drug compounds used to treat cystinosis, 
CSSC and PSSP, to determine the extent of generation of the active compound, CSH, from each 
of them. The differences in the metabolism of the two drugs correlate with their clinical 
effectiveness and tendency to produce side effects. We also monitored the changes in the 
concentrations of CSH, PSH, Hcy and Cys in the extracellular space of the CA3 region in the 
OHSCs while perfusing the tissue with CoA. Direct evidence for complete degradation of CoA 
to cysteamine in the extracellular space of OHSCs was observed, based on which the in situ 
overall kinetic parameters were calculated. To the best of our knowledge, this is the first in situ 
study that directly measures conversion rate of CSH during extracellular CoA degradation in 
tissues.  
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5.2 EXPERIMENTAL SECTION 
5.2.1 Chemicals and reagents 
ACSF was composed of (mM), NaCl (128), KCl (3), CaCl2 (2), MgSO4 (1.2), KH2PO4 (0.4), 
NaHCO3 (25), D-(+)-glucose (10). The ggACSF was prepared by replacing 75 mM NaCl in the 
ACSF with 125 mM Gly-Gly with all other components unchanged. Both solutions have similar 
osmolarity (~310 mOsm/L) and pH value (pH = 7.4). NaCl and KCl were obtained from Avantor 
Performance Materials (Center Valley, PA). CaCl2 and KH2PO4 were from EM Science 
(Gibbstown, NJ). MgSO4 and NaHCO3 were purchased from EMD Millipore (Billerica, MA). 
Gly-Gly and D-(+)-glucose were from Sigma-Aldrich Chemical Co. (St. Louis, MO). 
For tissue culture and characterization, Gey’s balance salt solution (GBSS) (Sigma-
Aldrich) was supplemented with 2.7 mM MgSO4 and 0.5% D-(+)-glucose. The culture medium 
consisted of 50% Opti-MEM, 25  horse serum, 25  Hank’s balanced salt solution (HBSS) with 
phenol red, and 0.45% D-(+)-glucose. Propidium iodide solution was prepared with GBSS at a 
final concentration of 0.35 mM and stored at -20 C. All reagents except those mentioned 
previously were from Life Technologies (Grand Island, NY).  
The running buffer for microfluidic electrophoresis consisted of 40 mM Bis-tris propane 
with 15 mM NaCl at pH 8.5. On-chip thiol derivatizing buffer was 20 mM Tris-HCl at pH 7.5. 
The sampling buffer preloaded in the capillary was composed of 20 mM Tris-HCl and 60 mM 
NaCl at pH 7.5. All buffers were filtered through 0.1 μm polyethersulfone membrane (EMD 
Millipore) and degassed by ultrasonication prior to use. The derivatizing stock solution was 
made by dissolving ThioGlo-1(EMD Millipore) to anhydrous DMSO at a final concentration of 
2.5 mM and stored in freezer. The stock solutions of different thiol/disulfide, CoA (CoA, ~95%) 
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and CSH, DL-Hcy, L-Cys and D-PSSP, CSSC were prepared by dissolving the solids to 
degassed Milli-Q water (EMD Millipore) to final concentrations of 7.1 mM, 272.4 mmol/1 mL 
H2O, 69.1 mM, 49.7 mM, 182.7 mM/1 mL H2O, 138.8 mmol/1 mL H2O respectively. These 
solutions were stored at -20 C in aliquots and diluted serially to desired concentrations before 
use. The pantetheinases inhibitor solution, 8-cyclopentyl-1, 3-dipropylxanthine (DPCPX), was 
prepared with DMSO to a final concentration of 26.3 mM. All these chemicals were from 
Sigma-Aldrich Chemical Co.. 
5.2.2 Preparation of OHSCs  
The preparation of OHSCs is modified from Gogolla’s protocol273 and has been described 
previously. In short, the hippocampal region of 7 days postnatal Sprague-Dawley rat pups was 
dissected out and chopped into 350 μm thick slices by a McIIwain tissue chopper (the Mickle 
Laboratory Engineering Co. Ltd., UK). After cold incubation for 30-90 min, slices with the right 
more morphology were selected and placed onto the Millicell standing inserts (hydrophilic PTFE 
membrane, 0.4 μm, EMD Millipore)  in a 6-well tissue culture plate (Sarstedt Inc., Newton, NC) 
preloaded with culture medium. The OHSCs were incubated in 5% CO2 and 95% air for 5-8 days 
before use. Culture medium was exchanged every 2-3 days. This protocol has been approved by 
the IACUC of the University of Pittsburgh.  
5.2.3 Microfluidic chip design and instrumentation  
The design of the microfluidic chip is illustrated in Fig. 61. It is fabricated using lithography 
techniques as described previously
274
 with a 30 μm mask width for all channels. The etching 
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depth is 20 μm and the channel length (solid line) is drawn to scale. The total length of the 
reaction channel is ~ 46 mm and the distance between the detection point and injection cross is 
23 mm. The electrical connection to all liquid access holes, the derivatization (+HV), the sample 
input (+HV), the auxiliary (ground), the gate (switched between ground and floating through a 
HV relay) and the waste (-HV) are represented by the short dashed lines as shown in Fig. 60. 
Microfluidic reservoirs were bought from IDEX Health & Science LLC (Oak Harbor, WA) and 
adapted to accommodate ~500 μL reagents each. An 11 cm (length) x 50 μm (ID)/360 μm (OD) 
fused silica capillary (long dashed line, Polymicro Technologies, Phoenix, AZ) are connected to 
the microfluidic chip via a NanoPortTM assembly (IDEX Health & Science LLC) with a 
minimized dead volume.  
The detection of ThioGlo-1 derivatized thiol compounds was accomplished by a home-
made laser induced fluorescence (LIF) detector.
274
 Two four-channel high voltage power 
supplies (HVPS), flow gated sample introduction, PMT voltage and signal collection are all 
controlled by a locally written program in LabVIEW 8.2 (National Instruments, Austin, TX). 
During the experiment, The PMT control voltage was set at 0.6 V and the laser power was 
maintained at 3.0 mW. An inverted fluorescent microscope IX 71 (Olympus, Center Valley, PA) 
was used to check and characterize OHSCs.  
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Figure 61. Sketch of the microfluidic device integrated with online electroosmotic sampling 
Channel (solid line) lengths are drawn to scale and all channels are 20 μm in depth. The short dashed line represents 
the electrical connection in each reservoir. Long dashed line labeled with electroosmotic sampling input stands for 
the fused silica sampling capillary 
5.2.4 Online sampling experiments 
At the beginning of the experiment, an OHSC was transferred to a Petri dish with 1.2 mL pre-
warmed and gassed GBSS and then to another Petri dish containing 1.2 mL of ggACSF alone or 
augmented with a substrate, inhibitor or drug compound at a desired concentration. Microfluidic 
chips and sampling capillaries were preconditioned with 1 M NaOH or 0.1 M NaOH, followed 
by deionized water and the experimental buffers for 5 minutes each. The auxiliary reservoir and 
the sampling capillary were preloaded with sampling buffer. The gate and waste reservoirs were 
filled with running buffer. The derivatization reservoir contained 2.7 μM ThioGlo-1 in 
derivatizing buffer. The liquid volume at each reservoir was 300-310 μL. The electroosmotic 
sampling setup and voltage settings were described in another paper.
297
 Briefly, for 
electroosmotic sampling, the end of the sampling capillary was lowered perpendicularly towards 
the OHSC by a Sutter MP-285 micromanipulator (Sutter Instrument Company, Novato, CA) 
until the tip made contact with the thin layer of liquid on the tissue surface in the CA3 region and 
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then was lifted up 20 μm while remaining in contact with the tissue through the thin layer of 
liquid. There was a pre-sampling step prior to each experiment. In this step, +3000 V and “GND” 
were applied to Petri dish and auxiliary reservoir, respectively for 6 min. All other reservoirs 
were set at “floating”. After this step, +300 V and -4500 V were applied to derivatization and 
waste reservoirs, respectively. The gate reservoir was switched between sample loading (floating, 
0.5 sec) and separation modes (GND, 24.5 sec) alternately using a high voltage relay. Electrical 
settings at the auxiliary reservoir and the Petri dish were kept unchanged from the pre-sampling 
step. Extracellular fluid collected by the electroosmotic sampling in the CA3 region of the 
hippocampal slice was analyzed online with the microfluidic chip with the confocal LIF detector 
through continuous gated injections. There were about 30-40 repeated injections per run. 
Experiments were carried out at room temperature.  
5.3 RESULTS AND DISCUSSIOIN 
5.3.1 Calibration and quantitation 
In the process of electroosmotic sampling of the extracellular space of an OHSC with a natural 
enzyme substrate, the substrate will be metabolized. The conditions used for electroosmotic 
sampling are always the same, thus the residence time of a particular substrate in the tissue is 
constant. As the fluid flow is governed by the electric field in the tissue (and in the sampling 
capillary), the velocity of the sampling buffer/extracellular fluid is not constant. Because the 
electric field in the tissue is proportional to the current density and the current density decreases 
away from the opening of the sampling capillary, the fluid velocity is highest near the sampling 
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capillary (Fig. 62). As a result of this, substrate conversion to product will be highest far from the 
sampling capillary. We estimate that the residence time of the substrates, tS, is approximately 55 
s (see Appendix C for detailed derivatization).   
 
Figure 62. Simulated electric field and current density in both OHSC and sampling capillary during online 
perfusion experiment. 
Parameters are based on the laboratory conditions described in the Experimental Section. Simulation is carried 
out for the entire region, but only a portion of the capillary, tissue, membrane and perfusate is shown in the 
plot for clarity purposes. The red arrows indicate the direction and magnitude of the current density (arrow 
length is logarithmically proportional to the magnitude of the current density) and the color in the background 
represents the magnitude of electric field, which is much higher inside the sampling capillary than that in 
OHSCs. Due to the stronger electric field near the capillary lumen, the magnitude of the velocity in that region 
is highest in the tissue below the sampling capillary. 
 
As described in our previous work
274, 297
 solutes from the tissue arrive at the chip after a 
short delay time. Peak heights increase over a short time and reach a steady state. Plots of peak 
height vs. time describe a symmetrical sigmoidal curve. We use the steady state peak heights for 
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measurements with one exception. PSH has calculated logP values of of -0.92 ± 0.72 (Advanced 
Chemistry Development, ACD/Labs 12.0) and -0.10 (ALOGPS 2.1,
299
 
http://146.107.217.178/lab/alogps/index.html). Thus it can pass across the cell membrane 
through passive diffusion and the volume accessible to PSH is greater than the volume accessible 
to charged solutes. The peak height of PSH changes more slowly over time as it reaches a steady 
state in comparison to, e.g. CSH (Fig. 63). In fact, because the time for a single measurement is 
restricted to about fifteen minutes, in some cases a clear steady state is not reached. In these 
latter cases, we use the slope (dH/dt) at the inflection point of the sigmoidal curve as the 
measurement as this slope is directly proportional to the plateau height, H (see Appendix D for 
equation derivation). 
 
Figure 63. Progress curves for CSH and PSH based on peak heights and migration times 
Petri dish contains 21.8 μM CoA in ggACSF buffer. Other conditions are same as the online sampling of the CA3 
region in OHSCs. 
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Many of our inferences are based on quantitative determinations of CSH in the sampling 
fluid. We have determined earlier
297
 that the basal concentration of cysteamine in OHSCs is 10.6 
± 1.0 nM. Errors for the derived parameters from fittings are the standard error of the mean 
(SEM), and data points in the plots are shown as mean ± standard deviation (SD). The calibration 
procedure is to introduce CSH into the sampling buffer at various concentrations and establish a 
linear relationship between the signal and the concentration of analyte added in the sampling 
buffer. It is important to note that this process provides a measurement that is not sensitive to the 
presence of biochemical processes that remove CSH from the extracellular space as long as the 
rates of the processes are constant and first order in CSH (see Appendix E for equation 
derivation). Thus, even though the analyte CSH may also be a substrate in one or more enzyme 
reactions or transport processes, the calibration will be accurate. If the processes removing CSH 
are significant and non-first order, the calibration graph would not be linear. CSH calibrations 
are linear in the examined concentration range (see Appendix F for a summary of calibration 
curves). 
Other inferences are based on measurements of changes in PSH concentrations. PSH is 
neutral under our experimental conditions. Neutral thiols can in principle be determined by our 
measurement approach. However, because the separation is based on electrophoresis, neutral 
molecules are not separated from each other. As a result, a peak in the electropherogram can only 
be used for relative quantitation of a neutral compound when it can be certain that under the 
specific conditions used the change in the peak height of the neutral peak correlates with changes 
in the concentration of the sought for species. We have three observations that allow us to use the 
change in the height of the neutral peak to infer changes in pantetheine. Details are discussed 
below, but a statement of the observations here will support our use of changes in the neutral 
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peak height to infer changes in pantetheine concentration in the following discussion. (I) 
Perfusion with the disulfide pantethine leads to an increase in the neutral peak height that is 
linearly related to the pantethine concentration in the perfusate. This is consistent with the 
expectation that pantethine engages in disulfide exchange reactions. (II) Perfusion with CoA 
leads to an increase in the neutral peak height. Other thiol products in the proposed catabolic 
pathway (Fig. 60) are charged, thus they cannot augment the neutral peak height. (III) 
Coperfusion of CoA and the pantetheinase inhibitor 8-cyclopentyl-1, 3-dipropylxanthine 
(DPCPX) leads to an increase in the neutral peak height with a corresponding decrease in the CSH 
peak height (Fig. 64). These observations permit us to use changes in the neutral peak height to 
infer changes in pantetheine. 
 
Figure 64. Inhibition of the pantetheinase by 8-cyclopentyl-1, 3-dipropylxanthine (DPCPX) 
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Petri dish contains 115.6 μM CoA with or without DPCPX 107.3 μM in ggACSF buffer. Other conditions are same 
as the online sampling of the CA3 in OHSCs. (a) Representative electropherograms obtained with and without 
inhibitor in the sampling buffer; (b) The peak height, H, (for CSH) and the peak height growth rate, dH/dt, around 
the inflection point of the sigmoid curve (for PSH) obtained with or without inhibitor are normalized for 
comparison. Data is shown as mean ± SEM (n ≥ 16). Two sample t-test of CSH peak height and ANCOVA analysis 
of the pantetheine peak growth rate indicate there are significant differences between results obtained with and 
without DPCPX treatment at p = 0.04%. 
 
5.3.2 CSSC is converted more rapidly than PSSP to CSH 
Many bioactive functions of the disulfides cystamine and pantethine rely on their conversion to 
cysteamine through disulfide exchange with endogenous thiols and an additional metabolic step 
for pantethine with the help of pantetheinase as shown in Fig. 3.
285, 289
 
 
Figure 65. The formation of CSH from CSSC and PSSP through disulfide exchange and catalysis by 
pantetheinase. 
RSSC and RSSP are mixed typed of disulfide aminothiols with CSH and PSH respectively. 
 
CSH was determined in perfusate containing CSSC or PSSP. Fig. 66 demonstrates the 
electropherograms from all of the injections in a single measurement. ThioGlo-1, which is 
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neutral and weakly fluorescent, has a small peak with a migration time 9.4 s (Fig. 66 (a)). 
Because the source of the reagent is on the chip, it appears in the 5
th
 injection, which is earlier 
than the arrival time of thiols coming from the tissue. Peaks from the latter compounds were not 
detected until the 16
th
 injection. This is attributed to the time spent in the sampling capillary. 
Although the maleimide reagent (ThioGlo-1) is intended to react with thiols, it also reacts with 
amines at a much lower rate.
280
 Due to the relatively high concentration of Gly-Gly in ggACSF, 
we also observed the derivatized Gly-Gly peak in the electropherogram most easily seen in Fig. 
66 (c) and Fig. 66 (d) with a migration time near 21 s. Fig. 66 (a) and Fig. 66 (b) show that 
cystamine is converted to cysteamine, while Fig. 66 (c) and Fig. 66 (d) show that PSSP is 
converted to PSH (increase in the neutral peak). Fig. 67 (a) shows that the dependence of 
measured CSH concentration on that of the initial CSSC concentration (Δ[CSH]/[CSSC]0) in the 
extracellular space is high (91% ± 4% with the assumption that one cysteamine is formed from a 
disulfide exchange reaction with cysteamine) and linearly related to the concentration of CSSC 
in the perfusate over the range investigated up to ~700 µM (high concentration data not shown). 
The in situ measurement on intact tissue result reflects a biochemically relevant result for 
extracellular conversion. To determine the effect of added PSSP on PSH concentration, we use 
the peak height growth rate around the inflection point of the sigmoid progress curve, dH/dt 
which is directly proportional to Δ[PSH] (see Appendix D). Linear regression of dH/dt vs. the 
added concentration of PSSP yields Fig. 67 (b). We find that the production of PSH is linearly 
related to the concentration of PSSP introduced. This is consistent with an uncatalyzed disulfide 
exchange reaction being responsible for the conversion.  
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Figure 66. Series of electropherograms obtained from online sampling in the CA3 region of OHSCs 
 The initial CSSC or PSSP concentrations in the ggACSF that OHSCs imbibe are (a) CSSC: 3.578 μM; (b) CSSC: 
12.20 μM; (c) PSSP: 1.059 mM; (d) PSSP: 8.005 mM.  
 
In Fig. 67 (c), the concentration of CSH is plotted against the initial concentration of 
PSSP. The relationship is nonlinear implying the presence of an enzyme-catalyzed step. The 
dependence of measured CSH concentration on that of the initial PSSP concentration 
(Δ[CSH]/[PSSP]0) in the extracellular space is very low, from 0.03% to 0.01% when the 
concentration of PSSP varies from 1.1 mM to 8.0 mM. Pantetheinase, the ectoenzyme that 
creates CSH from PSH, is inhibited by disulfides. An uncompetitive inhibition of pantetheinase 
by PSSP at pH 8.0 has been observed and the inhibition effect is increased as the incubation time 
of the pantetheinase and PSSP is prolonged.
300
 Therefore the rate equation based on the 
production of CSH can be written as follows where KM,C, Vmax,C, and Ki,C are the Michaelis 
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constant, maximum reaction rate, and the inhibitor constant of pantetheinase with PSH as the 
substrate and PSSP as the uncompetitive inhibitor, respectively.
250
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 (30) 
The factor  is the fraction of initial PSSP, [PSSP]0, that is converted with 1:1 
stoichiometry to PSH. [PSH] and [PSSP] are the concentrations of PSH and PSSP in the 
sampling fluid. The results of a nonlinear fitting of Eq. 29 to Δ[CSH] as a function of [PSSP]0 
indicates that the last term of the denominator, [PSSP]0
2
(1-α)/Ki,C, is negligible compared to 
other two terms. By omitting this term, Eq. 29 is reduced to Eq. 30. A nonlinear fittting of Eq. 30 
is plotted in Fig. 67 (c), which gives KM,C/α = 4.4 ± 1.1 mM and Vmax,C = 29 ± 3 nM/s. Reported 
KM,C values for pantetheinase in in vitro assays using pantetheine or its analogs as substrate are 
in the range of ~20 µM.
301-303
 Based on that, we can estimate that the percentage yield, α, for 
pantethine to pantetheine to be approximately 0.5%, which is much lower than that of CSSC to 
CSH. 
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Figure 67. The conversion of drug compounds in the CA3 region of OHSCs during electroosmotic sampling 
(a) The conversion of CSSC to CSH; (b) PSSP to PSH, and (c) PSSP to CSH at different drug concentrations are 
given in plots. Error bar indicates ± standard deviation (n ≥ 4). Black dot indicates experimental data. Linear fitting 
or non-linear Michaelis-Menten fitting in red was performed based on the experimental data.  
 
CSH is the active molecule in the treatment of cystinosis, however CSH is cytotoxic at 
high concentration; the LC50 of cysteamine to the human leukemia cell line B4D is 52 µM.
288, 
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304
 CSH precursors CSSC and PSSP have also been used as drugs against cystinosis.
285, 286, 305
 
Differences in the conversion rates of the two precursors to CSH in the OHSCs may well explain 
their distinct clinical profiles. The generation rate of CSH from precursors CSSC or PSSP will 
determine the concentration of active substance. PSSP is as effective as PSH in lowering cystine 
levels in cystinosis,
285
 however, PSSP is less effective.
305
 This is consistent with our observation 
that the production rate of CSH from PSSP is significantly lower than the production rate from 
CSSC. Side effects and toxicity are common in the treatment with CSH or CSSC.
285-287
 To the 
contrary, PSSP has no or limited side effects even at high doses.
305, 306
 The same rationale 
mentioned above can be used to explain this difference. Moreover, other beneficial effects of 
PSSP, such as its anti-catabolic effect and the acceleration of fatty acid oxidation, are related to 
its promotion of CoA concentration due to the biological conversion of PSSP to PSH, and the 
following metabolism of PSH to 4’-phospho-PSH and finally to CoA, which bypasses the first 
three steps in the CoA biosynthesis.
286, 307
  
5.3.3 Enzymatic degradation of CoA: CSH  
Endogenous CSH, Hcy and Cys in the extracellular space of the OHSCs can be observed under 
the conditions used (Fig. 68 (a)). To monitor the metabolism of CoA in OHSCs, different 
concentrations of CoA were added to the ggACSF in Petri dish containing OHSCs. Fig. 68 
shows the reconstructed plots of PMT reading vs. time for all injections in two experiments. 
Endogenous CSH, Hcy and Cys in the extracellular space of OHSCs were observed when only 
ggACSF was in the Petri dish (Fig. 68 (a)). ThioGlo-1 together with an unknown in the reagent 
solution appears earlier than all other peaks in the 5
th
 injection as expected from the design of the 
microfluidic chip. Endogenous CSH peaks from OHSCs, followed by Hcy and Cys, were not 
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detected until the 17
th
 injection, which is attributed to the sample’s traveling time spent in the 
transporting capillary tube. As expected from the proposed pathway of CoA degradation, an 
increase in the CSH peak height was observed when ggACSF was spiked with 0.12 mM CoA as 
shown in Fig. 68 (b). CSH was first detected in the 16
th
 injection and its height reached 
maximum in the 20
th
 electropherogram and quickly formed a plateau thereafter. The abnormal 
heights for the first several CSH peaks are probably from the cation-specific preconcentration at 
the interface of different buffer zones along the flow path. To better elucidate the dependence of 
the plateau peak heights of CSH on the concentrations of CoA in ggACSF, four representative 
electropherograms from online electroosmotic sampling experiments under the same conditions 
except for the CoA concentration in ggACSF are shown in Fig. 69. There is a remarkable 
increase in the plateau peak height of CSH when CoA concentration in the ggACSF is elevated 
from 0 to 58 μM. As the plateau peak height is directly proportional to the concentration of CSH 
produced from the CoA metabolism, we use it in determining the effect of CoA concentration on 
the CSH production rate. Thus by measuring the CSH concentration as a function of CoA 
concentration, we should observe a nonlinear dependence. The plateau concentration, Δ[CSH] 
was obtained from the calibration curve based on the plateau peak height of the analyte. Δ[CSH] 
is plotted against the initial [CoA]0 concentration in Fig. 70 (a). 
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Figure 68. Electropherograms obtained from online electroosmotic sampling of the CA3 region in OHSCs 
Initial CoA concentrations in the ggACSF that OHSCs imbibe are (a) 0 mM; (b) 0.12 mM. Peaks marked with ‘*’ 
are impurity in the dye.  
 
Figure 69. Representative electropherograms from online electroosmotic sampling of the CA3 region in OHSCs 
All conditions are the same except the CoA concentrations in the ggACSF (a) 0 μM; (b) 7.3 μM; (c) 22 μM; (d) 58 
μM. Neutral peak is contributed from ThioGlo-1 and pantetheine.  
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As discussed above, it is appropriate to assume that CSH is the last product of a multi-
enzyme reaction with CoA as the initial substance. Therefore, the overall initial reaction rate of a 
multi-enzyme reaction such as one of the paths shown in Fig. 60 can be obtained by noting the 
change in cysteamine concentration over the residence time of the substrate in the tissue, ts. 
According to Michaelis-Menten kinetics, the overall reaction rate of the system d[CSH]/dt is 
given by
250
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 (32) 
where Δ[CSH] is the measured CSH concentration; [CoA]0 represents the initial CoA 
concentration in the perfusate, K’M and V’max and are the apparent Michaelis constant and 
apparent maximum reaction rate for the multi-enzyme reaction with CoA as the substrate, 
respectively. A nonlinear fit of Eq. 32 to the data shown in Fig. 70 (a) gave K’M = 16 ± 4 μM and 
V’max = 7.1 ± 0.5 nM/s, respectively. 
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Figure 70. Michaelis-Menten fittings based on CSH and PSH 
 (a) Δ[CSH] vs. [CoA]0 (b) dH/dt vs. [CoA]0, were obtained by online sampling of the CA3 region in OHSCs. Error 
bar indicates ± standard deviation (n ≥ 7). Black dot indicates experimental data and red curves are the fitting result. 
5.3.4 Enzymatic degradation of CoA: PSH  
PSH is an intermediate molecule in the metabolic pathway of CoA (Fig. 60) and is expected to 
show up as a neutral molecule on the electropherogram. When CoA is added in sampling buffer, 
the height of the neutral peak stops decreasing around the 19
th
 injection and starts to increase in 
Fig. 68 (b), which suggests that PSH elutes together with the unreacted ThioGlo-1 as expected. If 
the measured PSH signal is used to estimate the multi-enzyme reaction rate, a relationship 
analogous to Eq. 32 can be established. This relationship, Eq. 33, has the same form as the 
Michaelis-Menten equation, where K’M,p and V’max,p are the apparent Michaelis constant and the 
apparent maximum reaction rate based on the production of pantetheine. As discussed above, 
peak height growth rate, dH/dt, is directly proportional to Δ[PSH]. 
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 (33) 
Here q is a constant that connects the steady state concentration of PSH with the PSH 
peak height growth rate. Fig. 70 (b) shows dH/dt for PSH plotted against [CoA]0 with a nonlinear 
fitting of Eq. 33. From the fit, we find that K’M,p is 18 ± 6 μM. K’M,p is statistically 
indistinguishable from the K’M obtained above based on CSH concentration. The fact that this 
constant is the same for the ultimate product formation rate, Δ[CSH]/tS and the penultimate 
product formation rate, Δ[PSH]/tS, suggests that the final enzyme, pantetheinase, is not limiting 
and is operating in the first-order regime.  
The electroosmotic perfusion technique used here is capable of collecting extracellular 
fluid under conditions that only cause minimal damage to the tissue.
105, 297
 The damage of tissue 
is mainly located in the region near the capillary lumen, where the fluid velocity in tissue is the 
highest and the substrate conversion to product is minimal. Therefore the damaged tissue will 
exert negligible effect on the total enzyme reaction. In addition, CoA and its metabolite 4’-
phosphopantetheine are negatively charged. These molecules and their derivatives do not cross 
the cell membrane found in E. coli, rat liver and neuronal cells.
307-309
 Together with these facts, 
our results directly show that CoA can be completely degraded to CSH in the extracellular space. 
The proposed CoA metabolic routes I, II and III (Fig. 60) involve lysosomal acid phosphatase 
which is in lysosomes and nucleotide diphosphatase and pantetheinase which are ectoenzymes 
on the plasma membrane and nudix hydrolase which is in peroxisomes.
65, 68, 88
 Assuming that the 
in vivo degradation of CoA is carried out through one of these routes, there would be extensive 
trafficking of CoA and its metabolites between lysosomes or peroxisomes and outer surface of 
the plasma membrane. Due to the transport obstacles for intermediate metabolites to access these 
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enzymes in sequential reactions, it is quite difficult to envision these pathways in practice and to 
explain the efficient degradation of CoA found in rat liver.
68
 Our results demonstrate that 
extracellular CoA is very likely to be degraded in a pathway similar to route I or III, but with all 
the dephosphorylation process taking place in the extracellular space. It is also possible that 
dephospho-CoA in lysosomes produced by lysosomal acid phosphatase is released to the 
extracellular space through lysosomal exocytosis
310, 311
 and is then metabolized outside the cells 
similar to route II. The nucleotide diphosphatase involved in this process prefers dephospho-CoA 
as a substrate over CoA.
68, 312
  
5.4 CONCLUSIONS 
We have demonstrated here the successful integration of electroosmotic perfusion with online 
microfluidic analysis to study the metabolism of two drug compounds and CoA when these 
analytes passed through the extracellular space of OHSCs. The much higher percentage yields of 
cysteamine from cystamine than that from pantethine are directly correlated with the differences 
of these drug compounds in their effectiveness and toxicity observed clinically. The detection of 
cysteamine and pantetheine while perfusing CoA directly demonstrate the complete degradation 
of CoA to cysteamine in the extracellular space of OHSCs. Unlike other proposed pathways for 
CoA degradation, the route proposed here is easier to visualize in vivo as it does not involve 
extensive trafficking of CoA and related metabolites. The products of CoA biodegradation in the 
extracellular space, namely pantetheine, pantothenic acid and cysteamine can each be retaken by 
cells and reenter the CoA biosynthesis pathway or other metabolic pathways. The kinetic 
parameters of the overall sequential multi-enzyme reaction of CoA biodegradation obtained by 
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measuring the cysteamine formation rates in the OSHCs at different CoA concentrations are 
useful for evaluating the taurine flux through cysteamine pathway and for understanding and 
solving the challenges remaining in the mechanism, regulation and turnover rate of CoA 
degradation.  
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APPENDIX A 
EQUIVALENT CIRCUIT OF THE MICROFLUIDIC CHIP 
 
Figure A-1. Equivalent circuit of the microfluidic chip 
 
  ,   ,   ,   ,   ,   , are equivalent resistances of the derivatizing, the sample, the reaction, 
the separation, the waste and the final mixing channels, respectively. 
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(A-1) 
ρ is the resistivity, l is the length, A is area of the cross section, i represents the equivalent 
resistor number; 
 : is the voltage applied on the whole system; 
Therefore the electric field    on resistor i is 
 
   
   
  
 (A-2) 
where     : Voltage drop on resistor i; 
According to the equivalent circuit, the total resistance can be expressed by 
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When reservoir 2 is floating, 
Case 1: solution concentration is same everywhere in the microfluidic chip 
We have 
                   (A-4) 
                   (A-5) 
       (A-6) 
According to Eq. A-1 to 6 
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Therefore, divide Eq. 7 by Eq. 8 will give  
  
  
 
  
  
    
Or           (A-9) 
According to  
    
  
 
   (A-10) 
We have    
         (A-11) 
Case 2: reservoir 5 is replaced with high conductivity solution  
After the solutions achieve steady state in each channel, we have 
                  (A-11) 
                    (A-12) 
                  (A-13) 
      (A-14) 
According to Eq. A-1 to 3 and Eq. A-12 to 14 
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(A-16) 
Similarly, divide Eq. A-15 by Eq. 16 will give  
  
  
 
  
  
 
  
    
     
   
  
  
 (A-17) 
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According to Eq. A-12, we will have  
  
  
 
  
  
    
Or          (A-18) 
Therefore, according to Eq. A-10 (to simplified the estimation, we assume that -potential is the 
same for all channels) 
         (A-19) 
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APPENDIX B 
STANDARD ADDITION METHOD  
Standard addition method was applied to calculate the basal concentration of CSH, Hcy and Cys. 
Some main parameters used in the establishment of the calibration curve are listed in Table B-1. 
The standard curves for CSH, Hcy and CSH used in the standard addition method are given in 
Fig. B-1. 
Table B-1. Parameters and results for the standard addition method 
 CSH Hcy Cys 
LOD (S/N=3) 5.4 nM 25 nM 1.4 μM 
Linear range 0 - 99.2 nM 0 - 2.43 µM 0 - 98.4 µM 
# of concentrations measured 
(equals to # of slices used* ) 
5 
3 repeats at 0 nM 
6 
3 repeats at 0 µM 
8 
3 repeats at 0 µM 
# of points used in fitting 70 53 70 
Calculated basal concentration 10.6 ± 1.0 nM 0.18 ± 0.01 μM 11.1 ± 1.2 μM 
Slope 2.56 × 10
1
 8.74 1.17 × 10
-1
 
Slope SD 0.05 × 10
1
 0.13 0.03 × 10
-1
 
Intercept 2.72 × 10
-4
 1.54 × 10
-3
 1.31 × 10
-3
 
Intercept SD 0.25 × 10
-4
 0.12 × 10
-3
 0.14 × 10
-3
 
Adjusted R
2
 0.97 0.99 0.94 
               *Any single slice is only used at a particular concentration once 
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Figure B-1. Calibration curves used in the standard addition method for CSH, Hcy and Cys 
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APPENDIX C 
ESTIMATIION OF THE SAMPLED TISSUE VOLUME AND THE AVERAGE TIME 
THE ANALYTE SPENDS INSIDE OHSCS 
 
Figure C-1. Estimation the tissue volume being sampled 
 
Assuming that the shape of the sampled tissue is a frustum of a cone with the top diameter equal 
to that of a sampling capillary, 50 μm, and the bottom diameter is 1 mm (estimated from the 
tissue geometry). Fig. C-1 is a side view of the cross section of the sampled region in OHSCs. 
For illustration purpose, the shape is not drawn to scale. The thickness of the OSHC is L. Let’s 
consider an element of the tissue slice with a thickness of dl. The volume of that element slice 
dV is a function of l (l is the distance between the element slice and the bottom of the tissue). 
According to the law of mass conservation, the sample flow rates F (m
3
/s) at each any element 
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slice are the same. Therefore the time the analyte will be retained in the element tissue slice (or 
undergo enzyme catalyzed reaction) is given by  
 𝑡  
 
 
   (C-1) 
Therefore the total reaction time tS (analyte will be exposed to the enzyme)  
𝑡  ∫
 
 
   
   
   
      
 
 
    
 
 (C-2) 
Where VOHSC is the volume of the sampled tissue and Φ is the porosity of the brain tissue. 
According to the given parameters, VOHSC = 4.7×10
-11
 m
3
. Assuming that the brain tissue has a 
porosity of 0.4,
313
 the effective volume of the sampled tissue would be Veff = 19 nL. The average 
time required for PSH to arrive at the injection cross is 972 s and the total migration length for 
PSH is 170 mm. Therefore, the average linear velocity for PSH is 0.175 mm/s and the volume 
velocity in a 50 µm ID capillary would be 0.34 nL/s. Combining volume velocity with the 
effective volume of sampled tissue will give tS to be 55 s.  
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APPENDIX D 
RELATIONSHIP BETWEEN THE CORRECTED PANTETHEINE PEAK HEIGHT 
GROWTH RATE AND THE BULK CONCENTRATION 
In our experiment, products of the enzyme reaction in OHSCs is collected by electroosmotic 
sampling and transported to the microfluidic channel by the sampling capillary. Sample stream 
with a spreading front will result in a sigmoid progress curve when the peak heights of an analyte 
from consecutive electropherograms in a single experiment are plotted against the time point of 
sample injection. There are many reasons that may result in a broadened frontal edge, such as the 
mass transfer in the enzyme reaction inside OHSCs, convective diffusion of analyte during the 
transport of sample in tissue, capillary and microfluidic channels due to non-uniform ζ-potential 
along the channel.
255, 314, 315
 For simplicity, all these effects are represented by an apparent axial 
diffusion coefficient, Dapp. And the sigmoid curve can be mathematically expressed by the 
apparent axial diffusion of analyte from a continuous source at a velocity, vapp, along the flow 
path. The concentration profile C(x, t) at any point on the flow path in the channel at time t is 
given by
117
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      𝑡
 √    𝑡
 (D-1) 
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Here x represents the distance between point and initial position of the frontal surface of 
the continuous source at t = 0, assuming there is no initial axial diffusion. C0 is the bulk 
concentration of an analyte in the continuous source.  
At any given location x = xp, for example the injection cross, P, let    
  
       𝑡
 √    𝑡
 (D-2) 
The first derivative of concentration profile (D-1) with t as the independent variable can be 
written as follows: 
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 (D-3) 
So that  
      𝑡  
  
 √     
   
 
[  𝑡
         𝑡
    ] (D-4) 
C’(xp, t) is a bell shaped curve with a maximum at t = tm. tm is the location of the inflexion point 
on the sigmoid curve C(xp, t). According to D-4, 
  (   𝑡 )      and                    (D-5) 
For a specific analyte under same experimental conditions, k is a constant with a unit of 
1/s. Meanwhile, it is obvious that the observed analyte peak height (H) directly proportional to 
concentration of analyte in the injected sample. Therefore, by introducing another coefficient g, 
which converts the concentration to voltage signal of PMT, and combining it with D-5, we have   
  
  
    (   𝑡 )              (D-6) 
where q is a coefficient contributed from both g and k.  
Meanwhile, if we expand the function C(xp, t) at t = tm as N
th
 degree Taylor polynomials 
will give 
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Then truncate D-7 at 2
nd
 order, we have  
 (   𝑡)   (   𝑡 )   
 (   𝑡 ) 𝑡  𝑡   
   (   𝑡 )
  
 𝑡  𝑡  
  (D-8) 
At t = tm, we have 
   (   𝑡 )    (D-9) 
Therefore 
 (   𝑡)   (   𝑡 )   
 (   𝑡 ) 𝑡  𝑡   (D-10) 
When t is approaching tm, C(xp, t) is a linear function of t, which explains the linear characteristic 
around the inflexion point of the sigmoid curve C(xp, t). 
It is obvious that the plateau peak height, H, is also directly proportional to C0. Based on 
the above mathematical deduction, there should be a linear correlation between H and dH/dt. To 
prove that, in the following experiment, PSSP was added into the sampling buffer ggACSF in the 
Petri dish with concentration ranging from 0 mM to 8.0 mM. The peak height of PSH is obtained 
by subtracting the contribution from ThioGlo-1 based on the ThioGlo-1 peaks observed before 
PSH is observed on the electropherogram. Other conditions are the same as that of online 
sampling experiments described in experimental section. In Fig. D-1 (a), the plateau peak height 
of PSH is plotted against the peak # with the initial concentrations of PSSP in the sampling 
buffer varying from 0 to 8.0 mM; in Fig. D-1 (b) plateau peak height, H, is plotted as a function 
of dH/dt. Linear fitting proves the linear relationship between H and dH/dt.   
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Figure D-1. Plot of plateau peak height, H, as a function of peak height growth rate, dH/dt 
(a) Plateau peak height of PSH is plotted vs. the peak #; (b) plateau peak height, H, is plotted as a function of dH/dt 
around the inflection point of the sigmoid progress curve. Data is shown as mean ± SD (n ≥ 4). 
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APPENDIX E 
QUANTITATIVE EXPLANATION OF CYSTEAMINE BEING TREATED AS THE 
FINAL PRODUCT 
According to Michaelis–Menten kinetics 
  
              
            
 (E-1) 
Where KM,ADO and Vmax,ADO, are Michaelis constant and maximum reaction rate of 
cysteamine dioxygenase (ADO, EC 1.13.11.19) with cysteamine as the substrate, respectively, 
[CSH]0 is the initial cysteamine concentration and k is the initial reaction rate. The reported Km 
of ADO at pH 8.0 with cysteamine as the substrate is around 3.8 mM,
70
 while the highest 
concentration of cysteamine generated in experiments of CoA or pantethine metabolism is 
around 1 µM. Because [CSH]0 << KM,ADO, E-1 can be reduced to  
  
        
     
               (E-2) 
Where c=Vmax, ADO/KM,ADO. In the absence of ADO, the measured plateau peak height, H, 
is the function of the concentration of cysteamine as follows 
            (E-3) 
where a and b are slope and intercept of the calibration curve, respectively. 
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Adding the effect of ADO, the relationship between peak height and the concentration of 
cysteamine becomes 
           𝑡                 𝑡           (E-4) 
Where tS is the average reaction time that the substrate spends interacting with the 
OHSCs during electroosmotic perfusion. It is clearly that peak height is still directly proportional 
to [CSH]0 but with a modified slope in comparison to E-4. Therefore, if the calibration curve is 
established using the same conditions as that for the actually measurement (e.g. both are affected 
by the ADO), the analyte concentration read from the calibration curve reflects the value before a 
small portion of this compound is oxidized by ADO.  
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APPENDIX F 
CALIBRATION CURVES USED IN THE METABOLISM OF COA AND TWO DRUG 
COMPOUNDS 
                
 
Figure F-1. Calibration curves CSH, Hcy and Cys 
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Table F-1. Linear fitting results for the calibration curves of CSH, Hcy and Cys 
 CSH (low conc.) CSH (high conc.) Hcy Cys 
Slope (V/mV) 2.52×10
1
 2.98×10
-2
 7.29 1.26×10
-1
 
Slope SD (V/mV) 0.09×10
1
 0.18×10
-2
 0.36 0.08×10
-1
 
Intercept (V) 1.66×10
-4
 2.52×10
-2
 2.50×10
-3
 7.39×10
-4
 
Intercept SD (V) 3.06×10
-4
 1.79×10
-2
 1.10×10
-3
 5.78×10
-4
 
Adjusted R
2
 0.99 0.98 0.99 0.98 
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APPENDIX G 
ABBREVIATION LIST 
ACSF artificial cerebrospinal fluid GSH reduced glutathione 
ADO cysteamine dioxygenase GSSG oxidized glutathione 
APD avalanched photodiode γGT γ-glutamyl transpeptidase 
ATP adenosine triphosphate Hcy homocysteine 
BR/RR/SR/WR   buffer/reagent/sample/waste reservoir LIF laser induced fluorescence 
CDO cysteine dioxygenase LOC Lab on chip 
CE capillary electrophoresis NADPH β-nicotinamide adenine dinucleotide  
CoA coenzyme A  phosphate, reduced form 
CSH cysteamine NMDA N-methyl-D-aspartate 
CSSC cystamine OHSCs organotypic hippocampal slice  
Cys cysteine  cultures 
CysGly cysteinylglycine PD photodiode 
1, 6-DAH 1, 6-diaminhexane PMT Photomultiplier tube 
DPCPX 8-cyclopentyl-1, 3-dipropylxanthine PSH pantetheine 
ggACSF gly-gly modified ACSF PSSP pantethine 
Gly glycine QE quantum efficiencies 
Gly-Gly glycylglycine ROS reactive oxygen species 
γGluCys γ-glutamylycysteine RSSC/RSSP mixed disulfide with CSH/ PSH 
GND ground SD standard deviation 
GPx glutathione peroxidase SEM standard error of the mean 
GR glutathione reductase µTAS miniaturized total analysis systems 
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